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Abstract 
Serious mental illness (SMI) affects 5% of the United States population and is associated 
with increased morbidity and mortality. Use of high-cost healthcare services is common, 
including hospitalizations and emergency department (ED) visits. Integrating behavioral 
and physical healthcare may improve care for consumers with SMI, but prior research 
findings have been mixed. This quantitative retrospective cohort study addressed the 
impact of integrated care on physical health and ambulatory care sensitive (ACS) 
utilization via a program evaluation of an integrated health clinic (IHC) at a community 
mental health center (CMHC). The research questions assessed whether there was a 
predictive relationship between IHC enrollment and physical health and ACS-specific 
service utilization for consumers with SMI when controlling for demographic 
characteristics and disease severity. Secondary administrative healthcare data, including 
authorization and electronic medical record data, were provided by the CMHC. Logistic 
regressions assessed the odds of experiencing an inpatient admission or ED visit before 
or after IHC enrollment; the predictive relationship between IHC enrollment and service 
utilization was assessed using multiple linear and Poisson regression analyses. There was 
no statistically significant impact of integrated care clinic enrollment on physical health 
or ACS-specific utilization. The sample had lower levels of physical health utilization 
than would have been expected. In terms of positive social change, results may help the 
CMHC assess the IHC program, overall clinic success, and use of data. Since policy and 
payment structures continue to support integrated care models, further research on 
different programs are encouraged, as each setting and practice pattern is unique.  
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Chapter 1: Introduction to the Study 
Introduction 
The problem I addressed in this quantitative retrospective cohort study was the 
lack of evidence on the impact of collocated integrated physical healthcare within the 
community behavioral health setting on healthcare utilization for physical health 
conditions among consumers with serious mental illness (SMI). This study was a 
program evaluation of an integrated health clinic (IHC) collocated within a large 
community mental health center (CMHC). The main outcome variables of interest were 
inpatient and emergency department (ED) utilization pre- and post-IHC enrollment. 
Recent changes in the payer landscape indicated a move toward quality-based 
reimbursement rather than quantity-based reimbursement. Therefore, an understanding of 
the effectiveness of integrated care programs and their ability to reduce cost of care and 
improvement of quality will be important (Burwell, 2015). From a practical perspective, 
results from this study may help leaders at the CMHC assess the success of the IHC 
program and identify potential changes to optimize outcomes. As integrated care models 
become more common, assessments of various care models will improve the level of 
evidence available to inform optimal care for this population.  
In this chapter, I provide a background and overview of the study, including the 
scope of the problem to be addressed, gaps in the current literature, and need for this 
study. The study design, research questions, hypotheses, and variables are then 
introduced. The theoretical underpinning of the study, the chronic care model (CCM), 
will be discussed briefly, highlighting its relevance to the current study. Important terms 
  
 
2 
will be defined and the study assumptions, delimitations, and limitations will be outlined. 
Lastly, the significance of the study will be explained. 
Background 
SMI affects almost 5% of the United States population (Substance Abuse and 
Mental Health Services Administration [SAMHSA], 2013). Consumers with SMI die 15-
20 years earlier than people without SMI (Thornicroft, 2011). This population also has 
higher rates of comorbid physical illness, including cardiovascular disease and diabetes, 
due in part to lifestyle factors, medication side effects, and suboptimal physical 
healthcare (De Hert et al., 2011; Mitchell & Lawrence, 2011; Thornicroft, 2011). Use of 
high-cost healthcare services is also common among consumers with SMI, including 
inpatient hospitalizations with long stays and ED visits (Heslin & Weiss, 2015). Multiple 
chronic comorbidities have been associated with high spending among Medicaid and 
Medicare dual-eligible consumers with mental health disorders (Frank & Epstein, 2014).  
Integrating behavioral and physical healthcare may help improve care for 
consumers with SMI (Druss, Rohrbaugh, Levinson, & Rosenheck, 2001; Frank & 
Epstein, 2014), but the degree of coordination or integration is important. Heath and 
colleagues (2013) described six levels of care, ranging from cross-referrals to co-location 
without joint treatment planning, through fully integrated care involving joint treatment 
planning and integrated medical records (Heath, Wise Romero, & Reynolds, 2013). 
Cross-referrals often prove ineffective because patients rarely reach the referral site 
(Manderscheid & Kathol, 2014). Researchers assessing collocated  models have primarily 
focused on behavioral health clinicians collocated  in primary care facilities treating 
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depression; these studies have shown positive outcomes (Druss et al., 2001; Solberg et 
al., 2013; Thiejke, Vannoy, & Unutzer, 2007).  
Optimal care integration involves development and implementation of combined 
physical and mental health treatment plans (Gerrity, 2015). Researchers assessing 
integrated care programs have rarely focused on SMI, co-location in behavioral health 
clinic, or collaborative care that includes joint treatment planning (Gerrity, 2015). Since 
the majority of persons with SMI seek care at behavioral health clinics, this setting may 
be the more appropriate setting for integrated care programs serving consumers with SMI 
(Manderscheid & Kathol, 2014). A few effective models of collocated care for consumers 
with SMI exist, but the studies have been conducted within the Veteran’s Health 
Administration (VHA) and do not involve joint treatment planning (Pirraglia et al., 2012; 
Randall, Mohr, & Maynard, 2014; Schaps & Post, 2015). There is a gap in knowledge 
regarding such programs in community mental health settings. 
The RAND Corporation recently reviewed 56 programs funded by the Substance 
Abuse and Mental Health Services Administration (SAMHSA) under the Primary and 
Behavioral Health Care Integration grant program. The authors of the review described 
challenges faced by models of physical health collocated in behavioral health settings 
including culture, space, consent to treatment and information sharing, maintenance of 
medical records, and referral processes. The review yielded only one study that 
demonstrated a reduction in ED visits and an increase in screening for hypertension and 
diabetes (Schaps & Post, 2015). However, this program involved training psychiatrists to 
provide additional medical care, rather than integrating a medical specialist into the 
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behavioral health setting. One example of a truly integrated care program was provided in 
the review, but no results were available from this system at the time of publication 
(Schaps & Post, 2015).  
Recent changes in health policy address the need for improving care for 
consumers with SMI and suggest financing structures for integrated care pilots (Barry & 
Huskamp, 2011; Druss & Mauer, 2010; SAMHSA, 2014). It will be important to assess 
how integrated care programs perform in terms of reducing costly inpatient and ED 
utilization, since payers are moving toward reimbursing providers on the basis of quality 
rather than quantity of services (Burwell, 2015). In this study, I focused on the impact of 
integrated care and collaborative treatment planning on high-cost service utilization for 
consumers with SMI in a community-based mental healthcare setting. 
Problem Statement 
In this study I addressed the lack of evidence about the impact of integrated care 
on overall physical health and ambulatory care sensitive (ACS)-specific utilization. 
Integrated care involving the development and implementation of combined physical and 
mental health treatment plans is necessary in providing high-quality care for consumers 
with SMI (Gerrity, 2015). However, few effective models of integrated care within 
community behavioral health settings exist (Collins, Hewson, Munger, & Wade, 2010; 
Gerrity, 2015). Recently several healthcare policies, including the Patient Protection and 
Affordable Care Act (PPACA), have been implemented; they emphasize quality of care 
for consumers with SMI and provide potential financing structures for integrated care 
pilots (Barry & Huskamp, 2011; Druss & Mauer, 2010; SAMHSA 2014). SAMHSA has 
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also established the Primary and Behavioral Health Care Integration Program that funds 
coordinated and integrated services through the colocation of primary and specialty care 
medical services in community-based behavioral health settings (SAHMSA, 2014). It 
will be important to understand how these integrated care programs perform in terms of 
reducing costly inpatient admissions and ED services as payers move toward 
reimbursement of providers based on quality rather than quantity of services provided 
(Burwell, 2015).  
For a majority of consumers with SMI, the behavioral health clinic serves as the 
primary, and sometimes only, provider of healthcare. As a result, these clinics may be the 
best setting in which to integrate physical and behavioral healthcare (Kilbourne, Welsh, 
Mccarthy, Post, & Blow, 2008; Manderscheid & Kathol, 2014). Use of collaborative 
approaches to patient care is common in behavioral health settings because care managers 
can help coordinate the sharing of information among the treatment team, engage patients 
in their treatment, encourage adherence to treatment plans, track outcomes, and monitor 
progress (Norquist, 2014). The majority of studies that have assessed collocated primary 
care within a behavioral health setting have taken place in the Veterans Health 
Administration (VHA) system; however, results of these studies were mixed (Kilbourne, 
Welsh, McCarthy, Post, & Blow, 2008; Kilbourne et al., 2011). Therefore, in this study I 
addressed the lack of evidence about the impact of integrated care on overall physical 
health and ACS-specific utilization.  
  
 
6 
Purpose of the Study 
The purpose of this quantitative study was to assess the impact of integrated care 
on overall physical health and ACS inpatient and ED utilization when controlling for 
demographic characteristics and disease severity for consumers with SMI through 
evaluation of an IHC program at one large CMHC.  
Research Questions and Hypotheses 
RQ1: What is the predictive relationship, if any, between IHC enrollment and 
overall physical health utilization for consumers with SMI when controlling for 
demographic characteristics and disease severity?  
H01: There is no statistically significant predictive relationship between IHC 
enrollment and overall physical health service utilization (number of inpatient admissions 
and ED visits, number of inpatient days) when controlling for demographic 
characteristics (age and gender) and disease severity (primary psychiatric diagnosis, 
disease burden). 
HA1: There is a statistically significant predictive relationship between IHC 
enrollment and overall physical health service utilization (number of inpatient admissions 
and ED visits, number of inpatient days) when controlling for demographic 
characteristics (age and gender) and disease severity (primary psychiatric diagnosis, 
disease burden). 
RQ2: What is the predictive relationship, if any, between IHC enrollment and 
ACS-specific service utilization for consumers with SMI when controlling for 
demographic characteristics and disease burden?  
  
 
7 
H02: There is no statistically significant predictive relationship between IHC 
enrollment and ACS-specific service utilization (number of inpatient admissions and ED 
visits, number of inpatient days) when controlling for demographic characteristics (age 
and gender) and disease severity (primary psychiatric diagnosis, disease burden). 
HA2: There is a statistically significant predictive relationship between IHC 
enrollment and ACS-specific service utilization (number of inpatient admissions and ED 
visits, number of inpatient days) when controlling for demographic characteristics (age 
and gender) and disease severity (primary psychiatric diagnosis, disease burden). 
Theoretical Framework 
The theory most applicable to this study was the chronic care model (CCM). The 
CCM focuses on the need for collaboration when providing healthcare services and 
includes five aspects directly related to high quality care; (a) use of explicit care plans, 
(b) reorganization of healthcare practices to better meet patient needs, (c) the ability to 
identify patient needs, particularly related to information and behavior change, (d) access 
to the appropriate clinical expertise, and (e) information systems that support optimal 
care (Wagner, Austin, & Von Korff, 1996). Aspects of the CCM related to redesigning 
healthcare delivery systems and improving clinical information systems align with the 
concept of integrated physical and behavioral healthcare (McLellan et al., 2014). The 
CCM also emphasizes the need for collaboration among healthcare professionals to 
provide adequate care for patients, treating all conditions rather than treating each 
individual condition in isolation, and involves proactive patient management to prevent 
serious and expensive relapses (Rush, 2014). The CCM has been used as a basis for prior 
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studies in populations with mental health conditions, with mixed results (Bauer et al., 
2015; Bradford et al., 2013; Kilbourne et al., 2009; Thota et al., 2012). The CCM and its 
relevance to the current study will be described in detail in Chapter 2 
Nature of the Study 
In this quantitative retrospective cohort design study, I used secondary 
administrative healthcare data from the CMHC as the primary data source. The 
independent variable was enrollment in the IHC. The dependent variables included the 
number of physical health and ACS-specific inpatient admissions, inpatient days, and ED 
visits. Covariates included consumer age, gender, initial psychiatric diagnosis, and 
comorbidity burden. A quantitative research design was chosen because the dependent 
variables of interest (healthcare resource utilization) were best measured numerically, and 
the relationship between IHC enrollment and healthcare resource utilization was the aim 
of the study. Quantitative research methods using administrative healthcare data have 
successfully measured similar outcomes related to healthcare utilization and cost 
(Birnbaum et al., 1999). Furthermore, administrative healthcare data have also been used 
in outcomes research for decades with success in analyzing certain types of outcomes that 
can be measured with these data sources, including healthcare utilization and cost 
(Birnbaum et al., 1999). 
The independent variable was enrollment in the IHC, which was coded as “0” for 
preenrollment and “1” for postenrollment for each consumer. The dependent variables 
included the number of inpatient admissions, number of inpatient days, and number of 
ED visits. Only physical health inpatient admissions and ED visits were included in the 
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original analysis, and a further determination was made as to whether the visits were 
ACS-specific. Covariates included consumer age, gender, initial psychiatric diagnosis, 
and comorbidity burden. All-cause and mental health inpatient and ED utilization were 
assessed in a post-hoc analysis. 
The sample included all consumers who enrolled in the IHC between October 1, 
2013 and June 30, 2015. Several data files from the CMHC were used in this analysis 
including: (a) CMHC contact files containing consumer demographic information from 
October 1, 2013 to December 31, 2015 for all consumers of the CMHC; (b) inpatient 
admission and ED visit authorization data from October 1, 2013 to December 31, 2015 
for consumers of the CMHC enrolled in either AmeriGroup or UnitedHealth health plans; 
and (3) IHC electronic medical record data from October 1, 2013 to December 31, 2015. 
All data were stored in an SPSS data file for analysis and analyzed using SPSS Statistics 
for Mac, Student Edition, version 23 (IBM).  
I assessed inpatient admissions and ED use for physical health diagnoses, as well 
as diagnoses classified as ACS-specific, comparing the six months before to the six 
months following the initial IHC enrollment date. I planned to use paired-sample t-tests 
to calculate whether differences in the means of service utilization outcomes between the 
pre- and postenrollment timeframe for consumers in the IHC differed significantly (Field, 
2013). However, due to the skewed nature of the data, I instead used non-parametric 
Wilcoxon signed-rank tests to assess statistically significant differences in median 
utilization. 
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I chose to examine the odds of consumers experiencing any inpatient admission or 
ED visit before and after IHC enrollment through use of logistic regressions. I examined 
enrollment first as the sole fixed effect. Age, gender, initial psychiatric diagnosis, and 
Charlson Comorbidity Index (CCI) score were then added to the fixed-effects portion of 
the models. Separate logistic regression models were run for overall physical health 
service utilization and ACS-specific service utilization and for both inpatient admissions 
and ED visits, resulting in a total of four logistic regression models. I used multiple linear 
regression analyses to examine the predictive relationship between physical health 
service utilization and IHC enrollment, demographic characteristics, and disease severity. 
In the forced entry method, predictors were entered into the model at the same time, 
making no decisions regarding the order that the predictors were added (Field, 2013). 
Separate multiple regression models were run for overall physical health service 
utilization and ACS-specific service utilization for each type of service, including 
inpatient admissions, inpatient days, and ED visits, resulting in a total of six multiple 
regression models. I examined the predictive relationship between IHC enrollment and 
physical health service utilization using Poisson regression analyses. Enrollment was 
coded first as the sole fixed effect, adding age, gender, initial psychiatric diagnosis, and 
CCI score to the fixed-effects portion of the model. Separate Poisson regression models 
were run for overall physical health service utilization and ACS-specific service 
utilization, and for each type of service, including inpatient admissions, inpatient days, 
and ED visits, resulting in a total of six Poisson regression models. 
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For the statistical tests, a p-value >0.05 was used as the cutoff for statistical 
significance, with a confidence interval of 95%. Wilcoxon signed-rank tests were used to 
assess whether there were statistically significant median differences in inpatient 
admissions, days hospitalized, and ED visits pre- and post-enrollment in the IHC. 
Logistic regression results were interpreted using odds ratios assessing the odds of 
inpatient or ED visits occurring in the pre- and post-enrollment timeframe. Multiple 
linear regression results were interpreted using the F-test to assess whether the overall 
model was statistically significant and was predictive of service utilization while the t-
statistics for each predictor variable indicated the level of statistical significance of each 
independent variable.  
Definitions  
The following terms were important to the study and may have multiple 
meanings. The definitions below describe constructs included in the study and the 
independent and dependent variables as specifically related to this study. A more detailed 
analysis of coding, etc. is provided in Chapter 3. 
Ambulatory care sensitive conditions: These are conditions that could have been 
treated in an outpatient setting if appropriate access to primary care were available 
(Anderson & Knickman, 2001). 
Comorbidity burden: Comorbidity burden was assessed according to the Charlson 
Comorbidity Index (CCI), which identified 17 comorbid conditions predictive of 
mortality (Charlson, Wells, Ullman, King, & Shmukler, 2014; D’Hoore, Bouckaert, & 
Tilquin, 1996). 
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Integrated care: Integrated care involves the development and implementation of 
combined physical and mental health treatment plans by collocated providers (SMI; 
Gerrity, 2015). 
Initial psychiatric diagnosis: Initial psychiatric diagnosis was categorized 
according to prior research as psychotic disorder, mood disorder, or substance abuse 
disorder in combination with another psychiatric diagnosis (Ettner, Frank, McGuire, 
Newhouse, & Notman, 1998;  Ettner, Frank, Mark, & Smith, 2000). 
Serious mental illness: SMI was defined as current or past-year presence of any 
disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) that causes functional impairment or considerably interferes with one or more 
life activities among adults 18 years of age or older (SAMHSA, 2013). 
Assumptions 
The major assumption made at the outset of this study was that the secondary data 
received from the CMHC were authentic, not falsified, and reflected care patterns of 
consumers at the CMHC. Since I did not collect the data myself, I had to assume that the 
data for the study were reliable. This was a reasonable assumption to make, given that the 
original purpose of these data was to guide care for consumers of the CMHC. 
Scope and Delimitations 
The study sample was limited to consumers of one large CMHC who self-selected 
for enrollment in an IHC program. Analyses were limited to consumers age 18 years and 
older for whom six months of data before and after initial enrollment in the IHC were 
available. I used secondary data to assess whether enrollment in the IHC was associated 
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with changes in physical health inpatient and ED service utilization. There may have 
been other important indicators of IHC success or confounding variables affecting service 
utilization patterns that were not accounted for and could not be assessed using 
administrative secondary data. However, using administrative data for this study may 
allow others to more closely replicate the methodology with other integrated care 
programs using similar sources of data (Frankfort-Nachmias & Nachmias, 2008).  
While the CCM was chosen as the main theoretical underpinning of this study, 
systems theory may also have been applicable in explaining the lack of integration 
between physical and behavioral healthcare providers. Complex-adaptive systems are 
those in which diverse parts of a system must operate together (Tsasis, Evans, & Owen, 
2012). However, continuous change in the organization creates a lack of predictability 
(Tsasis, Evans, Rush, & Diamond, 2013). When applied to integrated care, systems 
theory may explain why, due to historical practice patterns and the patients they treat, 
mental health and primary care delivery systems have evolved differently over time and 
have not been able to coordinate effectively to meet patient needs (Thiejke et al., 2007). 
Limitations 
This study was subject to five limitations, (a) the data sources used and the 
scarcity of utilization data among the sample. While use of administrative data for this 
study was appropriate, there were fewer inpatient admissions and ED visits than expected 
and this affected interpretation of the results. (b) A second limitation of this study was 
that data were specialized. Inpatient and ED utilization were assessed via authorization 
data sent to the CMHC by two of the health plans to help the CMHC better manage its 
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consumers. A third payer did not send such authorization data and there may have been 
differences in service utilization between health plans that could not be ascertained. 
Furthermore, the sharing of real-time authorization data between a health plan and a 
CMHC is probably atypical and therefore may limit the ability of other researchers to 
reproduce the exact methodology used in the current study. (c) Another limitation related 
to data was that different people involved in the consumer’s care entered the data used in 
the analysis into the administrative systems. Data entry errors may have occurred leading 
to inaccuracies in the data or missing data. (d) A further limitation had to do with the 
study methodology. Since I chose a retrospective cohort design with a convenience 
sample, bias was introduced. (e) A related limitation to predictive validity was that of 
selection effects. Since clients at the CMHC self-selected into the IHC, there were likely 
differences between the study group and other consumers of the CMHC and consumers 
with SMI in general (Frankfort-Nachmias & Nachmias, 2008). Therefore, results were 
not generalizable to a population beyond the consumers of the particular CMHC who 
enrolled in the IHC program (Mann, 2003; Phua, 2007). However, this study added to the 
body of literature about collocated integrated care programs in general. Study sample 
retention was initially thought of as a threat to internal validity as well. Since the SMI 
population is transient, it was important to assess and account for attrition (Frankfort-
Nachmias & Nachmias, 2008). However, the consumers at the CMHC were covered by 
Medicaid and not as likely as consumers covered by commercial insurance to switch 
health plans or move to other locations. This threat was reduced by limiting the sample to 
those with a full six months of data pre- and post-enrollment in the IHC.  
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Significance 
First and foremost, the results from this study may help leaders at the data partner 
CMHC assess the success of the IHC program and clinic services in general, and identify 
opportunities for improvement. Since this study was a program assessment of a particular 
IHC program, the most immediate results will be realized there. However, the findings 
may also help inform other providers interested in implementing integrated physical and 
behavioral health programs by providing evidence to better inform decisions prior to 
spending resources during implementation. Authors of a recent meta-analysis of 
interventions for medical conditions among consumers with SMI found low to medium 
levels of evidence supporting these interventions, and called for further research on 
implementation strategies in real-world settings (McGinty, Baller, Azrin, Juliano-Bult, & 
Daumit, 2016). The current study may help fill this need.   
From a policy perspective, this study may also inform future health policy and 
assist payers in developing value-based payments. Recent implementation of new health 
policies and grant programs have placed emphasis on quality of care for consumers with 
SMI and provision of financing structures for integrated care pilots (Barry & Huskamp, 
2011; Druss & Mauer, 2010; SAMHSA, 2014). As payers in the United States move 
toward quality-based reimbursement rather than quantity-based reimbursement, an 
understanding of the effectiveness of these programs in the reduction of cost and 
improvement of quality will be important (Burwell, 2015).  
Apart from policy and practice implications, this study may make an important 
contribution to the literature. Researchers leading two studies within the VHA evaluated 
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the impact of coordinated care programs on service utilization. Neither of these studies 
showed significant differences in ED service utilization. There are also important 
differences between the two VHA studies and the current study. While authors of one 
study assessed veterans with SMI, the sample size was small, which may have affected 
the results (Pirraglia et al., 2012). Researchers involved in the second study assessed 
veterans with PTSD, rather than SMI (Randall et al., 2014), and the etiologies and 
treatment paradigms for these conditions differed markedly. Additionally, the 
intervention in that study involved health practitioners as part of a care team, not an 
integrated care model in a behavioral health clinic setting (Randall et al., 2014; Veterans 
Health Administration, 2015). Furthermore, generalizability to other populations may be 
limited due to use of EMR data in the VHA and the fact that the VHA serves a selected 
group of consumers who are likely not reflective of the general United States population 
(Goulet et al., 2007; Pirraglia et al., 2012). Therefore, in this study, I addressed integrated 
care in a community mental health center, which is likely more reflective of the United 
States population than the VHA studies.  
Another important outcome of this study relates to the social change implications 
for consumers with SMI. As integrated care models become more common, researchers 
assessing the various care models will improve the level of evidence available to inform 
optimal care for this population. While consumers with SMI often do not participate in 
traditional health home models (Lichstein et al., 2014), other models of care that are 
located within community behavioral healthcare settings may be more appropriate, thus 
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increasing access to physical healthcare and improving outcomes among the SMI 
population (Barry & Huskamp, 2011).  
Summary 
SMI is associated with high rates of mortality and comorbid physical illness and 
is associated with use of high-cost healthcare services including inpatient hospitalizations 
and ED visits. Integrating behavioral and physical healthcare may improve care for 
consumers with serious mental illness, but findings of prior research have been mixed. 
This quantitative retrospective cohort study addressed the lack of evidence about the 
impact of integrated care on overall physical health and ACS-specific utilization through 
a program evaluation of an IHC. The main research question assessed whether there was 
a predictive relationship between IHC participation and physical health or ACS-specific 
service utilization for consumers with SMI. The analyses controlled for demographic 
characteristics and disease severity. The study has implications for the CMHC 
implementing the IHC program as well as for policy makers assessing new models of 
care funded under the ACA. 
In Chapter 2, I expand upon the concepts presented here, and include an 
explanation of the CCM and its application to this study, an overview of SMI and its 
various implications to the United States healthcare system, and different models of 
integrated care with a focus on the model used by the data partner. I highlight gaps in 
prior research, point to a need for the current study, and explore the literature on the 
variables used in this study. 
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Chapter 2: Literature Review 
Introduction 
While integrated care has been defined in multiple ways, for the purposes of this 
study, I defined it as team-based care, including the development and implementation of 
combined physical and mental health treatment plans, rather than a simple colocation of 
services. Joint treatment planning may be necessary to provide the best care for 
consumers with serious mental illness (SMI; Gerrity, 2015). Researchers have assessed 
integrated care models within the Veteran’s Health Administration (VHA) system 
(Kilbourne, Lai, Bowersox, Pirraglia, & Bauer, 2011; Pirraglia et al., 2012); however, 
there are few effective models of integrated care collocating a physical health clinic in the 
community behavioral health setting (Collins, Hewson, Munger, & Wade, 2010; Gerrity, 
2015).  
The problem I addressed in this study was the lack of evidence assessing the 
impact of collocated integrated physical healthcare within the behavioral health setting on 
physical health utilization in a community setting. In this study, I assessed the impact of 
integrated care on physical health inpatient and emergency department (ED) utilization 
for consumers with SMI. I specifically evaluated the effects of an integrated health clinic 
(IHC) collocated within a large community mental health center (CMHC). The main 
research question I addressed in this study was: What is the predictive relationship, if 
any, between IHC enrollment and physical health service utilization (both overall and 
ambulatory care sensitive [ACS]-specific) for consumers with SMI when controlling for 
demographic characteristics and disease severity? 
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SMI affects slightly under 5% of the United States population (SAMHSA, 2013). 
Consumers with SMI experience higher rates of morbidity and mortality than those 
without SMI (Thornicroft, 2011). Comorbid physical illnesses commonly experienced by 
consumers with SMI include cardiovascular disease (CVD) and diabetes, caused in part 
by lifestyle factors, medication side effects, and suboptimal physical healthcare (De Hert 
et al., 2011; Mitchell & Lawrence, 2011; Thornicroft, 2011). The nature of illness of SMI 
and high rates of comorbidity may contribute to the high cost of healthcare among this 
population. Consumers with SMI use intensive healthcare resources including inpatient 
hospitalizations, and as such, the cost of care for SMI is high (Heslin & Weiss, 2015).  
Integrating behavioral and physical healthcare may help improve care for 
consumers with SMI (Druss, Rohrbaugh, Levinson, & Rosenheck, 2001; Frank & 
Epstein, 2014). While integration of behavioral health within primary care clinics has 
been studied in the past, these models are not always adequate for consumers with SMI, 
since the behavioral health clinic serves as their primary care setting (Manderscheid & 
Kathol, 2014). Several researchers have assessed the impact of collocated care in both 
physical and behavioral healthcare settings on access to care, quality of life, and service 
utilization. However, the majority of these studies have taken place within the VHA 
system and may not reflect care in community settings (Druss, Rohrbaugh, et al., 2001; 
Kilbourne et al., 2011; Pirraglia, Kilbourne, Lai, Friedmann, & O’Toole, 2011). 
Furthermore, the models of integrated care most commonly studied typically do not 
include coordinated treatment planning between physical and mental health clinicians 
(Gerrity, 2015). 
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This chapter covers the following topics: (a) a review of the literature search 
strategies, (b) an overview of the chronic care model (CCM), the theoretical foundation 
of this study, including a review of past studies applying CCM to mental health 
populations, (c) the problem of SMI, including incidence, prevalence, morbidity, 
mortality and healthcare resource use with a focus on high cost services such as inpatient 
hospitalization and ED visits, (d) different models of integrated care, focusing 
specifically on the model used by the data partner CMHC, and (e) gaps in prior research, 
pointing to a need for the current study and presented literature related to the variables 
used in the current study. 
Literature Search Strategy 
Citations for SMI prevalence and specific diagnoses of interest including serious 
mental illness, SMI, bipolar disorder, schizophrenia, or schizoaffective disorder were 
based on published review articles. I conducted a search of English-language publications 
in PubMed Health for dates of publication between 2010 and July 14, 2015 (the day the 
search was conducted) for integrated care, including integrated care, integrated 
behavioral care, collaborative behavioral care, and collocated care. When searching for 
these terms, 705 results were found. When combining a search for integrated care with 
mental illness, 249 results were found. A similar search using the same dates and English 
language was also conducted to search for articles regarding the CCM and SMI. The 
search for chronic care model or CCM yielded 1,321 results, but when combined with 
mental illness, the results dropped to five, for bipolar disorder the results dropped to 11, 
and when combined with schizophrenia, results dropped to one.  
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Following the initial searches, smaller supplemental searches were also conducted 
for articles cited in review articles retrieved from the initial search. This search was 
especially useful in identifying seminal articles about the CCM, which was initially 
developed in the 1990s (Wagner et al., 1996). Furthermore, weekly searches were 
conducted to identify recent literature published since the initial search for articles related 
to integrated behavioral healthcare using Google Scholar and searches of specific 
journals likely to carry articles of interest, including JAMA Psychiatry, Psychiatric 
Services, Schizophrenia Research, and Health Affairs.   
Theoretical Foundation 
I used the CCM as the theoretical foundation for this study. Wagner et al. first 
developed the CCM in the 1990s in response to the focus on acute illness by practitioners 
within the healthcare system. Therefore, the system did not adequately meet the needs of 
patients with chronic illness. Practitioners in the healthcare system focused on diagnosing 
and treating acute illness rather than addressing predictable needs related to chronic 
conditions. This resulted in suboptimal health outcomes related to an inability to identify 
complications in a timely manner, failing health due to inadequate assessment and 
follow-up, inability of the patient to recognize risk factors, suboptimal interventions 
leading to lower quality of care, and unmanaged patient distress (Wagner et al., 1996). 
The CCM was developed to provide appropriate evidence-based interventions, educate 
patients and caregivers about managing illness, and empower patients to better care for 
themselves (Austin, Wagner, Hindmarsh, & Davis, 2000).  
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The founders identified five aspects directly related to high quality care, including 
(a) use of explicit care plans, (b) reorganization of healthcare practices to better meet 
patient needs, (c) the ability to identify patient needs, particularly related to information 
and behavior change, (d) access to the appropriate clinical expertise, and (e) information 
systems that support optimal care (Wagner et al., 1996). The CCM as originally theorized 
contained four components: patient self-management assistance, clinical health 
information systems, redesign of practices to focus on prevention of disease, and use of 
evidence-based medicine (Wagner et al., 1996). Two other components were added later, 
including organizational support and linking the patient to community resources 
(Bodenheimer T, Lorig K, Holman H, & Grumbach K, 2002; Bodenheimer T, Wagner 
EH, & Grumbach K, 2002).  
There are six key components of CCM: (a) focus on chronic conditions and an 
emphasis on quality improvement and measurement against goals, (b) emphasis on the 
importance of the role that patients have in managing their care, (c) use of evidence based 
guidelines in clinical practice, (d) focus on teamwork and an expanded scope of practice 
for team members to support chronic care, (e) information systems that provide relevant 
data for clinical decision-making, and (f) use of community supports to help meet 
patients’ needs (Wagner et al.; 2001). While CCM theory in its entirety is important, 
several key aspects explain the concept behind integrated care and supported the current 
study assessing integration of physical healthcare into behavioral health settings for 
consumers with SMI (Woltmann et al., 2012). Specifically, aspects of CCM related to 
redesigning healthcare delivery systems and improving clinical information systems 
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aligned with the concept of integrated physical and behavioral healthcare (McLellan et 
al., 2014). Care plans have typically involved treatment of a single disease in isolation. 
However, appropriate care planning involves all conditions experienced by a patient and 
treating that patient as a whole, which matters greatly in patients who have multiple 
chronic conditions (Burt et al., 2014). The CCM emphasized the need for collaboration 
among healthcare professionals to adequately provide care for patients, treating all 
conditions rather than treating each individual condition in isolation, and involves 
proactive patient management to prevent serious and expensive relapses (Rush, 2014). 
This translates into teams of providers caring for patients, where tasks can be delegated 
among the team based on clinical experience, with coordination and communication 
between the various team members (Austin et al., 2000). Improved outcomes are related 
to strong and productive relationships between motivated patients and their teams of 
healthcare providers acting proactively (Barr et al., 2003).  
Successful management of chronic conditions also depends on providers having 
access to the necessary expertise. In traditional medicine, this is accomplished through 
referrals from primary care to specialists; however, this system often fragments care 
because referring physicians and specialists do not communicate effectively. Systems 
with distributed expertise, in which clinicians consult with one another to provide team-
based care, may be more effective in delivering treatment to consumers in need of 
chronic care (Austin et al., 2000). Use of shared electronic medical record (EMR) 
systems may facilitate sharing of information between providers and improve prevention 
of complications (Glasgow, Tracy Orleans, Wagner, Curry, & Solberg, 2001). The CCM 
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is used widely today as a framework for practice improvement, mostly in ambulatory care 
settings, that helps practice administrators translate ideas for change into specific tactics 
(Coleman, Austin, Brach, & Wagner, 2009). The CCM framework could also be used in 
the development and implementation of collaborative treatment planning between 
collocated physical and behavioral health providers.  
Due to its prior use in care for consumers with SMI, the CCM was chosen as the 
primary theory for the current study. Through this study, I built on earlier research based 
on the CCM to improve care for consumers with mental health conditions. Authors of a 
meta-analysis of 53 studies based on the CCM conducted to improve the quality of life in 
consumers with mental health disorders found that the majority of CCM-based studies 
assessed outcomes for consumers with depression in primary care and results indicated a 
positive impact of the CCM on depression and mental and physical quality of life (Miller 
et al., 2013). The original four components of the CCM were those most often 
implemented in the studies assessed, but no single element was statistically associated 
with success in model implementation (Miller et al., 2013). Authors of a similar literature 
review also showed improvements in depressive symptoms, response to treatment, 
reemission at six months, recovery at 12 months, and adherence to medication for 
consumers with depression (Thota et al., 2012). 
The CCM has also been used by researchers as a foundation for programs 
targeting the SMI population, but with mixed results. Authors of a study in consumers 
with bipolar disorder showed that a CCM-based program reduced time in bipolar and 
manic episodes and improved some functional outcomes such as work and familial 
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functioning; however, no effects were seen for time in depressive episode, number of 
symptoms, or marital/social functioning (Bauer et al., 2015). Researchers did show 
improvement on the Physical Component Score (PCS) of the SF-36 for consumers with 
bipolar disorder and cardiovascular disease within the VHA system, when implementing 
a program based on the CCM (Kilbourne et al., 2009). Similarly, authors of a literature 
review of four studies found mixed results when evaluating the effects of CCM-based 
care models on the PCS and Mental Component Score (MCS) of the SF-36 (Bradford et 
al., 2013). Authors of another systematic review of 46 articles demonstrated significant 
effects in 31.7% of studies of consumers with bipolar disorder and 47.6% of studies in 
multiple disorders. However, there were no favorable results with regard to cost of care 
reductions (Woltmann et al., 2012b).  
Literature Review Related to Key Variables and Study Concepts 
The Substance Abuse and Mental Health Services Administration (SAMHSA) 
defined SMI as current or past-year presence of any disorder in the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) that causes functional 
impairment or considerably interferes with one or more life activities among adults 18 
years of age or older (SAMHSA, 2013). In 2012, there were approximately 9.6 million 
adults in the United States living with SMI during the past year, which accounted for 
4.9% of the population (SAMHSA, 2013). Schizophrenia affects about 1% of the United 
States population, bipolar disorder affects approximately 2%, and 6% experience a major 
depressive episode (Regier et al., 1993; SAMHSA, 2013).  
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Authors of a recent meta-analysis assessing mortality rates for persons with 
mental disorders found the relative risk of death from mental disorders was 2.22%, 
attributable to both natural and unnatural causes, and a potential of 10 years of life lost 
(Walker, McGee, & Druss, 2015). When looking at SMI as a subset of mental disorders, 
the data are even more concerning. Higher mortality rates among consumers with SMI 
have been well documented. Men with SMI die on average 20 years younger than their 
non-SMI counterparts and women die approximately 15 years earlier (Thornicroft, 2011). 
The risk of premature death was found to be 3 to 3.5 times greater for consumers with 
schizophrenia and two times higher for consumers with bipolar disorder than the general 
population (Khan, Faucett, Morrison, & Brown, 2013; Medici, Videbech, Gustafsson, & 
Munk-Jørgensen, 2015; Olfson, Gerhard, Huang, Crystal, & Stroup, 2015; Perkins, 2015) 
Higher mortality rates are due to a multitude of reasons. Researchers in one study found 
that rates of death due to natural causes, accidents, suicide, and comorbid illness were 
higher in the population of consumers with schizophrenia than the general population 
(Perkins, 2015), while researchers involved in another study found that cardiovascular 
disease (CVD), cancer, chronic obstructive pulmonary disease (COPD), and influenza 
and pneumonia contributed to elevated morbidity rates among consumers with 
schizophrenia (Olfson et al., 2015).  
Comorbid physical illness is common among consumers with SMI, with authors 
of one study finding that 74% of consumers with SMI had at least one chronic medical 
condition, while half were diagnosed with two or more (Jones et al., 2004). The reasons 
for high levels of comorbidity include side effects of psychiatric medication, unhealthy 
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lifestyle, and low rates of screening and suboptimal care for physical health conditions in 
the SMI population (De Hert et al., 2011; Mitchell & Lawrence, 2011; Thornicroft, 
2011). Only 21% of consumers with SMI in one study received recommended levels of 
primary care (Druss et al., 2009) while inadequate levels of screening for physical health 
conditions including Papanicolaou (Pap) tests and mammograms have been highlighted 
in other studies (De Hert et al., 2011; Salsberry et al., 2005). Researchers demonstrated 
that among the VHA population, the presence of a mental health disorder alone, or in 
combination with a substance abuse disorder, decreased the likelihood of receiving 
preventive services (Druss, Rosenheck, Desai, & Perlin, 2002).  
When treating metabolic conditions including CVD and diabetes, the evidence is 
equally concerning. Consumers with SMI were less likely than those without SMI to 
receive hospital-based care or invasive procedures for CVD or diabetic complications, or 
to receive prescription medications to treat metabolic conditions according to the authors 
of one study (Scott, Platania-Phung, & Happell, 2012). Moreover, consumers with mental 
illness had fewer invasive coronary interventions after serious cardiac events and an 
increased likelihood of death from those events than people without mental illness. Once 
results were adjusted to control for indicators of care quality including medication and 
smoking cessation counseling, the association was no longer significant (Scott, Platania-
Phung, & Happell, 2012). This may indicate that lower quality of care received by 
consumers with SMI may greatly contribute to excess mortality in this population (Druss, 
Bradford, Rosenheck, Redford, & Krumhold, 2001; Mitchell & Lawrence, 2011). 
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Antipsychotic medication has been associated with cardiometabolic side effects 
including diabetes, obesity, lipid disregulation, and hyperglycemia (Nasrallah & 
Newcomer, 2004; Newcomer, 2007). Since different antipsychotics have different risk 
levels, it would seem intuitive that screening for these conditions would be routine for 
consumers taking antipsychotics in order to find the most appropriate medications for 
each patient. However, that is not necessarily true. Authors of one study of metabolic 
screening among those taking antipsychotics showed that less than 30% of consumers 
with SMI were screened for weight or metabolic indicators before or during treatment 
with antipsychotics (Scott et al., 2012). Even when guidelines were issued to reinforce 
metabolic screening, implementation of these guidelines is often short-lived. Small gains 
were initially seen in youth receiving screening for metabolic conditions prior to and 
following prescribing of an antipsychotic shortly after the 2004 American Diabetes 
Association guidance on the matter was issued, but screening returned to pre-guidance 
levels within four years (Connolly, Toomey, & Schneeweiss, 2015). 
Integrating Physical and Behavioral Healthcare 
Integrating behavioral and physical healthcare may help improve care for 
consumers with SMI (Druss, Rohrbaugh, et al., 2001; Frank & Epstein, 2014), but the 
degree of coordination or integration has been found to make a difference. Heath and 
colleagues (2013) described six levels of care, moving from minimal collaboration 
through fully integrated care (Heath et al., 2013). Traditional models of treating 
consumers with both physical and behavioral health conditions have relied on cross-
referrals between two separate care settings with little collaboration between the two 
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(Level 1), or periodic communication about shared consumers only (Level 2; Heath, Wise 
Romero, & Reynolds, 2013; Manderscheid & Kathol, 2014). However, these forms of 
collaboration depending on two different office sites often prove ineffective because 
consumers rarely reach the referral site (Manderscheid & Kathol, 2014). Historical 
practice patterns and the fact that mental health and primary care providers typically treat 
different patient populations, the two systems of care have evolved differently over time 
(Thiejke et al., 2007). However, optimal care depends on the different components of the 
healthcare delivery system working together toward shared patient outcomes.  
Collocated models where physical and mental health practitioners are collocated 
in the same facility comprised another level of collaborative care within Heath and 
colleagues’ model. Level 3 described basic collaboration in which behavioral and 
physical health providers saw the same consumers but developed separate treatment plans 
and had only sporadic discussions about shared consumers (Heath et al., 2013). Level 4 
involved collaboration where physical and behavioral healthcare practitioners share 
clinical practice space and some clinical information was entered in one another’s 
systems (Heath et al., 2013). Collocated care has been identified as one advancement in 
treating physical and mental health conditions (Powell et al., 2012). Researchers 
assessing collocated models have typically focused on integration of behavioral health in 
primary care facilities for consumers with depression and less serious mental health 
issues, and have shown positive outcomes (Druss, Rohrbaugh, et al., 2001; Pomerantz et 
al., 2010; Solberg et al., 2013; Thiejke, Vannoy, & Unutzer, 2007). SMI, however, has 
rarely been a focus of these studies, nor has Level 4 or 5 care (Gerrity, 2015).  
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Integrated care encompassed the final two levels of care described by Heath and 
colleagues (2013). Level 5 care involved development and implementation of 
collaborative treatment planning between collocated physical and behavioral healthcare 
providers. The providers acted as a team and clearly understood one another’s roles, but 
system integration was lacking. Level 6 care fostered collaborative treatment planning for 
all consumers seen at practice sites with fully integrated systems (Heath et al., 2013). 
Researchers compiling evidence from other countries have also shown that fully 
integrated systems allow for better communication among providers and sustained care 
for consumers (Malm, Ivarsson, & Allebeck, 2014; Pincus et al., 2015). Research has 
pointed to effective chronic care working best when supported by multidisciplinary teams 
with delegation of responsibilities to the appropriate team members, and without barriers 
between disciplines (Grol, Wensing, Bosch, Hulscher, & Eccles, 2013; Wagner, 
Glasgow, et al., 2001).  
Three primary factors have led to models of integration within the physical health 
setting not working optimally, including separate healthcare delivery systems for physical 
and behavioral health. Each consumer with SMI should have a behavioral health provider 
and a physical health provider who consults with the behavioral health provider 
(Manderscheid & Kathol, 2014). However, that seldom happens in the physical 
healthcare setting, and is more likely to succeed in the behavioral health clinic 
(Manderscheid & Kathol, 2014). The second factor is that separate payment systems exist 
for behavioral health conditions, and were originally put into place to adequately 
maximize care (Manderscheid & Kathol, 2014). Separate financing systems were 
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identified by researchers as one of the top barriers to integrating physical and mental 
healthcare because physicians were not held accountable for all aspects of care 
(Manderscheid & Kathol, 2014). The third factor involves stigma related to behavioral 
health conditions. Stigma is less likely to be present in a behavioral health setting 
compared to a physical health clinic where mental health issues may not be treated as 
often, especially SMI (Manderscheid & Kathol, 2014).  
Since many consumers with SMI use behavioral health clinics as their primary 
care setting, these clinics may be most appropriate for implementing integrated care 
programs serving consumers with SMI (Kilbourne, Welsh, Mccarthy, Post, & Blow, 
2008; Manderscheid & Kathol, 2014). There is some evidence that this may be true. 
Authors of a recent study using Missouri Medicaid data revealed that youth and adult 
consumers with SMI were more likely to receive guideline-based metabolic screening in 
CMHCs than in other settings of care (Nicol et al., 2015). However results may have 
proved more positive for CMHCs due to a specific CMHC-focused program 
implemented by Missouri Medicaid prior to the study (Nicol et al., 2015). Use of 
collaborative approaches to patient care based on the CCM are more common in 
behavioral health settings in which care managers play a primary role than in physical 
health settings. As such, care managers help communicate information among members 
of the treatment team, ensure patients are engaged in treatment, encourage adherence to 
treatment plans, track outcomes, and monitor progress (Norquist, 2014).  
The majority of research conducted assessing collocated primary care within a 
behavioral health setting have taken place within the VHA system. The VHA is the 
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largest of the three administrations that comprise the Veterans Administration system, 
and addresses physical and mental health of veterans in the United States (Veterans 
Health Administration, 2015b). The VHA is the largest integrated healthcare system in 
the country and is comprised of 152 hospitals, 800 outpatient clinics, 126 nursing homes, 
and 35 domicillaries (Perlin, Kolodner, & Roswell, 2004; Veterans Health 
Administration, 2015b). The VHA implemented an EMR system in 1997, which allows 
for coordination of care across its sites and also assists with research efforts (Perlin et al., 
2004). Mental health care within the VHA is focused on recovery and practitioners have 
implemented coordinated care models and provide evidence-based care (Veterans Health 
Administration, 2015a).  
Several large studies utilizing VHA administrative data, patient surveys, and chart 
reviews were conducted to assess the effects of colocation of care on receipt of physical 
health screening tests and guideline-concordant care. Results of these studies were mixed, 
with improvement in some, but not all, physical health screening tests and fewer patients 
with mental health issues receiving guideline concordant care than patients without 
mental health issues (Kilbourne, Welsh, Mccarthy, Post, & Blow, 2008; Kilbourne et al., 
2011). The large sample sizes in these studies allowed for robust findings and pointed to 
the need for improvement. Similar to the goals of this study, researchers within the VHA 
system have assessed the impact of collocated care on healthcare service utilization. A 
randomized controlled trial was conducted to assess differences in service utilization, 
cost, and health status associated with collocated care. Consumers with SMI (n=120) 
were randomized to receive physical healthcare either at primary care clinics or 
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collocated in mental health clinics. Researchers showed that consumers who were 
randomized collocated care within the mental health clinics had statistically significant 
increases in primary care visits, decreases in ED utilization, improvements in physical 
health status, and a greater likelihood to receive screening tests than consumers 
randomized to general medical care (Druss, Rohrbaugh, et al., 2001).  
More recently, a cohort study was conducted using chart review data from 97 
veterans with SMI in the VHA system to assess whether enrollment in a collocated 
primary care clinic within a behavioral health setting impacted goal attainment for several 
physical health measures and primary care and ED utilization (Pirraglia et al., 2012). 
Enrollment in collocated primary care was associated with positive results for attainment 
of goals in blood pressure (adjusted odds ratio [AOR] =2.16; 95% confidence interval 
[CI], 1.47 - 3.18) low density lipoprotein cholesterol (AOR = 1.60; 95% CI, 1.10 - 2.34), 
triglyceride level (AOR = 1.64; 95% CI, 1.06 - 2.51), and body mass index (AOR = 1.8, 
95% CI, 1.29, 2.54). However, enrollment in collocated primary care was not associated 
with positive results for attainment of high density lipoprotein cholesterol or hemoglobin 
A1c goals. The number of primary care visits increased significantly from the 
preenrollment  to postenrollment  periods (adjusted count = 3.4; 95% CI, 2.5 - 4.8; p < 
.001), but there was no significant difference in ED service utilization (Pirraglia et al., 
2012). While authors of this study found significant differences in several important 
aspects of care, they did not find significant results for ED service utilization, one of the 
primary endpoints in the current study (Pirraglia et al., 2012). 
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A second cohort study was conducted by researchers within the VHA system to 
assess the association of patient-aligned care teams (PACT) and utilization of healthcare 
services by veterans with posttraumatic stress disorder (PTSD; Randall, Mohr, & 
Maynard, 2014). PACT was put into place within the VHA to improve care coordination, 
management of chronic disease, preventive care, and access to medical specialists 
(Randall et al., 2014). While not identical to the IHC model of care assessed in the 
current study, some of the goals of treatment were similar. Researchers investigated one-
year pre- and post-PACT periods during the time period of 2009 to 2012 using medical 
records for 696,379 unique veterans with PTSD. Of those, 336,123 had PTSD in both 
time periods (Randall et al., 2014). The researchers found that PACT was associated with 
reduced inpatient admissions (incremental effect [IE] = -0.02; 95% CI, -0.03, -0.01), and 
use of specialty services (IE =  -0.45, 95% CI, -0.07, -0.23), and increased primary care 
visits (IE = 0.96, 95% CI, 0.67, 1.25). However, PACT was not associated with changes 
in mental health visits, ED visits, or urgent care visits (Randall et al., 2014). Similarly to 
the Pirraglia study (2012), Randall and colleagues also did not find significant results for 
ED service utilization (Randall et al., 2014). 
Gaps in Prior Research 
While authors of neither of the VHA studies noted above found significant 
differences in ED service utilization, there were some important differences between 
those studies and my study. First, the sample size in the Pirraglia study was small, and 
therefore the study may not have been powered to observe a difference in this indicator 
(Pirraglia et al., 2012). The population in the Randall study was different from the 
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consumers in my study that it included veterans with PTSD rather than community 
dwelling consumers with SMI (Randall et al., 2014). While both SMI and PTSD are 
mental health conditions, the etiologies and treatment guidelines differ. Additionally, the 
PACT services described above refers to specific care teams within VHA physical health 
clinics that include mental health practitioners as part of the care team, rather than 
integrated care within the behavioral health clinic setting (Randall et al., 2014; Veterans 
Health Administration, 2015a). Furthermore, generalizability of findings of studies in the 
VHA to other populations may be limited due to advanced use of EMR data in the VHA, 
as opposed to community settings with less experience. The VHA system also serves a 
selected group of consumers, who may not be reflective of the general United States 
population in terms of demographic characteristics including gender, race, or age (Goulet 
et al., 2007; Pirraglia et al., 2012). Therefore, I addressed integrated care in a community 
mental health center that likely included consumers who were more reflective of the 
United States population than those described in the VHA studies.  
Integrated care that involves combined physical and mental health treatment 
plans, rather than simple colocation of services may provide the highest quality of care 
for consumers with SMI (Gerrity, 2015). However, only a few effective models of 
integrated care within community behavioral health settings exist for consumers with 
SMI (Gerrity, 2015; Schaps & Post, 2015). Researchers from the RAND Corporation 
recently reviewed 56 programs funded by SAMHSA under the Primary and Behavioral 
Health Care Integration grant program. Authors of the review described challenges faced 
by models of physical health collocated in behavioral health settings including culture, 
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space, consent to treatment and information sharing, maintenance of medical records, and 
referral processes. Despite these barriers, one of the programs assessed provided 
additional medical training for psychiatrists in Massachusetts, and demonstrated a 42% 
reduction in ED visits and increases in screening for hypertension and diabetes (Schaps & 
Post, 2015). However, this program was not a true example of integrated care because the 
psychiatrist provided additional medical care, and did not include a medical specialist 
integrated in the behavioral health setting. Authors also identified one example of a 
unified system in Tennessee where primary care was collocated in a behavioral health 
setting at 22 different sites within the Cherokee Health System. In addition to colocation, 
practitioners in this model used regular meetings to discuss patient treatment plans and 
integrated EMR systems, much like Level 6 integrated care previously described by 
Heath et al., 2013. No results were available from this system at the time of publication, 
and therefore it is still unknown whether integrated healthcare within a community 
behavioral health setting lead to changes in patient outcomes (Schaps & Post, 2015). 
Authors of a recent meta-analysis of interventions for medical conditions among 
consumers with SMI found low to medium levels of evidence supporting these 
interventions, and called for further research on implementation strategies in real-world 
settings (McGinty et al, 2016). I conducted the current study to help fill this need.   
Literature Related to Variables 
Consumers with SMI also use intensive healthcare resources at a high rate, 
specifically inpatient and ED services. Of the 9.6 million adult consumers with SMI in 
the United States in 2012, almost 63% used healthcare services (SAMHSA, 2013). In 
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2012, there were 269.8 inpatient stays for mood disorders and 121.9 for schizophrenia. 
These stays were associated with an average length of stay of 6.6 days for mood disorders 
and 10.4 days for schizophrenia and costs of 4.5 billion and 3.1 billion respectively. 
Moreover, the all-cause readmission rate within 30 days of hospital discharge was 15% 
for mood disorders and 22.4% for schizophrenia. Mean cost per readmission was $7,200 
for mood disorders and $8,600 for schizophrenia (Heslin & Weiss, 2015). General 
medical comorbidities and use of acute care services such as EDs were found to be 
predictors of readmission within 30 days for consumers with schizophrenia as was 
increased use of outpatient services (Boaz et al., 2013; Vijayaraghavan, Messer, Xu, 
Sarkin, & Gilmer, 2015). Furthermore, multiple chronic conditions have been associated 
with high expenditures among Medicaid and Medicare dual eligible consumers with 
mental health disorders (Frank & Epstein, 2014). Patients with co-occurring 
schizophrenia and multiple medical comorbidities incurred higher monthly all-cause 
healthcare costs as well as costs related to comorbidities including hypertension, 
substance abuse, and diabetes (Lafeuille et al., 2014).     
Research also points to the contribution of ED to the overall high cost of care 
among consumers with SMI. Researchers noted that a sharp increase in ED use between 
1997and 2007 among Medicaid beneficiaries indicated that the ED may be a safety net 
care center for persons with poor access to healthcare (Tang, Stein, Hsia, Maselli, & 
Gonzales, 2010). Excess use of the ED has been associated with poor access to regular 
primary care. Canadian researchers showed that lack of a regular general practitioner was 
associated with higher ED use when controlling for demographic characteristics 
  
 
38 
(McCusker et al., 2010). A decline in inpatient psychiatric beds over the past few decades 
has resulted in consumers with SMI being boarded in EDs waiting for inpatient care or 
community treatment programs to meet their needs. Researchers have shown that acutely 
ill consumers with SMI may be held in the ED for as long as 36 hours while waiting for 
care (Alakeson, Pande, & Ludwig, 2010; Treatment Advocacy Center, 2015; Zeller, 
Calma, & Stone, 2014). 
In addition to assessing resource use, I also assessed ACS utilization as part of 
this study. ACS conditions have been previously defined as those physical health 
conditions that could be treated in outpatient settings with appropriate access to 
preventive care (Anderson & Knickman, 2001). ED visits of this nature have been 
referred to as ACS conditions, while resulting inpatient admissions for these condition 
were termed preventable admissions (McCusker et al., 2010; Oster & Bindman, 2003). 
Researchers have found that ACS admissions increase as the number of chronic 
conditions increase (Anderson & Knickman, 2001), making this an important construct to 
assess in persons with SMI. The Agency for Healthcare Research and Quality (AHRQ) 
defined ACS hospitalizations as those with primary discharge diagnoses of diabetes, 
perforated appendix, COPD, asthma, hypertension, congestive heart failure (CHF), 
dehydration, bacterial pneumonia, urinary tract infection, angina without procedure, and 
lower-extremity amputation in people with diabetes (AHRQ, 2015). Researchers 
identified these conditions through discharge diagnoses using International Classification 
of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes and procedural 
codes for surgery. Prior researchers utilizing claims data to identify ACS conditions 
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narrowed the original list to include asthma, COPD, CHF, diabetes, and hypertension 
identified using ICD-9-CM codes only (McCusker et al., 2010; Oster & Bindman, 2003). 
For the purposes of this study, the shortened list was used due to data constraints 
preventing use of the procedural codes defined by AHRQ. ACS ED visits and inpatient 
hospitalizations were defined using the same set of ICD-9-CM codes as in prior research. 
In the United States, Federally qualified health centers (FQHC) provide services 
to minimize access barriers to care. Researchers assessing FQHCs showed that their use 
was associated with fewer inpatient admissions and ED visits for ACS conditions in a 
dual-eligible population (Wright, Potter, & Trivedi, 2015). FQHCs provide 
comprehensive services to underserved populations, and as such qualify for enhanced 
funding from Medicare and Medicaid (United States Department of Health and Human 
Services, n.d.-b). Since FQHCs provide services that have been shown to reduce barriers 
to care (Wright et al., 2015), results from this study may help inform a possible role of 
integrated care for consumers with SMI within the behavioral healthcare setting. 
Summary and Conclusions 
SMI affects approximately 5% of the United States population (Regier et al., 
1993; SAMHSA, 2013). Consumers with SMI have shorter lifespans than the general 
population and higher rates of comorbid physical illness due to lifestyle, side effects from 
antipsychotic medication, suboptimal screening, and poor care of physical illnesses (De 
Hert et al., 2011; Mitchell & Lawrence, 2011; Thornicroft, 2011). Intensive healthcare 
resource utilization by consumers with SMI and multiple is common, with medical 
comorbidities and use of acute care services predicting 30-day inpatient readmission rates 
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in schizophrenia (Boaz et al., 2013; Heslin & Weiss, 2015). Researchers also 
demonstrated that multiple chronic conditions were associated with high spending in 
Medicaid and Medicare dual eligible beneficiaries with mental health disorders (Frank & 
Epstein, 2014).  
Integrating behavioral and physical healthcare may help improve care of 
consumers with SMI (Druss, Rohrbaugh, et al., 2001; Frank & Epstein, 2014), but the 
degree of coordination or integration makes a difference. Heath and colleagues (2013) 
described six levels of care, moving from minimal collaboration defined by simple cross-
referrals to fully integrated care defined by creation of joint treatment plans and shared 
medical records (Heath et al., 2013). Traditional models care for consumers with both 
physical and behavioral health conditions typically rely on cross-referrals only, and often 
prove ineffective because consumers often do not attend appointments at the referral sites 
(Heath et al., 2013; Manderscheid & Kathol, 2014). Collocated models in which physical 
and behavioral healthcare practitioners share facility space are an improvement over 
referral models because providers see the same consumers and have a greater degree of 
collaboration, but still fall short of ideal (Heath et al., 2013). Researchers assessing these 
care models have typically focused on integration of behavioral health within primary 
care facilities to treat depression or other less serious mental health issues. These 
researchers have shown some positive outcomes in consumers with depression (Druss et 
al., 2009; Solberg et al., 2013; Thiejke, Vannoy, & Unutzer, 2007); however SMI has 
rarely been a focus of colocation studies (Gerrity, 2015). Integrated care encompasses the 
final two levels of care described by Heath et al., (2013). Level 5 care is characterized by 
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collaborative treatment planning, with Level 6 care also including fully integrated 
electronic medical record systems (Heath et al., 2013).  
Since most consumers with SMI utilize behavioral health clinics as their primary 
care setting, these clinics may be the most appropriate setting for integrated care 
programs serving consumers with SMI (Manderscheid & Kathol, 2014). Authors 
conducting a review of the literature identified several studies that assessed the impact of 
collocated care in behavioral healthcare settings on access to care, quality of life, and 
service utilization (Druss, Rohrbaugh, et al., 2001; Kilbourne, Zongshan, Bowersox, 
Pirraglia, & Bauer, 2011; Pirraglia, Kilbourne, Lai, Friedmann, & O’Toole, 2011). These 
studies, which were described in detail above, were generally conducted within the VHA 
system and therefore may not be generalizable to populations outside of the VHA. 
Through this study, I made an original contribution to the research by assessing the 
impact of a collocated integrated care program with integrated treatment planning on 
primary care-related service utilization within a community-based setting.  
Recent implementation of new health policies and grant programs have advanced 
the issue through emphasis on quality of care for consumers with SMI and provision of 
financing structures for integrated care pilots (Barry & Huskamp, 2011; Druss & Mauer, 
2010; SAMHSA, 2014). The Patient Protection and Affordable Care Act (PPACA) 
strengthened earlier mental health parity laws and provided additional funding for 
physical and behavioral healthcare collocation programs (Davis, 2010; Druss & Mauer, 
2010; Golberstein & Busch, 2013; Mechanic, 2012). SAMHSA has also established the 
Primary and Behavioral Health Care Integration Program to fund pilot programs 
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collocating primary and specialty medical care services in community-based behavioral 
healthcare settings (SAMHSA 2014). While payers in other countries provide funding 
mechanisms for integrated care, such mechanisms are lacking in the United States 
(Pincus et al., 2015). As payers including the Centers for Medicare and Medicaid 
Services (CMS) move toward quality-based reimbursement rather than quantity-based 
reimbursement, an understanding of the effectiveness of these programs in reduction of 
cost and improvement of quality will be important (Burwell, 2015). Through the findings 
from study, I may help inform future health policy regarding value-based payments. 
From a practical perspective, results of this study may help leaders within the data 
partner CMHC assess the success of the IHC program and identify opportunities for 
improvement and confounding variables that need to be addressed for optimal 
implementation. The findings may also enlighten other providers who are interested in 
implementing integrated physical and behavioral health programs by providing evidence 
to better inform decisions prior to spending resources during implementation. The most 
important outcome of this study was the social change implications for consumers with 
SMI. As integrated care models become more common, assessments of the various care 
models will improve the level of evidence available to inform optimal care for this 
population. While consumers with SMI often do not participate in traditional health home 
models (Lichstein et al., 2014), other models of care that are located within community 
behavioral healthcare settings may be more appropriate, thus increasing access to 
physical healthcare and improving outcomes among the SMI population (Barry & 
Huskamp, 2011).  
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In Chapter 3 I provide an overview of the study methodology, including the 
research questions and hypotheses, research design and rationale for choosing that 
design, and a detailed overview of the study data sources. I clearly define the variables 
and the statistical methods as well as threats to study validity. Ethical considerations are 
also outlined.  
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Chapter 3: Methods 
Introduction 
The purpose of this quantitative, retrospective cohort study was to assess the 
impact of integrated healthcare on overall physical health and ambulatory care sensitive 
(ACS)-specific inpatient and emergency department (ED) utilization for consumers with 
serious mental illness (SMI). This was accomplished by evaluating data from an 
integrated health clinic (IHC) within one large community mental health center (CMHC). 
The IHC is a primary care clinic located within the CMHC that offers physical health 
services to adult consumers who receive mental health services at the site. Integrated 
treatment planning between the physical health and mental health providers is an integral 
part of the program (CMHC CEO, Personal communication, May 7, 2015). In this 
chapter, I include a review and rationale for choosing a cohort design, including a 
discussion of how the design built on prior research and added to the body of literature on 
integrated care for consumers with SMI. The methods are also discussed in detail, 
including the population, sample size calculations, and the use of administrative 
secondary data as the basis for this study. I explore threats to validity resulting from the 
study design, methods, and choice of data, along with ethical considerations related to the 
study. 
Research Design and Rationale 
In this study, I quantitatively assessed the nature of a predictive relationship, if 
any, between IHC enrollment and overall physical health and ACS-specific service 
utilization for consumers with SMI. The independent variable was pre- and post-IHC 
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enrollment, and the dependent variables included numbers of overall physical health and 
ACS-specific inpatient admissions, inpatient days, and ED visits. Covariates included 
demographic characteristics (age and gender) and disease severity (primary psychiatric 
diagnosis and comorbidity burden). A retrospective cohort study of secondary 
administrative healthcare data was used in this quantitative study. Researchers use 
quantitative research to test theories objectively by assessing numerical relationships 
among variables, and thus measure the relationship statistically, whereas qualitative 
analyses are used to understand the meaning that people assign to issues (Yilmaz, 2013). 
Researchers of quantitative studies use statistical inference to describe numerical changes 
in measurable characteristics of a population of interest, generalize to other situations, 
and explain causal relationships (Iversen, 2004; Kraska, 2010). A quantitative research 
design was chosen because the dependent variables of interest (healthcare resource 
utilization) were best measured numerically, and assessing the relationship between IHC 
enrollment and healthcare resource utilization was the aim of the study. Researchers have 
used quantitative research methods and administrative healthcare data to successfully 
measure similar outcomes related to healthcare utilization and cost (Birnbaum et al., 
1999). 
Compared to experimental or other observational designs, the retrospective cohort 
design was the more appropriate choice because this study was a program evaluation and 
service utilization and cost available in healthcare administrative data are central to the 
purpose (Mann, 2003). Cohort studies are typically conducted to determine the incidence 
or natural history of a condition and retrospective cohort studies use previously collected 
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data to perform analyses ad hoc (Mann, 2003). Cohort studies allow for examination of 
multiple variables and calculation of the effect of each on the outcome of interest, in this 
case physical health and ACS-specific service utilization (Mann, 2003). An advantage of 
conducting a retrospective cohort study was that the data were collected for a purpose 
other than the study at hand, which helped reduce bias. However, the likelihood of data 
deficiencies exists, as was evident in this study (Mann, 2003).  
A prospective experimental design, in which participants would have been 
randomized to receive IHC, was not appropriate as randomization would not have been 
ethical and was not as naturalistic (Frankfort-Nachmias & Nachmias, 2008). Consumers 
at the CMHC self-selected for inclusion in the IHC, and randomization was therefore not 
possible (Frankfort-Nachmias & Nachmias, 2008). If randomization was attempted there 
may have been ethical concerns regarding one group of consumers receiving physical 
healthcare and another group being withheld from that care (Frankfort-Nachmias & 
Nachmias, 2008). Therefore, choosing a cohort study design using administrative claims 
and EMR data was more appropriate for this study. A time-series design may also have 
been an appropriate approach because this design would have allowed for consumers 
with SMI to be evaluated in their natural treatment settings (Frankfort-Nachmias & 
Nachmias, 2008). However, this study design was not chosen due to time constraints and 
restrictions of Walden University to implement an intervention.  
Secondary data refers to data previously collected by others for purposes not 
related to the current research study (Frankfort-Nachmias & Nachmias, 2008). 
Administrative healthcare data that have been collected by the CMHC for purposes of 
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patient management and billing were used since the purpose of the study was to evaluate 
existing care strategies employed by the CMHC. Administrative healthcare data have 
been used in outcomes research for decades with success in analyzing certain types of 
outcomes that can be measured with these data sources, including healthcare utilization 
and cost (Birnbaum et al., 1999). Linking administrative data to other sources of clinical 
information such as EMR data may help provide additional useful information about the 
quality of patient care (Birnbaum et al., 1999), and I applied this method to my study.  
Several researchers have assessed integrated care programs in the United States 
using cohort studies and nonprobability-sampling methods due to the scarcity of these 
programs, with some using data from the Veteran’s Health Administration (VHA) system 
(Kilbourne et al., 2011; Pirraglia et al., 2011), and others studying small accountable care 
organizations or patient-centered medical homes that have integrated care pilot programs 
(Mueser, Bartels, Santos, Pratt, & Riera, 2012b; Reiss-Brennan, 2014). However, larger 
scale studies of integrated care programs are not possible due to the fact that nation-wide 
sources of data such as administrative claims databases do not capture sufficient 
information to identify which patients are part of integrated care models; therefore 
smaller datasets or chart reviews that identify integrated care program participation 
provide the best opportunity for analysis (Gerrity, 2015).  
The work of two previous groups of researchers within the VHA system helped 
inform the study design and endpoints of the current study (Pirraglia et al., 2012; Randall, 
Mohr, & Maynard, 2014). Pirraglia et al. (2012) assessed 97 veterans with SMI enrolled 
in a collocated integrated primary care clinic within a VHA behavioral health outpatient 
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center and assessed primary care clinic enrollment on outpatient and ED service 
utilization as well as physical health goal attainment. They analyzed change in these 
parameters between the 6-months before and 6-months after enrollment in the primary 
care clinic and found that clinic enrollment was associated with attainment of some 
cardiovascular risk goals and an increase in primary care visits. While Pirraglia and 
colleagues (2012) also employed a cohort design, there were several important 
differences between their study and my study reported here. Pirraglia et al. used chart 
review data from the VHA system as the primary source of data, and thus were able to 
collect physical health measures such as body mass index, hemoglobin A1c (HbA1c) 
level, and lipid test results that were not available to me to assess due to data limitations. 
Furthermore, I assessed inpatient admissions and length of inpatient stay, which were not 
assessed by Pirraglia and colleagues, although primary care outpatient visits were not 
captured in the current study. 
Randall, Mohr, and Maynard (2014) also used a cohort study design to assess the 
association of the patient-aligned care teams (PACT) model of care to use of healthcare 
services among veterans with post-traumatic stress disorder (PTSD). One-year pre- and 
post-PACT periods were assessed and the authors indicated that PACT was associated 
with a lower rates of hospitalization and specialty service, with an increase in primary 
care visits (Randall et al., 2014). Unlike the current study, the pre- and post-PACT 
periods were not assessed by veteran, but rather pre- and post- a particular point in time 
(2010) when PACT was implemented within the VHA system. Therefore, sample sizes 
differed in the pre- and post-PACT periods (Randall et al., 2014). Randall et al. (2014) 
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assessed healthcare service utilization using VHA administrative data; however, data for 
all levels of care were available, while only inpatient admissions and ED visit data were 
available for the current study (Randall et al., 2014).  
Methodology 
An overview of the methodology will be provided in this section, including the 
population and sampling procedures, the use of archival data, and the specific data 
sources used for this study, with an explanation of considerations to be taken into account 
and permissions necessary to obtain the data. In the latter half of the chapter, I will 
address the variables and how they are operationalized.  
Population 
Approximately 5% of the United States population has a diagnosis of SMI 
(SAHMSA, 2013), including 1% with schizophrenia, 2% with bipolar disorder, and 6% 
with major depressive disorder (Regier et al., 1993; SAHMSA, 2013). The CMHC 
system providing the data for this study served approximately12,600 consumers in 2013 
in nine locations throughout the region, with about 3,500 consumers served at the 
primary site, from which data were obtained (CMHC CEO, Personal communication, 
May 7, 2015). It was estimated that approximately 1,000 consumers would the IHC 
during the study period (CMHC CEO, Personal communication, May 7, 2015), and 
approximately 1,500 actually did. Therefore the target population consisted of all CMHC 
consumers who enrolled in the IHC. 
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Sampling and Sampling Procedures 
Since this was an analysis of secondary data, the IHC cohort was extracted from 
the parent population (all consumers at the CMHC accessing IHC services) based upon 
operational definitions and inclusion criteria (purposeful convenience sample). The 
sample for this program evaluation was a nonprobability purposeful convenience sample. 
Nonprobability sampling refers to samples in which there is no way to specify the 
probability of each consumer’s inclusion in the sample or assure that each consumer has a 
chance for inclusion, and a convenience sample is chosen from those available for 
measurement (Frankfort-Nachmias & Nachmias, 2008). This was the most appropriate 
method for this study because the study evaluated integrated health program at a specific 
CMHC. Although nonprobability sampling is not as robust as probability sampling 
(Trochim, 2006), a convenience sample was necessary for this study because of the 
nature of the study. Furthermore, there are no publically available data sets that contain 
information on integrated care programs. Convenience sampling was the most efficient 
way to access this population and answer the questions posed for this study.  
The sample included all consumers who enrolled in the IHC between October 1, 
2013 and September 30, 2015. Patient identification numbers from the IHC electronic 
medical record (EMR) data file were used to identify these consumers. Inpatient and ED 
authorization data were sent to the CMHC by two payers beginning in October 2013. In 
order to maximize available data for consumers enrolled in the IHC, the latest possible 
date to receive files was chosen. Data for consumers whose first visit with the IHC 
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occurred after September 30, 2015 were not analyzed, as a full six months of data 
following initial contact was required.  
The alpha level (or p-value) is the chance of error that researchers are willing to 
accept (Walden University, 2014). For the statistical tests, a p-value less than 0.05 was 
used as the cutoff for statistical significance, with a confidence interval of 95%. A p-
value of less than 0.05 indicates that one in twenty results would be by chance, while the 
confidence interval of 95% indicates that 95 out of 100 times the observed score will fall 
within the range of values (Greenhalgh, 2014). Effect size identifies the strength of the 
conclusions about group differences or the relationships among variables. An effect size 
of 0.1 is considered a small effect size and was chosen to calculate sample size for the 
regression analyses (Cohen, 1992). Power refers to the likelihood of finding a statistical 
difference when one exists and was set at 80% (Field, 2013).  
Using G*Power to compute sample size, estimates were derived for multiple 
linear regression, multiple logistic regression, and paired sample t-tests to arrive at the 
appropriate sample size. The sample size calculation for multiple linear regression with 
an alpha of 0.05, effect size of 0.1, power of 0.80, and 4 predictors yielded a sample size 
of 126 (Faul, Erdfelder, Lang, & Buchner, 2007). Calculations the other tests yielded 
lower sample sizes. The calculations for the t-test yielded a sample of 102, with 51 in 
each cohort. The calculation for multiple logistic regression, one sided, odds ratio of 3.86, 
Pr (Y=1 | X=1) H0 = 0.1, with a p-value of 0.05, power of 0.80, R2 other X of 0.0625, and 
X parm π of 0.5, and Poisson distribution yielded a sample size of 49 and for a binomial 
distribution, a sample size of 108. The calculation for a Poisson regression considered the 
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following input parameters: one tail, Exp(Β1) of 0.8, p-value of 0.05 and power of 0.80, 
base rate of 0.04, mean exposure of 180, R2 other X of 0.0625, binomial distribution and 
X parm π of 0.5, and yielded a sample size of 83 (Faul et al., 2007). Therefore the larger 
sample size calculation of 126 for the multiple linear regression analysis was relied upon 
for the necessary sample size of this study.  
Data for the entire population of consumers enrolled in the IHC who were 18 
years and older, and for whom a full six months of data were available pre- and post-
enrollment was analyzed, resulting in a sample size of 370, greater than the minimum 
sample size required. There were several reasons for using the larger sample for the study 
cohort rather than selecting the minimum number necessary. First, increasing the sample 
size helped control for Type II error, even if just increasing the sample by 10% 
(Frankfort-Nachmias & Nachmias, 2008). Furthermore, a larger sample size helped 
control for attrition in the sample (Frankfort-Nachmias & Nachmias, 2008). There could 
have been a great deal of attrition in a sample of consumers with SMI, due to the transient 
nature of this population, and a full six months of data were necessary pre- and post-IHC 
enrollment. In this study, the difference between the sample size estimate and the 
population expected in the IHC was large enough to account for attrition. 
Archival Data 
The IHC is a primary health clinic that offers physical health care to adult 
consumers who are enrolled in mental health services at the data partner CMHC. 
Consumers seeking mental health services were referred to the IHC by their mental 
health treatment team. Consumers could choose whether or not to access IHC services. 
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The mental health and physical health providers engaged in integrated treatment planning 
for those consumers who chose to seek care with the IHC. Clinical data were stored in 
EMRs for mental health and IHC services; however, the EMRs were separate, non-
integrated systems (CMHC CEO, Personal communication, May 7, 2015).  
Several data files were obtained from the data partner CMHC, including: 
1. CMHC contact files containing consumer demographic information from 
October 1, 2013 to December 31, 2015 for all consumers of the CMHC  
2. Inpatient admission and ED visit authorization data from October 1, 2013 
to December 31, 2015 for consumers of the CMHC enrolled in either 
AmeriGroup or UnitedHealth health plans 
3. IHC EMR data from October 1, 2013 to December 31, 2015 for 
consumers seeking care at the IHC 
Contact files were available for all consumers of the CMHC, and contained basic 
demographic information (e.g. age, gender, insurance provider) and primary psychiatric 
diagnosis, as well as a patient identification number, which enabled linking of the other 
sources of data at a patient level. This file also contained the first date of service at the 
CMHC for each consumer, which was used to ensure a full six months of data pre- and 
postenrollment in the IHC. Two of the three major health plans sent authorization files 
for all CMHC consumers seen at an ED or admitted to an inpatient setting. AmeriGroup 
sent these files weekly while UnitedHealth sent them monthly. These data sets included 
the patient identifier, date of the admission/visit, the number of days of the authorization 
for inpatient admissions, and the International Classification of Diseases, Ninth Edition, 
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Clinical Modification (ICD-9-CM) code corresponding to the primary reason for the 
inpatient admission or ED visit. EMR data were available for the consumers enrolled in 
the IHC program, and contained the patient identifier and date of the visit to the IHC. The 
IHC began accepting consumers in July 2013; however, utilization data were not 
available for the IHC program until October 1, 2013.  
Data from all three of these secondary data sources were extracted from the 
CMHC’s information systems by a CMHC data analyst and transferred to me in 
Microsoft Excel format by the Chief Operations Officer using a secure file transfer 
protocol (SFTP). The data were not de-identified, and were stored on an encrypted hard 
drive until de-identification. The original files were destroyed, leaving only the de-
identified data files.  
Data considerations. Several considerations regarding the above-mentioned data 
files should be noted. First, not all consumers with entries in the CMHC contact files or 
authorization data participated in the IHC program. Therefore, those two data files were 
matched against the IHC EMR file using patient identification number to limit the 
analysis set to only those consumers who had used IHC services. 
Second, the majority of CMHC consumers were served by three health plans but 
only two of the three insurance carriers provided authorization data files for inpatient and 
ED visits back to the CMHC (AmeriGroup and UnitedHealth). Therefore the analyses 
were limited to the consumers covered under these two health plans, which accounted for 
approximately 67% of the CMHC’s population (CMHC CEO, Personal communication, 
May 7, 2015). These data files were de-duplicated to ensure that visits were not being 
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double-counted. For the inpatient data, there was a need to combine separate 
authorizations for the same stay to reflect a single inpatient stay. The earliest admission 
date and latest discharge date captured were used to accurately calculate number of 
inpatient days for each admission. To ensure accuracy in merging separate authorizations, 
rules were applied to ensure each authorization included the same patient identification 
number, authorization number, initial admission date, and facility to correctly define a 
single episode of care (Birnbaum et al., 1999). 
Data regarding physical health outpatient visits provided outside of the IHC were 
not reported back to the CMHC or available in the data files obtained for this study. 
Consumers referred to the IHC were unlikely to have a different primary care provider, 
but that was a possibility. This lack of outpatient data was noted as a potential confounder 
and a limitation to the study. 
Data acquisition and permissions. Permission to access and analyze the data 
used in this study was obtained from the Chief Executive Officer and Chief Operations 
Officer of the CMHC. In June 2015, a Business Associate Agreement (BA) was executed 
between me and the data partner CMHC (Appendix A), which was required by the 
CMHC to ensure compliance as a Covered Entity under the Health Insurance Portability 
and Accountability Act (HIPAA) of 1996 (United States Department of Health and 
Human Services, n.d.-a). A letter of Cooperation (Appendix B), required by Walden 
University, was also executed, further detailing how I used the data. 
Following execution of the Walden University Confidentiality Agreement 
(Appendix C) and Data Use Agreement (Appendix D) the data files were made available 
  
 
56 
to me by the CMHC using a SFTP, and data were stored on an encrypted hard drive. The 
data were not de-identified upon delivery; therefore, all original data was stripped of 
personally identifiable information and files were created for analysis, using the patient 
identification number as the common link between files. The original files were 
destroyed following conversion to the analysis files so that no files containing personally 
identifiable health information remained on my encrypted hard drive.  
Variable Operationalization  
Independent variable. The independent variable was enrollment in the IHC 
program. Enrollment was an identified field in the database, coded as “0” for 
preenrollment in the IHC and “1” for postenrollment in the IHC.  
Dependent variables. The dependent variables included: (a) number of inpatient 
admissions; (b) number of inpatient days; and (c) number of ED visits where the primary 
diagnosis was for a physical health condition. Each inpatient admission and ED visit was 
counted separately as one single event and the total number of admissions/visits were 
calculated for each consumer for the 6-month time periods before and after enrollment 
into the IHC. Similarly, the number of inpatient days were counted for each admission 
and summed to arrive at an absolute number of days hospitalized per consumer for the 
pre- and postenrollment timeframes. Means, standard deviations, medians and 
interquartile ranges for each dependent variable were calculated for the period before and 
after IHC enrollment. The percentage of consumers experiencing an inpatient admission 
or ED visit in both the pre- and postenrollment periods was also assessed. 
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Classification of dependent variables. Each inpatient and ED visit authorization 
contained a single ICD-9-CM code corresponding to the primary reason for the admission 
or visit. These ICD-9-CM codes were used to classify whether the admission or visit was 
for a physical health or mental health diagnosis, and only physical health diagnoses 
qualified for this analysis. A further determination was made as to whether the inpatient 
admission or ED visit was an ACS-specific condition, as defined by prior research. 
Generally, ACS conditions are those that could have been treated in an outpatient setting 
if appropriate access were available (Anderson & Knickman, 2001). ED visits of this 
nature are typically referred to as ACS conditions, while a resulting inpatient admission 
for the condition would be considered a preventable admission (McCusker et al., 2010; 
Oster & Bindman, 2003). For the purposes of this study, both inpatient admissions and 
ED visits were referred to as ACS, and are defined in Table 1 using the ICD-9-CM codes 
from prior research. 
Table 1 
ACS Conditions 
Condition ICD-9-CM Codes 
Asthma 493, 493.0, 493.01, 493.1, 493.2, 493.9 
Chronic obstructive 
pulmonary disease 
466, 491, 491.1, 491.20, 491.21, 491.8, 492, 492.0, 
492.8, 494, 496 
Congestive heart failure 402.01, 402.11, 402.91, 428, 428.0, 428.1, 428.9, 518.4 
Diabetes  250.0–250.3, 250.8–250.10, 250.12, 250.13, 250.20, 
250.22,250.23, 250.30, 250.32, 250.33, 250.90, 250.92, 
250.93 
Hypertension 401.0, 401.9, 402.00, 402.10, 402.90, 403.0, 404.0, 
405.0, 437.2 
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Covariates included the demographic characteristics of consumer age and gender 
and markers of disease severity including primary psychiatric diagnosis and comorbidity 
burden. Primary psychiatric diagnosis was categorized according to prior research 
(Ettner, Frank, McGuire, Newhouse, & Notman, 1998; Ettner, Frank, Mark, & Smith, 
2000) as: psychotic disorder, mood disorder, or substance abuse disorder in combination 
with another psychiatric diagnosis. Comorbidity burden was calculated according to the 
Charlson Comorbidity Index (CCI), which will be described in greater detail below. 
Table 2 
Coding of Variables  
Variable Type of 
Variable 
Coding 
Independent variable   
Enrollment in IHC Binary 0 = preenrollment ; 1 = postenrollment  
 
Dependent variables 
Absolute number of ED visits  Continuous Absolute number of ED visits in each 
study period 
Absolute number of inpatient 
admissions 
Continuous Absolute number of inpatient admissions 
in each study period 
Absolute number of inpatient 
days  
Continuous Sum of days in each study period 
ED visit type Nominal 0 = mental health; 1 = physical health 
non-ACS; 2 = physical health ACS 
Inpatient visit type Nominal 0 = mental health; 1 = physical health 
non-ACS; 2 = physical health ACS 
Covariates   
Age Continuous  Reported as a whole number and 
calculated by subtracting date of birth 
from index date 
Gender Nominal  0 = female; 1 = male 
Initial psychiatric diagnosis  Nominal 1= psychotic disorders (schizophrenia, 
schizoaffective disorder, bipolar 
disorder); 2 = mood disorders such as 
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depression or anxiety; and 3 = substance 
abuse in conjunction with another 
psychiatric disorder 
CCI comorbidity burden  Ordinal 0 = no comorbidity; 1 = mild 
comorbidity; 2 = moderate comorbidity; 
3 or more = severe comorbidity 
 
Data Analysis Plan 
All data were stored in an SPSS data file for analysis and analyzed using SPSS 
Statistics for Mac, Student Edition, version 23 (IBM). In addition to the data 
considerations noted previously in this chapter, several data cleaning procedures were 
also undertaken. First, outliers in the data were identified, defined as those data points 
more than three standard deviations outside of the mean. Outlier values in data can lead 
to both type 1 and type 2 errors (Field, 2013; Laureate Education (Producer), 2009). 
Rather than deleting the outlier data, data were transformed by calculating the square 
root, as recommended for positively skewed data (Laerd Statistics, 2015b). Normality of 
data was also problematic with these data, so Wilcoxon signed-rank tests, the 
nonarametric equivalent statistics, were run in place of paired-samples t-tests (Laureate 
Education (Producer), 2009). Rather than deleting consumers with missing data, missing 
data were treated as a separate category (Laureate Education (Producer), 2009).  
Research Question and Hypotheses. The following is a summary of the two 
main research questions and associated hypotheses of this study. 
RQ1:  What is the predictive relationship, if any, between IHC enrollment and 
overall physical health service utilization for consumers with SMI when controlling for 
demographic characteristics and disease severity?  
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H01: There is no statistically significant predictive relationship between IHC 
enrollment and overall physical health service utilization (number of inpatient admissions 
and ED visits, number of inpatient days) when controlling for demographic 
characteristics (age and gender) and disease severity (primary psychiatric diagnosis, 
disease burden). 
HA1: There is a statistically significant predictive relationship between IHC 
enrollment and overall physical health service utilization (number of inpatient admissions 
and ED visits, number of inpatient days) when controlling for demographic 
characteristics (age and gender) and disease severity (primary psychiatric diagnosis, 
disease burden). 
RQ2: What is the predictive relationship, if any, between IHC enrollment and 
ACS-specific service utilization for consumers with SMI when controlling for 
demographic characteristics and disease burden?  
H02: There is no statistically significant predictive relationship between IHC 
enrollment and ACS-specific service utilization (number of inpatient admissions and ED 
visits, number of inpatient days) when controlling for demographic characteristics (age 
and gender) and disease severity (primary psychiatric diagnosis, disease burden). 
HA2: There is a statistically significant predictive relationship between IHC 
enrollment and ACS-specific service utilization (number of inpatient admissions and ED 
visits, number of inpatient days) when controlling for demographic characteristics (age 
and gender) and disease severity (primary psychiatric diagnosis, disease burden). 
Risk Adjustment. Risk adjustment is a corrective tool used to equalize cohorts in 
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statistical analysis by adjusting for the differences in risk among specific patients 
(Society of Thoracic Surgeons, 2015). Risk adjustment has often been used to adjust 
payment under capitated insurance models to adjust for disease severity in a given 
population (Ettner et al., 1998; Ettner et al., 2000). Primary diagnosis has been used as a 
risk adjustment method in past studies, as have diagnosis related groups and demographic 
characteristics (Ettner et al., 2000; Newhouse, Buntin, & Chapman, 1997). Researchers 
have shown that models using only demographic characteristics perform poorly, but 
when adding psychiatric diagnosis the models performed much better (Ettner et al., 
1998). For the purposes of this analysis, risk adjustment included type of primary 
psychiatric diagnosis in the pre-IHC enrollment period, as defined by ICD-9-CM codes. 
Psychiatric diagnosis was divided into three categories, based on prior research: (a) 
psychotic disorders (schizophrenia, schizoaffective disorder, bipolar disorder); (b) mood 
disorders such as depression or anxiety; and (c) substance abuse in conjunction with 
another psychiatric disorder (Ettner et al., 1998; Ettner et al., 2000). 
The CCI was also used to risk adjust in this analysis. The CCI identified 17 
comorbid conditions predictive of mortality, and was used to assess overall comorbidity 
in the six months prior to enrolling in the IHC (Table 3). The CCI has been used 
extensively as a risk adjuster in database research, and has been shown to be predictive of 
mortality and future excess costs (Charlson, Wells, Ullman, King, & Shmukler, 2014; 
D’Hoore, Bouckaert, & Tilquin, 1996). Moreover, about half of the excess mortality 
among consumers with schizophrenia and bipolar disorder are attributable to diseases 
included in the CCI (Laursen, Munk-Olsen, & Gasse, 2011), indicating that it is an 
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appropriate index for risk adjustment in this study. Deyo, Cherkin, and Choi (1992) 
adapted the CCI for use with ICD-9-CM codes (Deyo, Cherkin, & Ciol, 1992; Quan et 
al., 2005). The CCI is calculated as a weighted measure, with each condition weighted 
according to its relative risk of mortality, and can be age-adjusted by adding a point for 
each decade over the age of 40 (Yang, Chen, Hsu, Chang, & Lee, 2015). Frequency of 
the identified ICD-9-CM codes on inpatient or ED authorizations in the six months prior 
to IHC initiation was used to calculate the age-adjusted CCI for each consumer.  
Table 3 
Charlson Comorbidity Index Coding and Weighting 
Comorbidity ICD-9-CM Codes Weight 
Myocardial infarction 410.x, 412x 1 
Congestive heart failure 428.x 1 
Peripheral vascular disease 443.9, 441.x, 785.4, V43.4, procedure 
38.48 
1 
Cerebrovascular disease 430.x–438.x 1 
Dementia 290.x 1 
Chronic pulmonary disease 490.x–496.x, 500.x–505.x, 506.4 1 
Rheumatic disease 710.0, 710.1, 710.4, 714.0–714.2, 
714.81, 725.x 
1 
Peptic ulcer disease 531.x–534.x 1 
Mild liver disease 571.2, 571.4–571.6 1 
Diabetes without 
complications 
250.0–250.3, 250.7 1 
Diabetes with chronic 
complication 
250.4–250.6 2 
Hemiplegia or paraplegia 344.1, 342.x 2 
Renal disease 582.x, 583–583.7, 585.x, 586.x, 588.x 2 
Any malignancy, including 
lymphoma and leukemia 
(excluding malignant 
neoplasm of skin) 
140.x–172.x, 174.x–195.8, 200.x–208.x 2 
Moderate or severe liver 
disease 
456.0–456.21, 572.2–572.8 3 
Metastatic solid tumor 196.x–199.1 6 
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AIDS/HIV 042.x–044.x 6 
 
Statistical procedures. Overall physical health and ACS-specific inpatient 
admissions and ED visits were assessed comparing the six months before versus the six 
months following the initial IHC enrollment date. Although paired-sample t-tests to 
determine differences in means of service utilization outcomes between the pre- and 
postenrollment timeframe for consumers in the IHC were originally planned, Wilcoxon 
signed-rank tests were used instead due to the skewed nature of the data. Logistic 
regression, a method for modeling a categorical response variable and either categorical 
or continuous predictor variables (Bewick, Cheek, & Ball, 2005; Field, 2013), were run 
to examine the odds of consumers experiencing any inpatient admission or ED visit 
before and after IHC enrollment. Enrollment was examined first as the sole fixed effect. 
Age, gender, initial psychiatric diagnosis, and CCI score were added to the fixed-effects 
portion of the model. Four separate logistic regression models assessed overall physical 
health service utilization and ACS-specific service utilization for inpatient admissions 
and ED visits.  
Linear regression is a technique used by researchers to assess the predictive 
relationship between variables. Simple linear regression involves an outcome variable 
and one predictor variable, while multiple regression involves multiple predictor 
variables (Field, 2013). Simple linear regression models were planned to examine the 
predictive relationship between physical health service utilization (both overall and ACS-
specific) and IHC enrollment alone. Multiple linear regression analyses using the forced 
entry method examined the predictive relationship between physical health service 
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utilization and IHC enrollment, demographic characteristics, and disease severity. 
Consistent with the forced entry method, predictors were entered into the model at the 
same time, making no decisions regarding the order that the predictors were added (Field, 
2013). Separate multiple regression models were run for overall physical health service 
utilization and ACS-specific service utilization for each type of service, including 
inpatient admissions, inpatient days, and ED visits, resulting in a total of six multiple 
linear regression models.  
Poisson regression models are useful when outcome data are counts, as in this 
current study (Field, 2013; Shanmugam, 2007) and also for low frequency, highly-
skewed data (Nussbaum, Elsadat, & Khago, 2008). The data in the current study was 
highly skewed, and therefore, Poisson regression analyses were employed to examine the 
predictive relationship between IHC enrollment and physical health service utilization. 
Enrollment was examined first as the sole fixed effect, with age, gender, primary 
psychiatric diagnosis, and CCI score added to the fixed-effects portion of the models. 
Separate Poisson regression models were run for overall physical health service 
utilization and ACS-specific service utilization, and for each type of service, including 
inpatient admissions, inpatient days, and ED visits, resulting in a total of six Poisson 
regression models. 
Interpretation of results. For the statistical tests, a p-value >0.05 was used to as 
the cutoff for statistical significance, with a confidence interval of 95%. A p-value of 
>0.05 indicates that one in 20 results would be by chance, while the confidence interval 
of 95% indicates that 95 out of 100 times the observed score will fall within the range of 
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values (Greenhalgh, 2014). Paired samples t-tests were planned to assess whether the 
means of inpatient admissions, days hospitalized, and ED visits were statistically 
significantly different pre- and post- enrollment into the IHC. However Wilcoxon signed-
rank tests were run instead as the non-parametric alternative and assessed using the same 
significance levels as the paired samples t-tests would have been.     
Logistic regression results were interpreted using odds ratios, which are the odds 
of an event occurring in one group versus another (Field, 2013). Odds ratios of less than 
one indicate a negative relationship between the independent variable and the dependent 
variable whereas those greater than one indicated a positive relationship (Morrow, 2014). 
In this study, odds ratio assessed the odds of any inpatient admission or ED visits 
occurring in the pre- and post-enrollment timeframe. Multiple linear regression results 
were interpreted using the F-test to assess whether the overall models were statistically 
significant and predictive of service utilization, while the t-statistics for each predictor 
variable indicated the level of its statistical significance.   
Threats to Validity 
The primary limitation of the study was associated with the methodology. Since a 
retrospective cohort design using a convenience sample, bias is introduced in that the 
consumers enrolled in the IHC of their own volition. Therefore, the results were not 
generalizable to a population beyond the clients at the CMHC who enrolled in the IHC 
program (Mann, 2003; Phua, 2007). However, this study will add to the body of literature 
about collocated  integrated care programs in general. Confounding variables are another 
threat to the study. Confounding variables are independently related to both the 
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independent and dependent variables (Mann, 2003). In this study, regression analyses 
were run to help control for demographic characteristics that may confound the study. 
However, other confounding variables not captured in the data available for analysis may 
have impacted the results, and this issue was addressed in the limitations section of 
Chapter 5. 
Furthermore, this study used secondary data (administrative claims and EMR 
data) to assess whether the IHC was associated with physical health inpatient and ED 
service utilization. The information that secondary data provided was more limited than 
what I would have collected if I gathered my own data (Frankfort-Nachmias & 
Nachmias, 2008). There may have been other important indicators of IHC success, such 
as consumer satisfaction, that were not assessed using administrative secondary data. 
However, using administrative data for this study may allow others to more closely 
replicate the methodology with other integrated care programs (Frankfort-Nachmias & 
Nachmias, 2008). There may also have been confounding variables not accounted for in 
the administrative data that influenced change in resource use. Due to these threats to 
internal validity, causality was not confirmed. Finally, different persons involved in the 
consumer’s care entered data used in the analysis into the administrative systems. 
Therefore, data entry errors may have existed leading to inaccuracies in the data. 
However, use of both authorization and EMR data sources to identify inpatient 
admissions and ED visits increased the validity of the findings through angulation 
(Frankfort-Nachmias & Nachmias, 2008).  
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I initially thought that study sample retention would pose a threat to internal 
validity and attrition would need to be accounted for (Frankfort-Nachmias & Nachmias, 
2008). However, this did not turn out to be the case with the consumers at the CMHC. 
One reason may be that they were covered by Medicaid and not as likely as consumers 
covered by commercial insurance to switch health plans or move to other locations. 
Experimental mortality may have been an issue, and consumers in the IHC cohort may 
have been lost to attrition following IHC initiation, but all data prior to initiation were 
available since I limited the analysis to those consumers with a full six months of data 
pre- and post- IHC enrollment (Frankfort-Nachmias & Nachmias, 2008). 
Data Considerations and Ethical Procedures  
There were several ethical considerations for this study; most relating to the fact 
that the research data included protected health information (PHI). The Health 
Information Portability and Authorization Act (HIPAA) provided federal protections for 
individually identifiable health information and gives patients rights with respect to use 
of that information. However, HIPAA is balanced to allow disclosure of PHI needed for 
patient care and other important purposes (United States Department of Health and 
Human Services, n.d.-a). Several documents regarding researcher access to the data were 
put into place prior to data transfer. In June 2015, I signed a Business Associate 
agreement with MHC, which is required by MHC, as it is a Covered Entity as defined by 
HIPAA (Appendix A). Before receiving data from the CMHC, a Confidentiality 
Agreement acknowledging researcher access to confidential information was signed, 
holding me accountable to not disclosing the confidential information, either formally or 
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informally (Appendix C). Furthermore, both representatives from the CMHC and I 
signed a Data Use Agreement (DUA) that identified the exact data to be transferred and 
indicated the purposes for which the data were used (Appendix D).  
HIPAA guidelines also dictate that data collection and storage must be secure to 
protect PHI of research subjects. To comply with HIPAA regulations, the data files were 
made available by the CMHC using a secure file transfer protocol, and data were stored 
on an encrypted hard drive. The data were not de-identified upon delivery; therefore, all 
original data was stripped of personally identifiable information and files were created for 
analysis, using the patient identification number as the primary patient identifier. The 
original files were destroyed following conversion to the analysis files so that no files 
containing PHI remained on an encrypted hard drive, preventing data from being linked 
back to an individual consumer of services (Frankfort-Nachmias & Nachmias, 2008). 
There were several other ethical considerations for this study. The consumers of 
the CMHC all have an SMI diagnosis, and therefore are considered a vulnerable 
population. No intervention was conducted as part of the study, as the IHC program had 
already been implemented by the CMHC. The lack of intervention with human 
participants minimized the risks of dealing with a vulnerable population. A quasi-
experimental design was chosen because this design allows for consumers with SMI to be 
evaluated in their natural treatment settings. Utilization of IHC and the associated 
outcomes, therefore, are naturally occurring in the CMHC setting. 
The data sources for this study were secondary data sources, so no informed 
consent was required. However, caution was used when analyzing the data and reporting 
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results. Due to the sensitivity of healthcare related information, I protected the privacy of 
the information (Frankfort-Nachmias & Nachmias, 2008). In addition to the storage of 
data described above, results were reported at the population level only for dissemination 
purposes; therefore data cannot be directly linked to an identified consumers, further 
protecting privacy (Frankfort-Nachmias & Nachmias, 2008). The Walden University 
Institutional Review Board (IRB) reviewed and approved the study prior to inception 
(IRB approval number 05-17-16-0449950). 
Summary 
As discussed in this chapter, the purpose of this study was to assess the 
association of integrated care with physical health inpatient and ED utilization for 
consumers with SMI through an evaluation of an integrated health clinic within one large 
CMHC. The main research question addressed by this study was: What is the relationship 
between IHC enrollment and physical health service utilization, including ACS-specific 
conditions, for consumers with SMI when controlling for demographic characteristics? 
The research question was answered using a retrospective cohort analysis of 
administrative healthcare data. 
The independent variable was enrollment in the IHC and the dependent variables 
included the absolute numbers of inpatient admissions and ED visits and absolute number 
of inpatient days where the primary diagnosis was for a physical health condition. In this 
study, I used a retrospective cohort design, in which administrative healthcare data for 
CMHC consumers was obtained for the period starting October 1, 2013 and ending 
December 31, 2015. Physical health inpatient admissions and ED visits (overall and 
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ACS-specific) were compared for the six months before versus six months following 
initial IHC enrollment date. In Chapter 4, I present the results of the study, including a 
detailed description of the statistical findings and associated results tables.  
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Chapter 4: Results  
Introduction 
In this quantitative study, I assessed the impact of integrated care on overall 
physical health and ambulatory care sensitive (ACS)-specific inpatient and emergency 
department (ED) utilization for participants with serious mental illness (SMI). The study 
evaluated the effect of an integrated health clinic (IHC) providing physical health care 
within a large community mental health center (CMHC). The first research question that 
was addressed by this study was: What is the predictive relationship, if any, between IHC 
enrollment and physical health service utilization for participants with SMI when 
controlling for demographic characteristics and disease severity? The second research 
question sought to assess the predictive relationship, if any, between IHC enrollment and 
ACS-specific service utilization for participants with SMI when controlling for 
demographic characteristics and disease severity. 
This chapter includes (a) secondary data used in the analysis, including the 
timeframes of the data and the final sample size, (b) baseline demographic information 
characterizing the sample and results from the univariate analyses, including a detailed 
description of risk stratification data, (c) findings from logistic, multiple linear, and 
Poisson regression analyses, first for the analyses of overall physical health utilization, 
and next for ACS-specific utilization, and (d) findings from additional analyses. 
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Data Collection 
Data were collected from three sources within the CMHC, including CMHC 
contact files containing consumer demographic information from October 1, 2013 to 
December 31, 2015 for all consumers of the CMHC, inpatient admission and ED visit 
authorization data from October 1, 2013 to December 31, 2015 for consumers of the 
CMHC enrolled in either AmeriGroup or UnitedHealth health plans, and IHC electronic 
medical record (EMR) data from October 1, 2013 to December 31, 2015 for consumers 
seeking care at the IHC. A total of 1507 potential participants had at least one visit to the 
IHC. Of those, 370 met the enrollment criteria, including having six months of data pre- 
and post- index date (first visit to the IHC) available for analysis, were 18 years of age or 
older, and insured by either Amerigroup or UnitedHealth. These participants (n = 370) 
comprised the full analysis set (FAS) for whom data were analyzed.  
Demographic characteristics of the FAS are displayed in Table 4. The mean 
(standard deviation [SD]) age at index of the FAS was 43.0 [12.3] years and 45.7% were 
male. AmeriGroup served as the primary insurer for 81.6% while 18.4% were enrolled in 
UnitedHealth. At index date, 329 (88.9%) of participants were in low intensity services 
such as assertive community treatment (ACT) or ACT case management style programs, 
which provided approximately two mental health visits per month at the CMHC. Another 
23 (6.2%) participants were in medium intensity community treatment team (CTT) 
programs, offering approximately four mental health visits per month. Finally 18 (4.9%) 
were in high intensity services such as program of assertive community treatment 
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(PACT) or PACT case management, which consisted of approximately six mental health 
visits per month to the CMHC.  
Table 4  
Baseline Demographic Characteristics  
Characteristic FAS 
(n = 370)  
Age, mean years (SD) 43.0 (12.3) 
Gender, male (%) 169 (45.7%) 
Insurance plan  
     AmeriGroup, n (%) 302 (81.6%) 
     UnitedHealth, n (%) 68 (18.4%) 
Level of service  
     Low, n (%) 329 (88.9%) 
     Medium, n (%) 23 (6.2%) 
     High, n (%) 18 (4.9%) 
Time pre-index, mean (SD) 40.8 (47.5) 
Time post-index, mean (SD) 20.9 (7.3) 
 
Risk Adjustment  
Primary psychiatric diagnosis and Charlson Comorbidity Index (CCI) score 
during the pre-IHC enrollment period, as defined by International Classification of 
Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes, were the main risk 
stratification variables. Participants were divided into three categories based on 
psychiatric diagnosis: (a) psychotic disorders, including schizophrenia, schizoaffective 
disorder, and bipolar disorder; (b) mood disorders such as depression or anxiety; and (c) 
substance abuse in conjunction with another psychiatric disorder (Ettner et al., 1998; 
Ettner et al., 2000). The majority of participants (74.3%) in the FAS had a primary 
psychiatric diagnosis of psychotic disorder, while 20.8% had mood disorders and .3% 
had a co-occurring substance use disorder (Table 5). Overall comorbidity was assessed 
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using the CCI, a standard measure of comorbidity and identifies 17 comorbid conditions 
predictive of mortality and future excess costs (Charlson, Wells, Ullman, King, & 
Shmukler, 2014; D’Hoore, Bouckaert, & Tilquin, 1996). Comorbidity burden was 
assessed in the pre-index period six months prior to enrolling in the IHC. The mean (SD) 
CCI score was .005 (.104), with a maximum value of 2.00 (Table 5). Of note, only one 
participant had preenrollment utilization that met the ICD-9-CM criteria for a CCI 
condition. The other participants were coded as “0” for CCI score and the mean CCI was 
calculated for the entire sample. 
Table 5 
Risk Stratification Variables 
Variable FAS 
(n = 370)  
Primary psychiatric diagnosis  
     Psychotic disorders, n (%) 275 (74.3%) 
     Mood disorders, n (%) 77 (20.8%) 
     Concomitant substance use, n (%) 1 (.3%) 
     Other, n (%) 14 (3.8%) 
     Missing, n (%) 3 (.8%) 
CCI score, mean (SD) .005 (.104) 
 
Descriptive Statistics 
Descriptive statistics were run for the utilization variables (Table 6). Overall 
physical health inpatient admissions, inpatient days, and ED visits were those with an 
ICD-9-CM code on the authorization for a physical health diagnosis. ACS-specific 
conditions were defined as conditions that could have been treated in an outpatient setting 
if appropriate access was available, and included asthma, chronic obstructive pulmonary 
disease, congestive heart failure, diabetes, and hypertension (Anderson & Knickman, 
  
 
75 
2001). Physical health pre-and post-index inpatient admissions and ED visits were low in 
this study sample, as were post-index ACS-specific inpatient admissions and ED visits. 
There was no pre-index ACS-specific utilization of any kind. 
Table 6 
Pre- and Post-IHC Index Utilization 
 
Results  
Research Question 1: Overall Physical Health Service Utilization 
The first research question was: What is the predictive relationship, if any, 
between IHC enrollment and overall physical health utilization for consumers with SMI 
when controlling for demographic characteristics and disease severity? The null 
hypothesis was that there was no statistically significant predictive relationship between 
IHC enrollment and overall physical health service utilization when controlling for 
Utilization  Min Max Mean (SE) SD 
Pre-index physical health inpatient 
admissions 
0.00 1.00 0.008 (.047) 0.090 
Post-index physical health inpatient 
admissions 
0.00 5.00 0.051 (.018) 0.353 
Pre-index physical health inpatient days 0.00 2.00 0.011 (.007) 0.127 
Post-index physical health inpatient days 0.00 51.00 0.297 (.150) 2.877 
Pre-index physical health ED visits 0.00 3.00 0.073 (.019) 0.372 
Post-index physical health ED visits 0.00 17.00 0.603 (.076) 1.456 
Pre-index ACS-specific inpatient 
admissions  
0.00 0.00 0.000 (.000) 0.000 
Post-index ACS-specific inpatient 
admissions 
0.00 2.00 0.014 (0.008) 0.156 
Pre-index ACS-specific inpatient days 0.00 0.00 0.000 (0.000) 0.000 
Post- index ACS-specific inpatient days  0.00 30.00 0.097 (0.082) 1.576 
Pre-index ACS-specific ED visits 0.00 0.00 0.000 (0.000) 0.000 
Post-index ACS-specific ED visits 0.00 2.00 0.019 (0.008) 0.155 
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demographic characteristics (age and gender) and disease severity (primary psychiatric 
diagnosis and CCI score). The alternative hypothesis was that there was a statistically 
significant predictive relationship between IHC enrollment and overall physical health 
service utilization when controlling for demographic characteristics and disease severity. 
Paired-samples t-tests were planned; however, due to the skewed nature of the 
data, Wilcoxon signed-rank tests were run instead, as these are the non-parametric 
equivalent of paired-samples t-tests (Field, 2013). Simple linear regression, multiple 
linear regression, and Poisson regression analyses were also planned. However, the since 
the primary predictor variable in the regression was binary (pre/post enrollment in the 
IHC), the simple linear regression analyses were not run, as they require a continuous 
predictor variable (Laerd Statistics, 2015a). 
Wilcoxon Signed-Rank test. Of the 370 participants, three experienced a 
decrease in overall physical health inpatient admissions and inpatient days post-index, 
whereas 11 had an increase, and 356 had no change. There were statistically significant 
median increases in physical health inpatient admissions (z = 2.433, p = .015) and 
inpatient days (z = 2.833, p = .005) following IHC enrollment compared to before IHC 
enrollment, as per Wilcoxon signed-rank tests. Of the 370 participants, 15 experienced a 
decrease in physical health ED visits post-index, whereas 109 had an increase, and 246 
experienced no change. There were also statistically significant median increase in 
overall physical health ED visits following IHC enrollment compared to before, z = 
7.547, p < .0005 according to the Wilcoxon signed-rank test. 
Logistic regression. Initially, I ran stepwise logistic regression analyses to 
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examine the odds of participants experiencing any physical health inpatient admission or 
ED visit pre- and post-index. For the logistic regression models, counts of inpatient 
admissions and ED visits were recoded into a bivariate variable where “0” = no 
admission/visit and “1” = any admission/visit. Inpatient admissions and ED visits were 
assessed separately for pre- and post-index periods so the analysis file had two rows per 
participant, one for pre-index and one for post-index, with either a 0 or 1 indicating 
whether or not the participant experienced a physical health inpatient admission or ED 
visit during each one of those periods. IHC enrollment was examined first as the sole 
fixed effect with age, gender, initial psychiatric diagnosis, and CCI score added to the 
fixed-effects portion of the models. Separate analyses were run for inpatient admissions 
and ED visits.   
Physical health inpatient admissions. There were 13 studentized residuals with 
values outside of two standard deviations above or below the mean. These were retained 
in the analyses following examination of the data and a determination that the outliers 
were flagged for having positive values for inpatient admissions. Since admissions were 
coded as “0” for no admission and “1” for any admission, transforming the data was not 
possible. Stepwise logistic regression was run entering IHC enrollment as the sole first 
effect, followed by the other variables in the second step. The model using IHC 
enrollment alone was the best fit as a predictor of overall inpatient admissions 
(Χ2(1,4.948), p = .026). The model indicated that between 3.9% and 7.7% of the variance 
in the criterion was explained by IHC enrollment depending on the use of the Cox & 
Snell R² (.077) or the Nagelkerke R² (.039). The model correctly predicted the odds of 
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any physical health inpatient admissions 98.1% of the time, while it successfully 
predicted 100% of the “no inpatient admission” category, and 0% of the “any inpatient 
admission” category. The second model adding age, gender, initial psychiatric diagnosis, 
and CCI score to the original model did not improve the ability to predict physical health 
admissions (Χ2(8, 12.361), p = .136). The odds ratios for the first block are reported in 
Table 7.  
Table 7 
Odds Ratio for Experiencing Any Physical Health Inpatient Admission  
    95% CI for Exp(B) 
 B p-value Exp(B) Lower Upper 
IHC enrollment 1.321 .044 3.748 1.037 13.547 
Constant -4.807 .000 0.008   
 
Although the model statistically significantly predicted any physical health 
admission (p = .026), the percentage of overall variance explained by the model was low 
and none of the “any admissions” category could be explained; therefore, the null 
hypothesis was retained.  
Physical health ED visits. I ran a stepwise logistic regression model to predict the 
odds of a participant experiencing any physical health ED visit. There were 17 
studentized residuals with values outside of two standard deviations above or below the 
mean. As in the first model, these cases were retained in the analysis. Although the first 
block of the logistic regression was a good fit to describe IHC enrollment as a predictor 
of a physical health ED visit (Χ2(1,94.657), p < .001), adding age, gender, initial 
psychiatric diagnosis and CCI score to the original model improved its statistical 
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significance (Χ2(8,115.011), p < .001). This model explained between 14.4% and 24.0% 
of the variance in physical health ED visits. The model had an overall success of 82.7% 
at predicting the odds of an ED visit (.1% less than the original predictor of enrollment). 
The model successfully predicted 99.3% of the “no ED visit” category, and 2.4% of the 
“any ED visit” category. IHC enrollment (Wald Χ2 = 66.317, p < .001) and gender (Wald 
Χ2 = 5.717, p = .017) were statistically significant predictors; however, the other 
variables were not. The odds ratios for the second block are reported in Table 8. The odds 
ratio for IHC enrollment (ExpB=10.150, CI [5.811, 17.729]) indicated that the odds of a 
physical health ED visit increased tenfold post-index. The odds ratio for gender 
(ExpB=1.714, CI [1.102, 2.665]) indicated that odds of an ED visit increased by 1.71 
with female gender.  
Table 8 
Odds Ratios for Experiencing Any Physical Health ED Visit  
    95% CI for Exp(B) 
 B p-value Exp(B) Lower Upper 
IHC enrollment 2.317 .000 10.150 5.811 17.729 
Age -0.017 .064 0.984 0.966 1.001 
Gender 0.539 .017 1.714 1.102 2.665 
Psychosis 0.402 .114 1.495 0.908 2.461 
Mood disorder 1.559 .353 4.756 0.177 127.562 
Substance use 0.537 .291 1.711 0.631 4.639 
CCI score 2.595 .121 13.400 0.505 355.671 
Constant -2.909 .000 0.055   
 
Although the model itself was a good predictor of a participant experiencing any 
physical health ED visit, not all inputs into the model individually statistically 
  
 
80 
significantly predicted the odds of experiencing an ED visit; therefore, the null 
hypothesis was retained. 
Multiple linear regression. Next, I examined the predictive relationship between 
physical health utilization and IHC enrollment, demographic characteristics, and disease 
severity using multiple linear regression analyses. In the forced entry method, predictors 
were entered into the model simultaneously, making no decisions regarding the order of 
the predictors (Field, 2013). Separate regression models were run for each type of 
service, including inpatient admissions, inpatient days, and ED visits, resulting in three 
regression models for overall physical health utilization.   
Initially I ran multiple regression models on the data set using original count data 
for the utilization variables. Although the Durbin-Watson statistics indicated that there 
was independence of residuals for the models, scatter plots showed evidence of non-
linearity and casewise diagnostics flagged all inpatient and ED utilization as outliers, 
since there were so few positive events. Therefore, a square root transformation was 
applied to the data to correct for moderately positively skewed data (Laerd Statistics, 
2015b).  
Physical health inpatient admissions. In the first regression model I assessed the 
predictive relationship between overall physical health inpatient admissions, as measured 
by the square root of inpatient admissions, and IHC enrollment, demographic 
characteristics, and disease severity. Partial regression plots and a plot of studentized 
residuals against the predicted values indicated linearity, and the Durbin-Watson statistic 
of 2.059 indicated independence of residuals. There was homoscedasticity, as assessed by 
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visual inspection of a plot of studentized residuals versus unstandardized predicted 
values. There was no evidence of multicollinearity, as assessed by tolerance values 
greater than 0.1. There were no studentized deleted residuals greater than ±3 standard 
deviations from the mean, no leverage values greater than 0.2, or values for Cook's 
distance above 1. The normality of errors assumption was violated, as assessed by the 
skewed nature of the data and the P – P plot. 
The model was a good fit, F(5, 734) = 2.264; p = .047; however, the R2 value 
indicated a small effect size, as the model accounted for 1.5% of the variance in inpatient 
admissions, with an adjusted R2 value of .8%. As shown in Table 9, enrollment in the 
IHC (p = .019) predicted inpatient admissions at a statistically significant level but none 
of the other variables were predictive. There was a significant positive correlation 
between IHC enrollment and inpatient admissions as noted by the standardized 
coefficient, indicating that following enrollment, inpatient admissions increased.  
Table 9 
Individual Predictors of Physical Health Inpatient Admissions 
Model Unstandardized coefficients 
Standardized 
coefficients   
 B SE B t p-value 
(Constant) -.002 .033  -0.055 .956 
IHC enrollment .029 .013 .086 2.351 .019 
Age (years) .001 .001 .045 1.218 .226 
Gender -.018 .013 -.052 -1.408 .163 
Psychiatric diagnosis .007 .004 .059 1.607 .108 
CCI score -.017 .060 -.010 -0.281 .778 
  
Although the p-value (p = .047) indicated that the model including IHC 
enrollment, age, gender, psychiatric diagnosis and CCI score statistically significantly 
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predicted physical health inpatient admissions, the R² value indicated that the model only 
predicted 1.8% of variance. Furthermore, only one of five variables was an independent 
statistically significant predictor (p = .019), and the assumption of normality was 
violated. Therefore no conclusive decision could be made about the null hypothesis. 
Physical health inpatient days. The model assessing the predictive relationship 
between overall physical health inpatient days and IHC enrollment, demographic 
characteristics, and disease severity also displayed linearity, independence of residuals 
(as assessed by a Durbin-Watson statistic of 2.067), and homoscedasticity. There was no 
evidence of multicollinearity. There were four studentized deleted residuals greater than 
±3 standard deviations, but these cases were retained in the analysis because there were 
no leverage values greater than 0.2 or values for Cook's distance above one. However, the 
normality of errors assumption was violated, as assessed by visual inspection of the 
histogram and the P – P plot, even after the dependent variable had been transformed. 
The model accounted for 2.3% of the variance in physical health inpatient days as 
indicated by the R2 value and was a good fit (F(5, 734) = 3.481; p = .004); however, the 
model did not generalize well, as indicated by the adjusted R2 value of .017. As shown in 
Table 10, both IHC enrollment and initial psychiatric diagnosis predicted physical health 
inpatient days at statistically significant levels, while the other variables did not. The sign 
of the standardized coefficients indicated that the correlations for both variables were 
positive; therefore, inpatient days increased in the post-index period following IHC 
enrollment. As the value for initial psychiatric diagnosis increased, so did overall 
inpatient days. 
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Table 10 
Individual Predictors of Physical Health Inpatient Days 
Model Unstandardized coefficients 
Standardized 
coefficients   
 B SE B t p-value 
(Constant) -.061 .076  -0.805 .421 
IHC enrollment .072 .028 .093 2.539 .011 
Age (years) .002 .001 .059 1.590 .112 
Gender -.033 .029 -.043 -1.160 .246 
Psychiatric diagnosis .027 .009 .104 2.829 .005 
CCI score -.032 .137 -.009 -0.233 .816 
  
The model predicted physical health inpatient days at a statistically significant 
level (p = .004); however, the model predicted less than 5% of variance, as indicated by 
the R² value. The assumption of normality was violated, and IHC enrollment (p = .011) 
and initial psychiatric diagnosis (p = .05) were the only statistically significant 
independent predictors of inpatient days. Therefore no conclusive decision was made 
about the null hypothesis. 
Physical health ED visits. I used a third regression model to assess the predictive 
relationship between physical health ED visits, as measured by the square root 
transformation, and IHC enrollment, demographic characteristics, and disease severity. 
There was linearity, independence of residuals as assessed by a Durbin-Watson statistic 
of 1.771, and homoscedasticity. There was no evidence of multicollinearity. There was 
one studentized deleted residual greater than ±3 standard deviations, but this case was 
retained due to low utilization no leverage values greater than 0.2 or values for Cook's 
distance above one. As in the other two models, the normality of errors assumption was 
violated, as assessed by the skewed histogram and the P – P plot.  
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The model accounted for 12.1% of the variance in ED visits as assessed by the R2 
value, and the model was a good fit, F(5, 734) = 20.244; p < .001, adjusted R2 = 11.5%). 
As shown in Table 11, IHC enrollment, gender, and initial psychiatric diagnosis predicted 
ED visits at statistically significant levels, but age and CCI score did not. The sign of the 
standardized coefficients indicated that there was a statistically significant positive 
correlation between all three significant variables and ED visits. Physical health ED visits 
increased following IHC enrollment, with female gender, and with larger values for 
psychiatric disorders.  
Table 11 
Individual Predictors of Physical Health ED Visits 
Model Unstandardized coefficients 
Standardized 
coefficients   
 B SE B t p-value 
(Constant) -.054 .099  -0.549 .583 
IHC enrollment .342 .037 .319 9.231 .000 
Age (years) -.002 .002 -.042 -1.187 .236 
Gender .091 .037 .085 2.436 .015 
Psychiatric diagnosis .030 .012 .084 2.405 .016 
CCI score .178 .179 .034 0.993 .321 
  
The model statistically significantly predicted physical health ED visits (p < 
0.001) and three of the five variables were independent predictors at statistically 
significant levels (IHC enrollment, p < .001; gender, p = .015; initial psychiatric 
diagnosis, p = .016). However, according to the R² value, only 12% of the variance in the 
model was explained, and visual inspection of the histogram revealed positively skewed 
data despite transformation of the dependent variable. Therefore no conclusive decision 
could be made about the null hypothesis. 
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Poisson regression. Poisson regression analyses were also used to examine the 
predictive relationship between IHC enrollment and overall physical health service 
utilization because the dependent variables were count data. IHC enrollment was 
examined first as the sole fixed effect, with age, gender, initial psychiatric diagnosis, and 
CCI score added to the models. Separate Poisson regression models were run for overall 
physical health inpatient admissions, inpatient days, and ED visits. However, when 
initially run, the CCI score caused Hessian matrix singularity due to the low number of 
participants with a CCI score. Therefore, this variable was removed from all models and 
the models were re-fit to include only age, gender, and initial psychiatric diagnosis in the 
second step of the model (Laerd Statistics, 2015c). 
The Poisson regression to predict physical health inpatient admissions that 
included IHC enrollment, age, gender, and initial psychiatric diagnosis showed slight 
overdispersion (Pearson chi-square = 2.034) but was statistically significant, per the 
omnibus test. IHC enrollment, age, and initial psychiatric diagnosis statistically 
significantly predicted inpatient admissions. In the post-index period, 0.158 (95% CI, 
0.047 to 0.534) times more inpatient admissions occurred (p = .003). For every additional 
year of age, 1.038 (95% CI, 1.002 to 1.075) times more inpatient admissions occurred (p 
= .040). For every additional increase in initial psychiatric diagnosis, 1.331 (95% CI, 
1.158 to 1.530) times more inpatient admissions occurred (p < .001). Since not all of the 
independent variables statistically significantly predicted inpatient admissions, the null 
hypothesis was retained. 
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For the Poisson regression to predict the number of overall physical health 
inpatient days based on enrollment in the IHC, the model including IHC enrollment, age, 
gender, and initial psychiatric diagnosis was the best predictor. Overdispersion was noted 
but to a lesser degree than in the model with IHC as the sole predictor variable (Pearson 
chi-square = 9.733). Following IHC enrollment, 0.036 (95% CI, 0.013 to 0.099) times 
more inpatient days occurred (p < .001). For every additional year of age, 1.065 (95% CI, 
1.047 to 1.083) times more inpatient days occurred (p < .001). If gender was male, 0.482 
(95% CI, 0.320 to 0.727) times more inpatient days occurred (p = .001). For every 
additional increase in initial psychiatric diagnosis, 1.569 (95% CI, 1.490 to 1.652) times 
more inpatient days occurred (p < .001). Since the model was statistically significant, per 
the omnibus test, and all variables significantly predicted inpatient days, the null 
hypothesis was rejected. 
In the Poisson regression to predict the number of overall physical health ED 
visits, the model including IHC enrollment, age, gender, and initial psychiatric diagnosis 
was the best fit to predict ED visits. Slight overdispersion was noted (Pearson chi-square 
= 2.695). The model was statistically significant, per the omnibus test, with IHC 
enrollment, gender, and initial psychiatric diagnosis statistically significantly predicting 
physical health ED visits. Following IHC enrollment, 0.121 (95% CI, 0.081 to 0.181) 
times more ED visits occurred (p < .001). If gender was female, 1.531 (95% CI, 1.179 to 
1.989) times more inpatient admissions occurred (p = .001). For every additional increase 
in initial psychiatric diagnosis, 1.123 (95% CI, 1.048 to 1.192) times more inpatient 
admissions occurred (p < .001). Since not all of the independent variables statistically 
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significantly predicted inpatient admissions, the null hypothesis was retained. The table 
below (Table 12) presents a summary of the analyses for research question one, the 
statistical tests run, and the findings with relation to the null hypothesis. 
Table 12 
Summary of Regression Analyses for RQ1 
Analysis type and 
purpose Variables Result 
Null hypothesis 
action 
Stepwise logistic regression 
Model 1:  
Examined the odds of 
experiencing any 
physical health 
inpatient admission 
before and after IHC 
enrollment 
Dependent: Any 
physical health 
inpatient 
admission 
 
Independent: IHC 
enrollment alone 
 
IHC enrollment predicted 
inpatient admissions (p = 
.026)  
 
Predicted less than 5% of 
the model’s variance 
 
 
Retained  
Model 2: 
Examined the odds of 
experiencing any 
physical health ED 
visit before and after 
IHC enrollment 
Dependent: Any 
physical health 
ED visit 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was good fit for 
physical health ED visits 
(p < .001) 
 
Predicted 14.4% - 24.0% 
of the variance 
 
IHC enrollment (p < 
.001) & gender (p = .011) 
were only two predictors 
of ED visit 
Retained  
Multiple linear regression using forced entry method 
Model 1: 
Examined predictive 
relationship between 
physical health 
inpatient admissions 
and IHC enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: 
Physical health 
inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
Model was a good fit (p 
= .047) 
 
Adjusted R2 = .08 
 
IHC enrollment (p = 
.019) only statistically 
significant predictor 
  
Assumption of 
No conclusive 
decision  
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score normality was violated 
 
Model 2: 
Examined predictive 
relationship between 
physical health 
inpatient days and 
IHC enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: 
Physical health 
inpatient days 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was a good fit (p 
= .004) 
 
Adjusted R2 = .017 
 
IHC enrollment (p = 
.011) and initial 
psychiatric diagnosis (p 
= .05) were statistically 
significant predictors 
  
Assumption of 
normality was violated  
 
No conclusive 
decision  
Model 3: 
Examined predictive 
relationship between 
physical health ED 
visits and IHC 
enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: 
Physical health ED 
visits 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was a good fit (p 
< .001) 
 
Adjusted R2 = .115  
 
IHC enrollment (p < 
.001), gender (p = 
.015), and initial 
psychiatric diagnosis (p 
= .016) predicted ED 
visits at statistically 
significant levels 
  
Assumption of 
normality was violated 
No conclusive 
decision  
Poisson regression  
Model 1: 
Examined predictive 
relationship between 
physical health 
inpatient admissions 
and IHC enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: 
Physical health 
inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis 
IHC enrollment (p = 
.003), age (p = .040), 
and initial psychiatric 
diagnosis (p < .001) 
were statistically 
significant predictors 
 
 
 
Retained 
Model 2: Dependent: IHC enrollment (p < Rejected 
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Examined predictive 
relationship between 
physical health 
inpatient days and 
IHC enrollment, 
demographic 
characteristics, and 
disease severity 
Physical health 
inpatient days  
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis 
 
.001), age (p = .001), 
gender (p = .001) and 
initial psychiatric 
diagnosis (p < .001) 
statistically 
significantly predicted 
inpatient admissions 
 
Model 3: 
Examined predictive 
relationship between 
physical health ED 
visits and IHC 
enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: Any 
physical health ED 
visit 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis 
IHC enrollment (p < 
.001), gender (p = 
.001), and initial 
psychiatric diagnosis (p 
< .001) statistically 
significantly predicted 
ED visits  
 
Retained 
 
Research Question 2: ACS-Specific Service Utilization  
The second research question was: What is the predictive relationship, if any, 
between IHC enrollment and ACS-specific utilization for consumers with SMI when 
controlling for demographic characteristics and disease severity? The null hypothesis was 
that there was no statistically significant predictive relationship between IHC enrollment 
and ACS-specific service utilization when controlling for demographic characteristics 
(age and gender) and disease severity (primary psychiatric diagnosis and CCI score). The 
alternative hypothesis was that there was a statistically significant predictive relationship 
between IHC enrollment and ACS-specific service utilization when controlling for 
demographic characteristics and disease severity. 
As with the first research question, I ran Wilcoxon signed-rank tests in place of 
paired samples t-tests due to the skewed nature of the data. Simple linear regression, 
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multiple linear regression, and Poisson regression analyses were planned. Since the 
primary predictor variable in the regression was binary (pre/post admission into the IHC), 
simple linear regression analyses were not run, as they require a continuous predictor 
variable. Furthermore, since there were only two ACS-specific inpatient admissions and 
two ACS-specific ED visits, all analyses were viewed with caution.  
Wilcoxon Signed-Rank tests. When assessing ACS-specific inpatient admissions 
and days, of the 370 participants, none experienced a decrease in the post-index period 
following IHC enrollment, whereas three had an increase, and 367 had no change. There 
were no statistically significant median differences in ACS-specific inpatient admissions 
(z = 1.633, p = .102) or days (z = 1.604, p = .109) in the post-index period compared to 
the pre-index period. However, there was a statistically significant median difference in 
ACS-specific ED visits. Of the 370 participants, none experienced a decrease in ACS-
specific ED visits following IHC enrollment, six had an increase, and 364 experienced no 
change. There was a statistically significant median increase in ACS-specific ED visits 
post-index following IHC enrollment compared to before IHC enrollment, z = 2.333, p = 
.020.  
Logistic regression. I examined the odds of participants experiencing any ACS-
specific inpatient admission or ED visit pre- and post-IHC enrollment using stepwise 
logistic regression. Counts of ACS-specific inpatient admissions and ED visits were 
recoded into a bivariate variable where “0” = no ACS-specific admission/visit and “1” = 
any ACS-specific admission/visit. Inpatient admissions and ED visits were assessed 
separately for pre- and post-index timeframes so the analysis file had two rows per 
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participant, one for preenrollment  and one for postenrollment , with either a 0 or 1 
indicating whether or not the participant experienced an ACS-specific event during each 
of those periods. IHC enrollment was examined first as the sole fixed effect with age, 
gender, initial psychiatric diagnosis, and CCI score added to the fixed-effects portion of 
the model. Separate analyses were run for ACS-specific inpatient admissions and ED 
visits.  
ACS-specific inpatient admissions. There were two studentized residuals with 
values outside of two standard deviations above or below the mean, but these were 
retained following examination of the data and a determination that the outliers were 
flagged due to positive ACS-specific admissions. Since admissions were coded as “0” for 
no admission and “1” for any admission, transforming the data was not possible. The first 
regression model for IHC enrollment alone was a good fit to describe IHC enrollment as 
a predictor of experiencing any ACS-specific inpatient admission, Χ2[1,4.171], p = .041. 
Adding age, gender, initial psychiatric diagnosis and CCI score improved the original 
model and the model was statistically significant (Χ2[8, 15.815], p = .045), explaining 
between 1.7% and 9.7% of the variance in the criterion. The model had an overall success 
of 99.7% at predicting the odds of a participant experiencing any ACS-specific inpatient 
admission (.1% more than the original predictor of IHC enrollment). The model 
successfully predicted 100% of the “no ACS-specific admission” category, and 33.3% of 
the “any ACS-specific admission” category. However, none of the predictor variables 
alone were statistically significant predictors of the odds of experiencing an ACS-specific 
inpatient admission (Table 13).  
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Table 13 
Odds Ratios for Experiencing an ACS-Specific Inpatient Admission 
    95% CI for Exp(B) 
 B p-value Exp(B) Lower Upper§ 
IHC enrollment 16.335 .993 12435361.9 0.000 0.004 
Age -0.043 .474 0.958 0.850 1.078 
Gender -16.431 .160 0.000 0.000 - 
Psychosisa -14.176 .995 0.000 0.000 - 
Mood disorder -0.531 1.000 0.588 0.000 0.004 
Substance abuse -15.558 .998 0.000 0.000 - 
CCI scoreb -15.659 1.000 0.000 0.000 - 
Constant -18.789 .991 0.000   
a Data for missing initial psychiatric diagnosis are not represented in the table. 
b The upper CI for enrollment and mood disorder were calculated based on Hanley’s 
formula, as cited in Eypasch, Lefering, Kum, and Troidl, 1995. 
 
The model itself was a good predictor of the odds of experiencing an ACS-
specific inpatient admission (p = .045), but none of the independent variables 
individually statistically significantly predicted the odds of any ACS-specific inpatient 
admission; therefore, the null hypothesis was retained. 
ACS-specific ED visits. In the stepwise logistic regression to examine the odds of 
participants experiencing an ACS-specific ED visit, there were five studentized residuals 
with values outside of two standard deviations above or below the mean, which were 
retained following examination of the data and a determination that the outliers were 
flagged due to positive ED visits. IHC enrollment alone was the best predictor of ACS-
specific ED visits (Χ2(1,8.367), p = .004). The model indicated that between 1.1% and 
12.5% of the variance was explained by IHC enrollment depending on the use of the Cox 
& Snell R² (.011) or the Nagelkerke R² (.125). The model correctly predicted the odds of 
experiencing ACS-specific ED visits 99.2% of the time (100% of the “no ED visit” 
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category, and 0% of the “any ED visit” category). Adding age, gender, initial psychiatric 
diagnosis and CCI score to the original model did not improve the significance of the 
model. There were six ACS-specific ED visits. The odds ratio for IHC enrollment (ExpB 
= 26628705.5, CI [0.000]) indicated that as enrollment increased by one, the odds of 
ACS-specific ED visits increased. Since the confidence intervals could not be calculated, 
the relationship between the two variables found in the sample was not reliable. The 
model was a good predictor of the odds of a participant experiencing an ACS-specific ED 
visit (p = .004), but the model predicted less than 15% of the variance and the model was 
not reliable; therefore, the null hypothesis was retained.  
Multiple regression. I examined the predictive relationship between ACS-
specific utilization and IHC enrollment, demographic characteristics, and disease severity 
using multiple linear regression analyses. In the forced entry method, predictors were 
entered into the model simultaneously, making no decisions regarding the order of the 
predictors (Field, 2013). Separate regression models were run for each type of service, 
including inpatient admissions, inpatient days, and ED visits, resulting in three regression 
models for ACS-specific utilization. As with the overall physical health utilization 
models, scatter plots showed evidence of non-linearity and casewise diagnostics flagged 
all ACS-specific inpatient and ED utilization as outliers, since there were so few positive 
events. Therefore, I applied a square root transformation to the data to correct for 
moderately positively skewed data and re-ran the multiple linear regression models using 
the transformed variables (Laerd Statistics, 2015b).  
ACS-specific inpatient admissions. In the model predicting the relationship 
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between ACS-specific inpatient admissions and IHC enrollment, demographic 
characteristics, and disease severity, there was independence of residuals as assessed by a 
Durbin-Watson statistic of 2.046, and homoscedasticity. There was no evidence of 
multicollinearity since none of the correlations were above 0.70 and tolerance statistics 
were greater than 0.10 (Laerd Statistics, 2015b). There were also no studentized deleted 
residuals greater than ±3 standard deviations. However, the assumptions of normality and 
linearity were not met, although the dependent variable had previously been transformed. 
The model accounted for 2.0% of the variance as assessed by the R2 value and was a good 
fit (F(5, 734) = 2.961; p = .012); however, the model did not generalize well, as indicated 
by the adjusted R2 value of .013. Both gender and initial psychiatric diagnosis 
significantly predicted ACS-specific inpatient admissions, while the other variables did 
not (Table 14). The sign of the standardized coefficients for gender indicated a significant 
negative correlation while a positive correlation between initial psychiatric diagnosis and 
inpatient admissions was found.  
Table 14 
Individual Predictors of ACS-specific Inpatient Admissions 
Model Unstandardized Coefficients 
Standardized 
Coefficients   
 B SE B t p-value 
(Constant) 0.006 .016  0.362 .718 
IHC enrollment 0.010 .006 0.063 1.726 .085 
Age (years) 9.262E-5 .000 0.014 0.373 .710 
Gender -0.012 .006 -0.073 -1.988 .047 
Psychiatric diagnosis 0.006 .002 0.106 2.872 .004 
CCI score -0.005 .029 -0.006 -0.162 .871 
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Although the p-value indicated that the model statistically significantly predicted 
ACS-specific inpatient admissions (p = .012), the assumptions of linearity and normality 
were violated and the R² value indicated that the model predicted only 1.8% of variance 
so no conclusive decision could be made about the null hypothesis. 
ACS-specific inpatient days. There was evidence of homoscedasticity and 
independence of residuals as assessed by a Durbin-Watson statistic of 2.076 in the model 
assessing the predictive relationship between ACS-specific inpatient days and IHC 
enrollment, demographic characteristics, and disease severity. There was no evidence of 
multicollinearity since none of the correlations were above 0.70 and tolerance statistics 
were greater than 0.10 (Laerd Statistics, 2015b). However, the assumptions of normality 
and linearity were violated, even though the dependent variable had already been 
transformed. There was also one studentized deleted residual greater than three standard 
deviations from the mean. The case was removed due to the large standard deviation 
statistic, and as a result, the model no longer retained independence of residuals. 
Therefore, the results reported are from the original model that retained the outlier case. 
The model accounted for 3.4% of the variance in ACS-specific inpatient days as assessed 
via the R2 value and was a good fit (F(5, 734) = 5.155; p < .0005) but did not generalize 
well, as indicated by the adjusted R2 value of .027. Only initial psychiatric diagnosis (p < 
.001) statistically significantly predicted ACS-specific inpatient days (Table 15), and the 
sign of the standardized coefficient indicated a significant positive correlation.  
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Table 15 
Individual Predictors of ACS-specific Inpatient Days 
Model Unstandardized coefficients 
Standardized 
coefficients   
 B SE B t p-value 
(Constant) -0.023 .043  -0.531 .596 
IHC enrollment 0.024 .016 0.055 1.504 .133 
Age (years) 0.001 .001 0.038 1.030 .303 
Gender -0.029 .016 -0.064 -1.763 .078 
Psych diagnosis 0.024 .005 0.166 4.539 .000 
CCI score -0.010 .077 -0.005 -0.129 .898 
  
Since the assumptions of linearity and normality were violated and the model did 
not generalize well as assessed by the R2 value, I determined that the model was not a 
good fit and no conclusive decision was made about the null hypothesis. 
ACS-specific ED visits. In the model assessing the predictive relationship 
between ACS-specific ED visits and IHC enrollment, demographic characteristics, and 
disease severity there was evidence of homoscedasticity but there was independence of 
residuals as assessed by a Durbin-Watson statistic of 2.030. There was no evidence of 
multicollinearity, as correlations were all below 0.70 and VIF statistics were below 10 
(Laerd Statistics, 2015b). There were no studentized deleted residuals greater than three 
standard deviations from the mean. However, the assumptions of normality and linearity 
were violated, despite transformation of the dependent variable. The model accounted for 
1.2% of the variance in ACS-specific ED visits as assessed by the R2 value and the model 
was not a good fit (F(5, 734) = 1.851; p = .101). Only enrollment in the IHC significantly 
predicted ACS-specific ED visits (Table 16), and the sign of the standardized coefficient 
indicated a significant positive correlation, meaning that ACS-specific ED visits 
  
 
97 
increased following enrollment.  
Table 16 
Individual Predictors of ACS-specific ED Visits 
Model Unstandardized coefficients 
Standardized 
coefficients   
 B SE B t p-value 
(Constant) -0.024 .019  -1.264 .206 
IHC enrollment 0.017 .007 0.055 2.439 .015 
Age (years) 0.000 .000 0.038 0.828 .408 
Gender 0.005 .007 -0.064 0.708 .479 
Psychiatric diagnosis 0.004 .002 0.166 1.548 .122 
CCI score -0.003 .034 -0.005 -0.086 .932 
 
The model did not predict ACS-specific ED visits (p = .101), and therefore the 
null hypothesis was retained.  
Poisson regression. There was no preenrollment ACS- specific utilization, and 
very little postenrollment ACS- specific utilization (two inpatient admissions and two ED 
visits); therefore, the Poisson regression analyses could not be run without violating the 
Hessian matrix and no model statistics were produced (Laerd Statistics, 2015c). The table 
below presents a summary of the analyses for research question two, the statistical tests 
run, and the findings with relation to the null hypothesis. 
Table 17 
Summary of Regression Analyses for RQ2  
Analysis type and 
purpose Variables Result 
Null 
hypothesis 
action 
Logistic regression 
Model 1:  
Examined odds of 
experiencing any 
Dependent: Any 
ACS-specific 
inpatient admission 
Full model was best fit to 
predict any inpatient 
admission (p = .045) 
Retained  
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ACS-specific 
inpatient admission 
before and after IHC 
enrollment 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI score 
 
 
Explained 9.7% of the 
variance in the criterion 
 
No variables were 
independent predictors 
 
Model 2: 
Examined odds of 
experiencing any 
ACS-specific ED 
visit before and after 
IHC enrollment 
Dependent: Any 
ACS-specific ED 
visit 
 
Independent: IHC 
enrollment alone 
 
IHC enrollment alone 
was a good fit to predict 
odds of ACS-specific ED 
visit (p = .026)  
 
1.1% - 12.5% of the 
model’s variance 
explained 
Retained  
Multiple linear regression using forced entry method 
Model 1: 
Examined predictive 
relationship between 
ACS-specific 
inpatient admissions 
& IHC enrollment, 
demographic 
characteristics, & 
disease severity 
 
Dependent: ACS-
specific inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI score 
Model was a good fit (p 
= .012) 
 
Adjusted R2 = .013 
 
Gender (p = .047) & 
initial psychiatric 
diagnosis (p = .004) 
were statistically 
significant predictors 
  
Assumptions of linearity 
& normality violated 
 
No conclusive 
decision  
Model 2: 
Examined predictive 
relationship between 
ACS-specific 
inpatient days & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
Dependent: ACS-
specific inpatient 
days 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI score 
Model was a good fit (p 
< .0005) 
 
Adjusted R2 = .027 
 
Initial psychiatric 
diagnosis (p < .001) was 
a statistically significant 
predictor 
  
Assumptions of linearity 
& normality violated; 
Homoscedasticity & 
No conclusive 
decision  
  
 
99 
independence of 
residuals 
 
Model 3: 
Examined predictive 
relationship between 
ACS-specific ED 
visits & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
Dependent: ACS-
specific ED visits 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI score 
Model was not a good 
fit (p = .101) 
 
Adjusted R2 = .012 
 
IHC enrollment (p = 
.015) was only 
statistically significant 
predictor 
  
Assumptions of linearity 
& normality violated; 
Homoscedasticity, 
independence of 
residuals 
Retained 
Poisson regression  
Model 1: 
Examined predictive 
relationship between 
ACS-specific inpatient 
admissions and IHC 
enrollment, 
demographic 
characteristics, and 
disease severity 
 
Dependent: ACS-
specific inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric diagnosis 
 
Hessian matrix 
violated due to no 
preenrollment  
ACS utilization; 
analyses not run  
 
 
 
Not applicable 
Model 2: 
Examined predictive 
relationship between 
ACS-specific inpatient 
days and IHC 
enrollment, 
demographic 
characteristics, and 
disease severity 
 
Dependent: ACS-
specific inpatient days  
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric diagnosis 
 
Hessian matrix 
violated due to no 
preenrollment  
ACS utilization; 
analyses not run  
 
 
 
Not applicable 
Model 3: 
Examined predictive 
relationship between 
ACS-specific ED visits 
Dependent: ACS-
specific ED visits 
 
Independent: IHC 
Hessian matrix 
violated due to no 
preenrollment  
ACS utilization; 
Not applicable 
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and IHC enrollment, 
demographic 
characteristics, and 
disease severity 
enrollment, age, 
gender, initial 
psychiatric diagnosis 
analyses not run  
 
 
 
 
Additional Analyses 
Due to the small amount of utilization within the sample, I also assessed all-cause 
and mental health-related utilization, using methods identical to the analyses above. As 
with the previous variables, there was little pre-index utilization of any kind, with the 
exception of mental health inpatient days. Pre-index mental health days were greater than 
post-index mental health days. For all other service categories, post-index utilization 
exceeded pre-index utilization (Table 18). 
Table 18 
Pre- and Post-Index Utilization Descriptive Statistics: Additional Variables 
Utilization Min Max Mean (SE) SD 
Pre-index all-cause inpatient admissions 0.00 2.00 0.016 (.009) 0.164 
Post-index all-cause inpatient admissions  0.00 9.00 0.143 (.038) 0.731 
Pre-index all-cause inpatient days 0.00 48.00 0.168 (.133) 2.561 
Post-index all-cause inpatient days 0.00 63.00 0.995 (.279) 5.360 
Pre-index all-cause ED visits 0.00 4.00 0.087 (.022) 0.427 
Post-index all-cause ED visits 0.00 18.00 0.754 (.088) 1.687 
Pre-index mental health inpatient 
admissions 
0.00 2.00 0.081 (.006) 0.116 
Post-index mental health inpatient 
admissions 
0.00 9.00 0.092 (.030) 0.582 
Pre-index mental health inpatient days 0.00 48.00 0.157 (.132) 2.548 
Post-index mental health inpatient days 0.00 43.00 0.697 (.214) 4.108 
Pre-index mental health ED visits 0.00 2.00 0.014 (.008) 0.156 
Post-index mental health ED visits 0.00 6.00 0.105 (.026) 0.496 
 
All-cause utilization. Of the 370 participants, four experienced a decrease in 
inpatient admissions and inpatient days post-index, whereas 18 had an increase, and 350 
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had no change. There were statistically significant median increases in all-cause inpatient 
admissions (z = 3.597, p > .0005) and inpatient days (z = 3.665, p > .0005) as indicated 
by Wilcoxon signed-rank tests. There was also a statistically significant median increase 
in ED visits (z = 8.605, p > .0005) following IHC enrollment.  
Logistic regression. In the logistic regression analysis assessing the odds of a 
participant experiencing any all-cause inpatient admission, there were 27 studentized 
residuals with values outside of two standard deviations of the mean, which were retained 
for analysis. The full model including all covariates was a statistically significant 
improvement over the original model using IHC enrollment alone, Χ2(8, 29.645), p < 
.001, explaining between 3.9% and 13.6% of the variance in the criterion. The improved 
model had an overall success of 95.9% at predicting the odds of experiencing an all-cause 
inpatient admission (100% of the “no admission” category and 0% of the “any 
admission” category). IHC enrollment (Wald Χ2 = 12.922, p < .001) remained a 
statistically significant predictor of the odds of an all-cause inpatient admission, but none 
of the new variables were individually statistically significant predictors. Since only IHC 
enrollment individually predicted the odds of experiencing an all-cause inpatient 
admission at statistically significant level, the null hypothesis was retained.  
There were 19 studentized residuals with values outside of two standard 
deviations of the mean in the logistic regression analysis assessing the odds of a 
participant experiencing any all-cause ED visit; however, these cases were retained 
following a determination that the outliers were flagged due to positive utilization. The 
model that included IHC enrollment, age, gender, initial psychiatric diagnosis, and CCI 
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score best predicted a consumer experiencing an all-cause ED visit (Χ2(8,128.273), p < 
.001), explaining between15.9% and 25.5% of the variance in the criterion. The model 
had an overall success of 80.0% at predicting the odds of any all-cause ED visit (97.8% 
of the “no ED visit” category and 4.9% of the “any ED visit” category). IHC enrollment 
(Wald Χ2 = 76.027, p < .001), age (Wald Χ2 = 7.232, p = .007) and gender (Wald Χ2 = 
5.364, p = .021) were statistically significant predictors. However, since not all variables 
individually statistically significantly predicted the odds of experiencing any m ED visit, 
the null hypothesis was retained. 
Multiple linear regression. I assessed the predictive relationship between all-
cause utilization, and IHC enrollment, demographic characteristics, and disease severity 
using multiple linear regression. The models for inpatient admissions (p < .001) and ED 
visits (p = .001) were good fits. IHC enrollment (p < .001) and age (p = .032) were 
statistically significant predictors of inpatient admissions with age being a negative 
predictor. All variables except initial psychiatric diagnosis were predictive of all-cause 
ED visits; however, they were not representative as indicated by adjusted R2 values 
accounting for low levels of variance. As such, I determined that the models were not 
good fits and no conclusive decision could be made about the null hypotheses. The model 
for all-cause inpatient days was not a good fit (p = .201) and none of the variables were 
independent predictors; therefore the null hypothesis was retained. Furthermore, the 
assumptions of linearity and normality were violated in all three models. 
Poisson regression. Poisson regression models were used to predict the number 
of all-cause inpatient admissions, inpatient days, and ED visits based on IHC enrollment 
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as the sole first effect, and adding age, gender, and initial psychiatric diagnosis to the 
models. In the first model, IHC enrollment and initial psychiatric diagnosis predicted an 
increase in all-cause inpatient admissions. Following IHC enrollment, 0.113 (95% CI, 
0.049 to 0.263) times more all-cause inpatient admissions occurred (p < .001) and for 
every additional increase in initial psychiatric diagnosis, 1.140 (95% CI, 1.014 to 1.280) 
times more admissions occurred (p = .028). In the second model, IHC enrollment, age, 
and initial psychiatric diagnosis significantly predicted all-cause inpatient days. 
Following IHC enrollment, 0.168 (95% CI, 0.129 to 0.220) times more inpatient 
admissions occurred (p < .001), with each additional year of age, 0.978 (95% CI, 0.971 to 
0.986) times more all-cause inpatient days occurred (p < .001), and for each additional 
increase in initial psychiatric diagnosis, 1.177 (95% CI, 1.133 to 1.224) times more all-
cause inpatient days occurred (p < .001); however the model was subject to 
overdispersion (Pearson chi-square = 26.901). In the final Poisson regression model IHC 
enrollment, gender, and initial psychiatric diagnosis predicted an increase in all-cause ED 
visits. Following IHC enrollment, 0.115 (95% CI, 0.080 to 0.165) times more all-cause 
ED visits occurred (p < .001). When gender was male, 1.487 (95% CI, 1.177 to 1.879) 
times more ED visits occurred (p = 0.001). For each additional increase in initial 
psychiatric diagnosis, 1.144 (95% CI, 1.055 to 1.177) times more ED visits occurred (p < 
.001). The null hypotheses were retained for all Poisson regression analyses since not all 
predictor variables statistically significantly predicted all-cause utilization (Table 21). 
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Table 19 
Summary of Regression Analyses for All-Cause Utilization  
Analysis type and 
purpose Variables Result 
Null hypothesis 
action 
Stepwise logistic regression 
Model 1:  
Examined the odds 
of experiencing any 
inpatient admission 
before and after 
IHC enrollment 
Dependent: Any 
inpatient admission 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric diagnosis, 
CCI score 
 
Model was a good fit (p 
< .001)  
 
3.9% - 13.6% of the 
variance in the criterion 
explained 
 
IHC enrollment (p < 
.001) was a statistically 
significant predictor of 
odds of an all-cause 
inpatient admission  
 
Retained  
Model 2: 
Examined the odds 
of experiencing any 
ED visit before and 
after IHC 
enrollment 
Dependent: Any ED 
visit 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric diagnosis, 
CCI score 
Model was a good fit (p 
< .001)  
 
Explained 15.9% - 
25.5% of the variance in 
the criterion  
 
IHC enrollment (p < 
.001), age (p = .007) & 
gender (p = .021) were 
statistically significant 
predictors  
Retained  
Multiple linear regression  
Model 1: 
Examined predictive 
relationship between 
all-cause inpatient 
admissions & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
 
Dependent: All-
cause inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was a good fit (p 
= .001) 
 
Adjusted R2 = .022 
IHC enrollment (p < 
.001) & age (p = .032) 
were statistically 
significant predictors 
(age = negative 
predictor)  
No conclusive 
decision 
reached 
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Assumptions of linearity 
& normality violated 
 
Model 2: 
Examined predictive 
relationship between 
all-cause inpatient 
days & IHC 
enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: All-
cause inpatient days 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was not a good 
fit (p = .201) 
 
Adjusted R2 = .003 
 
None of the variables 
were statistically 
significant predictors 
 
Assumptions of linearity 
& normality violated 
 
Retained 
Model 3: 
Examined predictive 
relationship between 
all-cause ED visits 
and IHC enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: All-
cause ED visits 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was a good fit (p 
> .001) 
 
Adjusted R2 = .120 
 
IHC enrollment (p < 
.001) age (p = .003; 
negative predictor) 
gender (p = .030), CCI 
score (p = .038) were 
independent predictors 
  
Assumptions of linearity 
& normality violated 
No conclusive 
decision 
reached 
Poisson regression  
Model 1: 
Examined predictive 
relationship between 
all-cause inpatient 
admissions and IHC 
enrollment, 
demographic 
characteristics, and 
disease severity 
 
Dependent: All-
cause inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis; CCI 
score 
 
IHC enrollment (p < 
.001) & initial 
psychiatric diagnosis 
(p = .028) were the 
only statistically 
significant predictors 
of inpatient 
admissions 
 
Retained 
Model 2: Dependent: All- IHC enrollment (p < Retained 
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Examined predictive 
relationship between 
all-cause inpatient 
days & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
cause inpatient days  
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis; CCI 
score 
 
.001), age (p < .001), 
& initial psychiatric 
diagnosis (p < .001) 
were statistically 
significant predictors 
of inpatient days  
 
Overdispersion was 
noted 
 
Model 3: 
Examined predictive 
relationship between 
all-cause ED visits & 
IHC enrollment, 
demographic 
characteristics, & 
disease severity 
Dependent: All-
cause ED visits 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis; CCI 
score 
IHC enrollment (p < 
.001), age (p = .001), 
& initial psychiatric 
diagnosis (p < .001) 
were statistically 
significant predictors 
of ED visits  
 
Retained 
 
Mental health utilization. When analyzing mental health utilization, two of 370 
participants experienced a decrease in overall mental health inpatient admissions and 
inpatient days following enrollment, whereas 18 had an increase, and 350 had no change. 
There were statistically significant median increases in mental health inpatient 
admissions (z = 3.189, p = .01) and mental health ED visits (z = 3.381, p = .01) following 
IHC enrollment compared to before IHC enrollment as assessed by Wilcoxon signed-
rank tests. However, there was a statistically significant decrease in inpatient days (z = 
2.784, p = .005) following IHC admission compared to before IHC admission. 
Logistic regression. In the stepwise logistic regression analysis assessing the odds 
of experiencing any mental health inpatient admission, there were 17 studentized 
residuals with values outside of two standard deviations of the mean; however these were 
retained for analysis following examination of the data and a determination that the 
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outliers were flagged due to positive utilization. The model including all covariates was 
the best predictor of experiencing a mental health inpatient admission (Χ2(8, 29.990), p < 
.001). Between 4.0% and 18.1% of the variance in the criterion could be explained and 
the model had an overall success of 97.3% at predicting any mental health admission, 
predicting 100% of the “no mental health admission” category and 0% of the “any mental 
health admission” category. IHC enrollment (Wald Χ2 = 9.870, p = .002) and age (Wald 
Χ2 = 8.011, p = .005) were statistically significant predictors, but none of the other 
variables were; therefore the null hypothesis was retained. 
The logistic regression for mental health ED visits included 25 studentized 
residuals with values outside of two standard deviations of the mean, and these cases 
were retained following a determination that the outliers were flagged due to positive ED 
visits. The model including IHC enrollment, age, gender, initial psychiatric diagnosis, 
and CCI score improved the significance of the original model (Χ2(8,26.534), p = .001) 
and was retained as the best predictor, explaining between 3.5% and 13.4% of the 
variance in the criterion. The model had an overall success of 96.5% at predicting the 
odds of participants experiencing mental health ED visits while successfully predicting 
100.0% of the “no mental health ED visit” category and 0% of the “any mental health ED 
visit” category. IHC enrollment (Wald Χ2 = 8.304, p = .001) remained a statistically 
significant predictor of the odds of experiencing a mental health ED visit, but none of the 
other variables were statistically significant predictors; therefore, the null hypothesis was 
retained. 
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Multiple linear regression. I assessed the predictive relationship between mental 
health utilization, and IHC enrollment, demographic characteristics, and disease severity 
through multiple linear regression. The models for mental health inpatient admissions (p 
< .001), inpatient days (p = .006), and ED visits (p = .001) significantly fit the data, but 
were not representative, as less than 5.0% of the variance was accounted for according to 
the R2 values. IHC enrollment was a statistically significant predictor of all three 
utilization variables while age was a statistically significant negative predictor of mental 
health inpatient admissions and days. The assumptions of linearity and normality were 
also violated in all three models; therefore it was determined that the models were not 
good fits and no conclusive decisions could be made about the null hypotheses.  
Poisson regression. In the Poisson regression assessing mental health inpatient 
admissions, the model that included IHC enrollment, age, gender, and initial psychiatric 
diagnosis was statistically significant but IHC enrollment and age were the only variables 
to significantly predict mental health admissions. Following IHC enrollment, 0.088 (95% 
CI, 0.027 to 0.287) times fewer mental health inpatient admissions occurred (p < .001). 
For every additional year increase in age, 0.965 (95% CI, 0.938 to 0.992) times more 
admissions occurred (p = .012). The second model assessing mental health inpatient days 
was subject to overdispersion (Pearson chi-square = 22.244). IHC enrollment, age and 
initial psychiatric diagnosis significantly negatively predicted an increase in mental 
health inpatient days. Following IHC enrollment, 0.225 (95% CI, 0.169 to 0.299) times 
fewer mental health inpatient days were incurred (p < .001), for every additional decrease 
in age, 0.939 (95% CI, 0.930 to 0.949) times fewer mental health days occurred (p < 
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.001), and for every additional decrease in initial psychiatric diagnosis, 0.885 (95% CI, 
0.814 to 0.962) times fewer mental health inpatient days occurred (p = .004). In the 
Poisson regression model assessing mental health ED visits, IHC enrollment predicted an 
increase in ED visits. Following IHC enrollment, 0.128 (95% CI, 0.051 to 0.325) times 
more mental health ED visits occurred (p < .001). After adding age, gender, and initial 
psychiatric diagnosis to the model, the model remained significant but no other variables 
significantly predicted mental health ED visits. The null hypotheses were retained for all 
three models due to the fact that not all variables were statistically significant predictors 
of mental health utilization (Table 20). 
Table 20 
Summary of Regression Analyses for Mental Health Utilization  
Analysis Type and 
Purpose Variables Result 
Null Hypothesis 
Action 
Stepwise logistic regression 
Model 1:  
Examined odds of 
experiencing any 
mental health 
inpatient admission 
before and after IHC 
enrollment 
Dependent: Any 
mental health 
inpatient admission 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
 
Model was a good fit (p 
< .001)  
 
4.0% - 18.1% of the 
variance in criterion 
explained 
  
IHC enrollment (p = 
.002) and age (p = .005) 
were statistically 
significant predictors  
 
Retained  
Model 2: 
Examined odds of 
experiencing a mental 
health ED visit before 
and after IHC 
enrollment 
Dependent: Any 
mental health ED 
visit 
 
Independent: IHC 
enrollment, age, 
gender, initial 
Model was a good fit (p 
= .001)  
 
Explained 3.5% - 13.4% 
of variance in criterion  
 
IHC enrollment (p = 
Retained  
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psychiatric 
diagnosis, CCI 
score 
.001) was a statistically 
significant predictor  
Multiple linear regression 
Model 1: 
Examined predictive 
relationship between 
mental health 
inpatient admissions 
& IHC enrollment, 
demographic 
characteristics, & 
disease severity 
 
Dependent: Mental 
health inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was a good fit (p 
< .001) 
 
Adjusted R2 = .024 
 
IHC enrollment (p < 
.001) & age (p = .003) 
were significant 
predictors (age was 
negative)  
 
Assumptions of linearity 
& normality violated 
 
No conclusive 
decision  
Model 2: 
Examined predictive 
relationship between 
mental health 
inpatient days & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
Dependent: All-
cause inpatient days 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was a good fit (p 
= .006) 
 
Adjusted R2 = .015 
 
IHC enrollment (p = 
.003) & age (p = .016) 
were significant 
predictors (age was 
negative)  
 
Assumptions of linearity 
& normality violated 
 
No conclusive 
decision  
Model 3: 
Examined predictive 
relationship between 
mental health ED 
visits & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
Dependent: Mental 
health ED visits 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis, CCI 
score 
Model was a good fit (p 
= .001) 
 
Adjusted R2 = .021 
 
IHC enrollment (p < 
.001) was a statistically 
significant predictor 
 
Assumptions of linearity 
& normality violated 
No conclusive 
decision 
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Poisson regression  
Model 1: 
Examined predictive 
relationship between 
mental health 
inpatient admissions 
and IHC enrollment, 
demographic 
characteristics, and 
disease severity 
Dependent: Mental 
health inpatient 
admissions 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis; CCI 
score 
 
IHC enrollment (p < 
.001) & age (p = .012) 
were statistically 
significant predictors 
of mental health 
inpatient admissions 
 
Retained 
Model 2: 
Examined predictive 
relationship between 
mental health 
inpatient days & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
Dependent: Mental 
health inpatient 
days  
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis; CCI 
score 
 
IHC enrollment (p < 
.001), age (p < .001), 
& initial psychiatric 
diagnosis (p = .004) 
were statistically 
significant negative 
predictors of mental 
health inpatient days  
 
Overdispersion was 
noted 
 
Retained 
Model 3: 
Examined predictive 
relationship between 
mental health ED 
visits & IHC 
enrollment, 
demographic 
characteristics, & 
disease severity 
Dependent: Mental 
health ED visits 
 
Independent: IHC 
enrollment, age, 
gender, initial 
psychiatric 
diagnosis; CCI 
score 
IHC enrollment (p < 
.001) was the only 
statistically significant 
predictor of mental 
health ED visits  
 
Retained 
 
Summary 
In summary, 370 participants met enrollment criteria of having six months of data 
pre- and post-index date (first visit to the IHC) available for analysis, were 18 years of 
age or older, and insured by either Amerigroup or UnitedHealth. For these participants, 
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there was very little physical health or ACS-specific utilization, with no pre-index ACS-
specific utilization of any kind. Since the data were skewed, Wilcoxon signed-rank tests 
were run in place of the planned paired-samples t-tests. Furthermore, the planned simple 
linear regression analyses were not run due to the fact that the independent variable was 
binary in nature. I ran logistic regression analyses examine the odds of participants 
experiencing any utilization by category before and after IHC enrollment. For these 
analyses, enrollment was examined first as the sole fixed effect with age, gender, initial 
psychiatric diagnosis, and CCI score added to the fixed-effects portion of the model. I 
next examined the predictive relationship between service utilization and IHC 
enrollment, demographic characteristics, and disease severity using multiple linear 
regression analyses. For the multiple regression models, a square root transformation was 
applied to the data to correct for moderately positively skewed data (Laerd Statistics, 
2015b) as a result of evidence of non-linearity and flagging of positive utilization. I also 
used Poisson regression analyses to examine the predictive relationship between IHC 
enrollment and service utilization since the data were count data. IHC enrollment was the 
sole fixed effect, with age, gender, initial psychiatric diagnosis, and CCI score added to 
the models. However, when initially run, the CCI score caused Hessian matrix singularity 
due to the low number of participants with a CCI score. Therefore, this variable was 
removed from all models and the models were re-fit to include only age, gender, and 
initial psychiatric diagnosis in the second step of the model (Laerd Statistics, 2015c). 
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Summary: Research Question 1 - Physical Health Service Utilization  
RQ1 was: What is the predictive relationship, if any, between IHC enrollment and 
overall physical health utilization for consumers with SMI when controlling for 
demographic characteristics and disease severity? According to the Wilcoxon signed-
rank tests for the first research question, there were statistically significant median 
increases in physical health inpatient admissions, inpatient days, and ED visits following 
the index date compared to before. Results from the logistic regression models indicated 
that IHC enrollment alone was a statistically significant predictor of the odds of 
participants experiencing any inpatient admission and ED visit. When age, gender, 
psychiatric diagnosis and CCI score were added to the models, they remained good 
predictors; however, not all inputs into the models individually statistically significantly 
predicted the odds of experiencing utilization; therefore, the null hypotheses were 
retained in favor of the alternative hypothesis for both models.  
For the multiple linear regression models assessing physical health inpatient 
admissions, inpatient days, and ED visits, the models were good fits but not 
representative due to small R2 values. Therefore, no conclusive decisions could be made 
about the null hypotheses. Results of the Poisson regression models were mixed. The 
models for inpatient admissions and ED visits were predictive, with small increases in 
utilization occurring following the index date (IHC enrollment). The models remained 
significant after adding the covariates, with age and initial psychiatric diagnosis 
significantly predicting inpatient admissions, age, gender and initial psychiatric diagnosis 
significantly predicting inpatient days, and gender and initial psychiatric diagnosis 
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significantly predicting physical health ED visits. Since not all of the covariates were 
statistically significantly predictive, the null hypotheses were retained. The Poisson 
regression model for inpatient days was statistically significant, per the omnibus test, and 
all variables significantly predicted inpatient days; therefore the null hypothesis was 
rejected in favor of the alternative hypothesis. 
Summary: Research Question 2 - ACS-Specific Service Utilization  
RQ2 was: What is the predictive relationship, if any, between IHC enrollment and 
ACS-specific utilization for consumers with SMI when controlling for demographic 
characteristics and disease severity? According to results of the Wilcoxon signed-rank 
tests for the second research question, there were no statistically significant median 
differences in ACS-specific inpatient admissions or days following IHC enrollment, but 
there was a statistically significant median difference in ACS-specific ED visits. The 
logistic regression models for ACS-specific inpatient admissions and ED visits were not 
good predictors of the odds of utilization, and none of the inputs into the model 
individually statistically significantly predicted the odds of ACS-specific inpatient 
admission or ED visits; therefore, the null hypotheses were retained.  
Although the multiple linear regression models for ACS-specific inpatient 
admissions and days were statistically significant, the assumptions of linearity and 
normality violated and the models did not generalize well as evidenced by low R² values. 
Therefore, no conclusive decisions were made about the null hypotheses. The multiple 
linear regression for ACS-specific ED visits was not statistically significant, and 
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therefore the null hypothesis was retained. Due to the scarcity of ACS-specific utilization, 
no model statistics were produced for the Poisson regression analyses. 
Summary: Additional Analyses   
I ran post hoc analyses for all-cause and mental health inpatient and ED 
utilization, using the same methods as in the key research questions. As with the previous 
variables, there was low pre-index utilization for all variables with the exception of 
mental health inpatient days. Pre-index mental health days were greater than post-index 
mental health days. For all other service categories, post-index utilization exceeded pre-
index utilization. There were statistically significant median increases in all-cause 
inpatient admissions, days, and ED visits following IHC enrollment compared to before 
IHC enrollment. 
IHC enrollment alone was a statistically significant predictor of experiencing an 
all-cause inpatient admission or ED visit in the logistic regression analyses. When 
covariates were added to the models, although the models were good predictors of the 
independent variables, not all inputs into the models individually statistically 
significantly predicted utilization; therefore, the null hypotheses was upheld in favor of 
the alternative hypotheses for both all-cause utilization models. Although the multiple 
linear regression models were good fits for the all-cause utilization data, these models 
accounted for less than 5.0% of variance in the all-cause utilization variables as 
evidenced by low R2 values and no conclusive decisions were made about the null 
hypotheses. Poisson regression model results indicated that following IHC enrollment, 
statistically significant (although small) increases were seen in inpatient admissions, 
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days, and ED visits. When covariates were added to the models, they remained 
significant, but not all covariates were statistically significant predictors so the null 
hypotheses were retained. Additionally, the model for all-cause inpatient days had a high 
degree of overdispersion.  
There were also statistically significant median increases in mental health 
inpatient admissions and ED visits following IHC enrollment, as evidenced Wilcoxon 
signed-rank tests, and a statistically significant decrease in mental health inpatient days 
following IHC enrollment. IHC enrollment alone was a statistically significant predictor 
of experiencing both a mental health inpatient admission and an ED visit in the logistic 
regression models. When covariates were added to the models they remained good 
predictors, but not all inputs into the models individually statistically significantly 
predicted the odds of utilization; therefore, the null hypotheses were upheld in favor of 
the alternative hypotheses for both models. The multiple linear regression models for 
mental health utilization were good fits, but were not representative due to R2 values of 
less than 5.0%, and therefore no conclusive decision were made about the null 
hypotheses. Finally, in the Poisson regression models, that IHC enrollment predicted an 
increase in mental health admissions and ED visits and a decrease in inpatient days. 
Following IHC enrollment, small but statistically significant increases were observed in 
inpatient admissions and ED visits, while a small but statistically significant decrease was 
seen in mental health inpatient days. When covariates were added to the models, they 
remained significant, but again, not all of the covariates were independent predictors, and 
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the model for mental health inpatient days had a high degree of overdispersion. As a 
result, the null hypotheses were retained for all three models. 
Chapter 5 provides an interpretation of these findings, including a comparison 
with what has been found in peer-reviewed literature and the theoretical framework. I 
discuss limitations of the study in detail, as well as recommendations for future research. 
Finally, social change implications are explored. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
This quantitative retrospective cohort design study evaluated the effect of an 
integrated physical health clinic (IHC) within a large community mental health center 
(CMHC). The research questions focused on the relationship between IHC enrollment 
and physical health and ambulatory care sensitive (ACS)-specific service utilization for 
consumers with serious mental illness (SMI) when controlling for demographic 
characteristics and disease severity. Despite expectations, IHC enrollment did not have a 
significant predictive relationship with inpatient or emergency department (ED) 
utilization for physical health or ACS-specific conditions. As assessed in post-hoc 
analyses, IHC enrollment also did not have a significant predictive relationship with all-
cause or mental health utilization. This chapter presents a summary of the analyses, 
interpretation of the findings, limitations of the findings, and implications for future 
research. 
The sample included 370 participants who met enrollment criteria; the number 
was adequate given the study methodology. There were few physical health or ACS-
specific inpatient admissions or ED visits in the study sample, an unexpected finding. 
Physical health utilization was defined by the presence of an International Classification 
of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) code for a physical health 
diagnosis on the authorization. Of the 370 participants meeting study criteria (six months 
of data pre- and post index date [defined as the first IHC visit] and insured by 
AmeriGroup or UnitedHealth), 149 participants had an inpatient or ED visit for any 
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reason pre- or post-IHC enrollment. Of these 149 participants, 132 (40.2%) had at least 
one physical health inpatient or ED visit in the sampling timeframe, with higher rates of 
utilization following IHC enrollment. Since the data were skewed, results proved 
inconclusive. Results for each of the research questions are summarized below. 
The first research question assessed the relationship between physical health 
service utilization and enrollment in the IHC, and was: What is the predictive 
relationship, if any, between IHC enrollment and overall physical health utilization for 
consumers with SMI when controlling for demographic characteristics and disease 
severity? There were statistically significant median increases in physical health inpatient 
admissions, inpatient days, and ED visits following IHC enrollment, as evidenced by 
Wilcoxon signed-rank tests. IHC enrollment was the best predictor of inpatient 
admissions and ED visits in the logistic regression models, but the models failed to 
remain good predictors of utilization following addition of covariates and the null 
hypotheses were retained for all three models. Multiple linear regression models 
assessing physical health inpatient admissions and days were statistically significant, but 
R2 values were small and no conclusions were made about the null hypotheses. The 
model assessing physical health ED visits was not a good fit and the null hypothesis was 
retained. The Poisson regression models for physical health inpatient admissions and ED 
visits were predictive, with small increases in utilization occurring following IHC 
enrollment. The models remained significant after adding the covariates, but not all of the 
covariates were statistically significantly predictive, and the null hypotheses were 
retained. The Poisson regression model for physical health inpatient days was statistically 
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significant, per the omnibus test, and all variables significantly predicted inpatient days; 
therefore the null hypothesis was rejected in favor of the alternative hypothesis. 
The second research question assessed the impact of IHC enrollment on ACS-
specific utilization, and was stated as: What is the predictive relationship, if any, between 
IHC enrollment and ACS-specific utilization for consumers with SMI when controlling 
for demographic characteristics and disease severity? ACS conditions were defined as 
conditions that could have been treated in an outpatient setting if appropriate access were 
available, and included asthma, chronic obstructive pulmonary disease, congestive heart 
failure, diabetes, and hypertension (Anderson & Knickman, 2001). There were no 
statistically significant median differences in ACS-specific inpatient admissions or days 
following IHC enrollment, but there was a statistically significant median increase in 
ACS-specific ED visits. The logistic regression models for ACS-specific inpatient 
admissions and ED visits were not good predictors of the odds of utilization, and not all 
of the inputs into the model individually statistically significantly predicted the odds of 
ACS-specific inpatient admission or ED visits; therefore, the null hypotheses were 
retained. Although the multiple linear regression models for ACS-specific inpatient 
admissions and days were statistically significant, the assumptions of linearity and 
normality violated and the models did not generalize well as evidenced by low R² values. 
Therefore, no conclusive decisions were made about the null hypotheses. The multiple 
linear regression for ACS-specific ED visits was not statistically significant, and 
therefore the null hypothesis was retained. Poisson regression analyses were not run due 
to the low amount of ACS-specific utilization in the sample. 
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Additional analyses mirroring the methodology used for the above two research 
questions were run for all-cause and mental health inpatient and ED utilization. There 
were statistically significant median increases in all-cause utilization following IHC 
enrollment. IHC enrollment alone was a statistically significant predictor of all-cause 
inpatient admissions and ED visits in the logistic regression models, but not all inputs 
into the models individually statistically significantly predicted utilization and the null 
hypotheses were retained. Multiple linear regression models for all-cause inpatient 
admissions, inpatient days, and ED visits significantly fit the data; however, the R2 values 
accounted for less than 5.0% of variance in each model and no conclusive decisions were 
made about the null hypotheses. In the Poisson regression models, there was a 
statistically significant relationship between IHC enrollment and inpatient admissions, 
days, and ED visits. However, the model for all-cause inpatient days had a high degree of 
overdispersion, and not all covariates were statistically significant predictors, so the null 
hypotheses were retained for these models.  
There were statistically significant median increases in mental health inpatient 
admissions and ED visits, and a statistically significant median decrease in mental health 
inpatient days following IHC enrollment. IHC enrollment alone was a statistically 
significant predictor of both mental health inpatient admissions and ED visits in the 
logistic regression models, but after adding other covariates, not all inputs into the 
models individually statistically significantly predicted utilization. As such, the null 
hypotheses were retained for both models. The multiple linear regression models for 
mental health utilization significantly fit the data, but were not representative as 
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evidenced by small R2 values and no conclusive decisions were made about the null 
hypotheses. IHC enrollment predicted decreases in mental health admissions and ED 
visits and an increase in inpatient days. The models remained significant following 
addition of the covariates but not all covariates were independent predictors of utilization 
and the null hypotheses were retained. 
Interpretation of Findings 
The sample in this study had much lower levels of physical health utilization than 
would have been expected. Prior research has shown increased inpatient and ED 
utilization and costs among the SMI population (Gerrity, 2015). For example, authors of 
a study of Medicaid claims data from Massachusetts found that comorbid physical illness 
was common among consumers with SMI. In that study, 74% of consumers with SMI 
had at least one chronic medical condition, while half were diagnosed with two or more 
and 50% of the sample was treated for a physical health comorbidity (Jones et al., 2004). 
Data for hospital admissions and readmissions in 2012 from the Agency for Healthcare 
Research and Quality (AHRQ) indicated that consumers with mood disorders 
experienced 269.8 inpatient admissions per 100,000 while consumers with schizophrenia 
experienced 121.9 per 100,000 population with average lengths of stay of 6.6 and 10.4 
days, respectively (Heslin & Weiss, 2015). In a commercially-insured population with 
schizophrenia, inpatient admissions were found to occur at a rate of 636 admissions per 
1,000 population and ED visits occurred at a rate of 2,240 visits per 1,000 population. 
While the majority of inpatient admissions were for psychiatric conditions, 67% of the 
ED visits were for non-psychiatric conditions (Fitch, Iwasaki, & Villa, 2014). Authors of 
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another study using data from two EDs found that there was a mean of 2.3 ED visits per 
year among consumers with psychiatric conditions, and 6.4 among the population with 
co-occurring psychiatric conditions and alcohol abuse (Minassian, Vilke, & Wilson, 
2013). However, in this study, mean visits in both the pre- and postenrollment timeframes 
were less than one.  
Several reasons may explain why there were fewer inpatient or ED visits among 
the sample in this study than expected. First, consumers may have switched health plans 
from their index health plan (either AmeriGroup or UnitedHealth) to a health insurer that 
did not provide authorization data back to the CMHC. Inpatient admissions and ED visits 
would not have been captured for the new health plan, as only AmeriGroup and 
UnitedHealth shared authorization data with the CMHC; however consumers were 
chosen for the study based on their index health plan. A second possibility concerns the 
psychiatric care given by the CMHC. The CMHC that provided data for this study was in 
the process of becoming a federally qualified health center (FQHC) for the SMI 
population that they serve, and therefore had many innovative programs underway to 
reduce admissions. Physical health utilization may have been impacted by one of these 
other programs, resulting in lower levels of utilization than what would be expected 
among the SMI population at large (CMHC Chief Information Officer, Personal 
communication, July 19, 2016). Intensive psychiatric case management, including 
Assertive Community Treatment (ACT) has been associated with a reduction in 
hospitalization regardless of physical healthcare provided (Gerrity, 2016). Third, some of 
the participants may have been seeking physical healthcare from other providers outside 
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of the CMHC/IHC setting resulting in lowered physical health inpatient and ED care. 
Those visits would not have been captured in the data available for this study.  
The lack of ACS-specific utilization in this study was particularly surprising. 
Increased ACS-specific utilization among populations of consumers with mental illness 
has been shown in prior research. Authors of a study of Maryland Medicaid data found 
that mental illness was associated with 32% higher odds of experiencing an ACS-specific 
hospital admission among adults aged 18-64, as well as among children and older adults 
(McGinty & Sridhara, 2014). These findings confirmed the findings from two previous 
studies in the SMI population regarding the prevalence of ACS-specific conditions in 
mental illness (Cahoon, McGinty, Ford, & Daumit, 2013; Li, Glance, Cai, & Mukamel, 
2008). I found very little ACS-specific utilization, with just two inpatient admissions and 
two ED visits in the sample during the one year study timeframe. Although the same 
ICD-9-CM codes were used to identify ACS-specific utilization as in prior research, 
authors of the prior studies used administrative claims data with primary and secondary 
diagnoses codes as the basis for analysis (Cahoon et al., 2013; Li et al., 2008; McGinty & 
Sridhara, 2014). I relied on ICD-9-CM codes on authorization data provided to the 
CMHC from two health plans, and there was only one code (the primary diagnosis code) 
per authorization. It is possible that the codes were incorrect, or that an ACS-specific 
condition was not the primary complaint and therefore not captured in the data available 
to me.  
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IHC Impact on Utilization 
I found no statistically significant impact of IHC enrollment on inpatient or ED 
utilization. Findings from previous research have varied regarding the ability of 
integrated care to impact utilization measures. Authors of a recent randomized study 
assessed a physical health program within a behavioral health home CMHC, with care 
provided by a nurse practitioner and some level of coordination and consultation with the 
mental health treatment teams (Druss et al., 2016). This level of care coordination was 
similar to that provided within the CMHC that I studied. In that study, 447 consumers 
with SMI were randomized to either the health home or usual care. Similarly to results of 
the current study, enrollment in the behavioral health home was not associated with 
differences in inpatient or ED utilization but was associated with improvement in some 
measures related to quality of care (Druss et al., 2016). Similarly, authors of a meta-
analysis assessing randomized controlled trials of integrated care programs found an 
increase in the use of outpatient services and improved quality of life associated with 
integrated care while findings were mixed in relation to inpatient service utilization and 
cost (Gerrity, 2015).  
In this study, there were statistically significant median increases in both physical 
health and ACS-specific ED visits following IHC enrollment, but results from the 
modeling were mixed regarding a predictive relationship to IHC enrollment. In the 
logistic regression models, the null hypotheses were retained, indicating no statistically 
significant predictive relationship between IHC enrollment and physical health or ACS-
specific ED visits. No specific conclusions could be drawn from the multiple regression 
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models. These trends held true for all-cause and mental health ED visits as well. Through 
this study, I confirmed findings from two studies within the Veteran’s Health 
Administration (VHA) that collocated care did not impact ED utilization. In the first 
study, collocated care within a behavioral health VHA clinic was associated with 
significantly increased outpatient visits following enrollment but no significant 
differences in ED service utilization were found (Pirraglia et al., 2012). Authors of a 
second cohort study within the VHA system assessed the association of patient-aligned 
care teams (PACT) and utilization of healthcare services by veterans with posttraumatic 
stress disorder (PTSD; Randall, Mohr, & Maynard, 2014). In that study, PACT was 
associated with a reduction of inpatient admissions and specialty services but not with 
changes in mental health visits, ED visits, or urgent care visits (Randall et al., 2014).  
Theoretical Context 
I used the Chronic Care Model (CCM) as the theoretical foundation of this study. 
Several key aspects of the CCM informed the concepts supporting this study assessing 
integration of physical healthcare into behavioral health settings for consumers with SMI 
(Woltmann et al., 2012). Specifically, aspects of CCM related to redesigning healthcare 
delivery systems and improving clinical information systems aligned with the concept of 
integrated physical and behavioral healthcare (McLellan et al., 2014). These aspects of 
CCM also related to the concepts of Level 5 and 6 integrated care as described by Heath 
and colleagues (2013). Level 5 care included development and implementation of 
collaborative treatment planning between collocated physical and behavioral healthcare 
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providers while Level 6 care referred to collaborative treatment planning for all 
consumers including fully integrated information systems (Heath et al., 2013).  
In my study, there was no indication that outcomes were improved due to a 
realignment of the healthcare system within the CMHC, although behavioral and physical 
healthcare were provided in a collocated manner. One explanation for these findings may 
be explained by the disparate data systems used for this study. Two different electronic 
medical record (EMR) systems were employed by the CMHC, one for the mental health 
clinic and one for the IHC. Furthermore, while the CMHC received authorizations for 
inpatient and ED utilization from two of the three health plans, the authorization data 
were received in Excel format each day, and did not integrate with either of the CMHC’s 
EMR systems. Therefore, the information systems were not fully integrated and may 
have impacted the ability of the providers at the CMHC to adequately monitor 
consumers’ health.  
The CCM also pointed to the need for collaboration among healthcare 
professionals to adequately care for patients, treating the person as a whole rather than 
each condition in isolation (Rush, 2014). Therefore, theorists have hypothesized that 
improved outcomes may result from relationships between motivated patients and 
treatment teams who treat proactively (Barr et al., 2003). This study did not assess the 
motivation levels of consumers in the CMHC, nor did it assess the specific kinds of 
treatment provided by either the mental health practitioners or the IHC.  
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Limitations of the Findings 
The primary limitation of the study was associated with the data sources used and 
the scarcity of utilization data among the sample. First, the study used secondary data to 
assess whether IHC enrollment was associated with physical health inpatient and ED 
service utilization. There may have been other important indicators of IHC success or 
confounding variables not accounted for that were not available for analysis in this study. 
However, use of administrative data for this study may allow other researchers to more 
closely replicate the methodology in assessing the success of other integrated care 
programs (Frankfort-Nachmias & Nachmias, 2008). Second, I assessed inpatient and ED 
utilization from authorization data sent to the CMHC by two health plans. These data 
were provided to the CMHC to help providers better manage its consumers, and not for 
research purposes. Other administrative data may have contained better information, such 
as administrative claims that typically include more ICD-9-CM codes for each claim. The 
authorization data files were limited to one primary code only. Further, other payers 
covering consumers of the CMHC did not provide authorization data to the CMHC and 
there may have been differences in service utilization between members enrolled in the 
two health plans sending data compared with those that did not. Moreover, the sharing of 
real-time authorization data between a health plan and a CMHC may be atypical and 
therefore may limit the ability of other researchers to reproduce the exact methodology 
used in the current study. 
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Recommendations 
I used a pre- post design to assess change in utilization before and after 
enrollment in an integrated physical health program. As mentioned above, selection bias 
limited generalizability of the findings as there were likely differences between the 
consumers enrolling in the IHC and those not enrolling (Frankfort-Nachmias & 
Nachmias, 2008). A comparison of consumers enrolling in integrated care programs and 
those not enrolling may be a more useful comparison for future research. Exploring the 
differences in consumers receiving care in integrated care models and those not, 
including the effect of those differences on service utilization may provide important 
insights for integrated care providers and policy makers. 
Researchers should also continue to assess integrated healthcare within 
community behavioral health settings since the majority of consumers with SMI utilize 
behavioral health clinics as their primary sources of medical care (Manderscheid & 
Kathol, 2014). The majority of evidence about these programs to date has come from the 
VHA, and findings have been mixed in terms of improvement in outcomes and resource 
utilization (Druss, Rohrbaugh, et al., 2001b; Kilbourne et al., 2009; Kilbourne et al., 
2011). However, the VHA system serves a selected group of consumers who may not be 
reflective of the general United States population in terms of demographic characteristics 
including gender, race, or age (Goulet et al., 2007; Pirraglia et al., 2012). Authors of a 
meta-analysis of studies of integrated care interventions in various settings among 
consumers with SMI found low to medium levels of evidence supporting these 
interventions (McGinty et al., 2016), and this study did not produce findings that were 
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reliable enough to form any solid conclusions due to low levels of utilization in the study 
sample. Since no two clinics are alike, research should continue on the effectiveness of 
integrated care programs within community behavioral health settings to determine the 
true extent of integrated care on service utilization, especially as recent health policy has 
focused on integrated care as a new treatment model (Barry & Huskamp, 2011; Druss & 
Mauer, 2010; SAMHSA, 2014).  
The lack of ACS-specific data in this study made drawing conclusions about the 
impact of IHC enrollment on utilization difficult. Results from past research indicated 
that collocated care might positively impact ACS-specific utilization. Pirragalia and 
colleagues (2011) found that fewer consumers within the VHA system at sites with 
collocated medical care had hospitalizations for ACS-specific conditions compared to 
consumers at other VHA sites (4.3% vs. 5.1%, respectively, p = 0.004; Pirraglia et al., 
2011). Future research on the ability of integrated care programs within the community to 
reduce ACS-specific care would be beneficial, since the VHA system is not 
representative of community care. 
Future research assessing the relationship between the number of visits with an 
integrated care provider and physical health utilization may be useful as well. I did not 
include an analysis of the number of postenrollment  IHC visits on service utilization. 
However, the regular receipt of outpatient primary care may be as important for 
consumer health as a reduction in inpatient and ED use. Researchers of earlier studies 
have suggested a relationship between suboptimal access to primary care and an increase 
in ED use between 1997and 2007 among Medicaid beneficiaries (Tang et al., 2010). 
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Increased ED use has also been associated with lack of regular general practitioner visits 
after controlling for demographic characteristics (McCusker et al., 2010).  
In addition to assessing the impact of integrated care on inpatient and ED service 
use, future researchers may also wish to incorporate outpatient and preventive care as 
study endpoints. I did not assess these categories of service utilization in the current 
study, as these data were not available to me. Authors of earlier studies found link 
between integrated care programs and increased use of outpatient services, certain 
physical health screening measures, and improved quality of life but little impact on 
higher levels of service utilization (Druss et al., 2016; Gerrity, 2015). While high-
intensity service utilization such as inpatient admissions and ED visits may be more 
important to payer cost-reduction efforts, increased outpatient care and achievement of 
health goals may be of greater importance to clinicians and patients. Aligning study 
outcomes with different stakeholder groups’ interests may add to the overall level of 
evidence for integrated care. 
Lastly, as mentioned above, this study did not assess several important aspects of 
integrated care as related to the CCM, including motivation levels of consumers or 
intensity of treatment provided by either the mental health or physical health 
practitioners. Future researchers should take these aspects into consideration when 
assessing the impact of integrated care programs. Furthermore, it is important for 
consumers with SMI to have both a behavioral health provider and a physical health 
provider who consult with one another regarding care (Druss, Rohrbaugh, et al., 2001; 
Manderscheid & Kathol, 2014). I did not assess the level of consultation or collaboration 
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between the behavioral health and IHC staff regarding patient care as this information 
was not available in the data sets provided. In the future, researchers should assess the 
level of collaboration, since this is an important aspect in the success of integrated care 
programs as indicated by earlier research (Gerrity, 2015). 
Implications 
Despite the limitations of this study, findings may help inform the data partner 
CMHC in some important ways. There was no evidence that IHC enrollment was 
statistically significantly predictive of physical health service utilization. However, 
inpatient and ED service utilization in this study was lower than would have been 
expected based on prior epidemiologic studies. The fact that there was very little inpatient 
or ED utilization, either prior to or following IHC enrollment, may indicate that the 
services provided by the CMHC as a whole are effective in managing the health of 
consumers. The CMHC was applying to become a certified FQHC. This designation 
means that the CMHC would need to provide comprehensive services to underserved 
populations, and as such would qualify for enhanced funding from Medicare and 
Medicaid (United States Department of Health and Human Services, n.d.). Researchers 
have shown an association between FQHCs and fewer inpatient admissions and ED visits 
for ACS-specific conditions in a dual-eligible population (Wright, Potter, & Trivedi, 
2015). Leaders at the CMHC may choose to further investigate the numbers of inpatient 
and ED visits among their consumers in comparison to regional or national FQHCs and 
conduct an assessment of the total package of care provided to determine the impact on 
consumers.   
  
 
133 
The lack of data available for this study may also point to an opportunity for 
improvement within the CMHC related to information management systems and the 
ability to adequately assess consumer outcomes. First, the IHC and mental health clinic 
used separate, nonintegrated EMR systems. Fully integrated Level 6 care involves fully 
integrated systems as well as close collaboration between physical and mental healthcare 
providers (Heath et al., 2013). Fully integrated systems may help reduce barriers and 
improve communication among providers (Grol, Wensing, Bosch, Hulscher, & Eccles, 
2013; Malm, Ivarsson, & Allebeck, 2014; Pincus et al., 2015). Administrators within the 
CMHC may want to consider better alignment of care through use of a single EMR 
system for both mental and physical health management.  
A second data issue had to do with underutilization of the IHC EMR. The IHC 
EMR contained fields to record results of physical health screenings such as cholesterol, 
hemoglobin A1c, and lipid tests; however these fields were not used and no results were 
recorded. Therefore, progress toward clinical goals could not be tracked over time as an 
outcome of this study, or by care teams at the CMHC in routine care monitoring of 
consumers. Assessing barriers to appropriate use of the IHC EMR may help improve 
future monitoring of the physical health of consumers at the CMHC and provide other 
ways to measure the impact of the IHC apart from resource utilization. 
I had hoped that this study would add to the growing body of evidence supporting 
integrated care models. Quality of care for consumers with SMI has been a focus of 
recent health policies and financing structures/grant programs for integrated care pilots 
(Barry & Huskamp, 2011; Druss & Mauer, 2010; SAMHSA, 2014). Additionally, the 
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Center for Medicare and Medicaid Services (CMS) and other payers are moving toward 
quality-based reimbursement rather than quantity-based reimbursement. Given these 
changes in the healthcare landscape, an understanding of the impact of integrated care 
programs on high-cost service utilization and quality of care to support policy and 
financing are necessary (Burwell, 2015). Unfortunately data issues limited the 
conclusiveness of the findings of this study and its ability to inform the debate on 
integrated care in either a positive or negative way.  
Conclusions 
In this study, I evaluated the effect of an integrated physical health program 
within a community behavioral health setting on physical health inpatient admissions and 
ED visits. Contrary to expectation, IHC enrollment did not have a significant predictive 
relationship with inpatient or ED utilization. While the sample size was adequate, there 
were fewer physical health or ACS-specific inpatient admissions or ED visits than would 
have been expected based on prior research. Since the data were skewed, results were 
tenuous and inconclusive. A meta-analysis of interventions for medical conditions among 
consumers with SMI found low to medium levels of evidence supporting these 
interventions, and called for further research on implementation strategies in real-world 
settings (McGinty et al., 2016). Although I had hoped that findings from the current study 
would help fill this need, it has added to the conflicting findings supporting the use of 
integrated care models on service utilization. Nevertheless, policy and payment structures 
continue to support integrated care models, and therefore further research of different 
programs are encouraged, as each setting and practice pattern is unique. Identifying those 
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settings and programs that improve outcomes, including reductions in high-cost service 
utilization, increased routine care, and better health will add to the growing body of 
evidence to build effective models of integrated care. 
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Appendix A: Business Associate Agreement (Redacted) 
Health information privacy addendum 
This Addendum is made as of May 18, 2015, by and between [REDACTED] (“Covered 
Entity”) and HEIDI WATERS (“Business Associate”). 
RECITALS: 
A. Business Associate and Covered Entity have entered into an agreement or 
agreements pursuant to which Business Associate provides certain services to Covered 
Entity.  Such agreement or agreements are collectively referred to herein as the 
“Agreement.” 
B. To enable Business Associate to carry out its obligations under the Agreement, 
Business Associate may, on the terms set forth herein, create, receive, maintain, or 
transmit from or on behalf of Covered Entity, Individually Identifiable Health 
Information, as such term is defined in 45 C.F.R. § 160.103.   
C. Pursuant to 45 C.F.R. Part C (the “Security Rule”) and 45 C.F.R. Part E (the 
“Privacy Rule”) Covered Entity is required to enter into a contract with Business 
Associate to ensure that Business Associate appropriately safeguards such information. 
D. Covered Entity and Business Associate desire to make this Addendum to the 
Agreement in order to enable Covered Entity to satisfy its obligations under the Security 
Rule and the Privacy Rule. 
NOW, THEREFORE, for and in consideration of the mutual promises herein contained 
and other good and valuable consideration, the receipt and sufficiency of which are 
hereby acknowledged, the parties hereto agree as follows: 
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Definitions. 
“Individual” shall have the same meaning as the term "individual" in 45 C.F.R. § 160.103 
and shall include a person who qualifies as a personal representative in accordance with 
45 C.F.R. § 164.502(g). 
"Protected Health Information" shall have the same meaning as the term "protected health 
information" in 45 C.F.R. § 160.103, limited to the information created, received, 
maintained, or transmitted by Business Associate from or on behalf of Covered Entity. 
“Representatives” means Business Associate’s directors, officers, employees, 
subcontractors and agents. 
Terms used in this Addendum and not otherwise defined herein shall have the same 
meaning of those terms as they are used in the Security Rule, the Privacy Rule, and the 
Breach Notification Rule (as defined herein). 
Obligations and Activities of Business Associate 
Confidentiality. Business Associate agrees to not use or disclose, and to prevent its 
Representatives from using or disclosing, Protected Health Information other than as 
permitted or required by this Addendum or as Required By Law. 
Safeguards. Business Associate agrees to use appropriate safeguards to prevent use or 
disclosure of the Protected Health Information other than as provided for by this 
Addendum. 
Mitigation.  Business Associate agrees to mitigate, to the extent practicable, any harmful 
effect that is known to Business Associate of a use or disclosure of Protected Health 
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Information by Business Associate or its Representatives in violation of the requirements 
of this Addendum.  
Reporting. Business Associate agrees to promptly report to Covered Entity’s Privacy 
Officer any use or disclosure of the Protected Health Information not provided for by this 
Addendum or by an agreement required by Section 0 of this Addendum of which it 
becomes aware, including any breach of Unsecured Protected Health Information as 
required by 45 C.F.R. § 164.410. 
Agents and Subcontractors. Business Associate agrees to ensure that any agent, including 
without limitation a subcontractor, that creates, receives, maintains, or transmits 
Protected Health Information on behalf of Business Associate agrees to the same 
restrictions and conditions that apply through this Addendum to Business Associate with 
respect to such information, pursuant to and in accordance with a written contract, as 
required by 45 C.F.R. § 502(e)(2). 
 Access and Amendment. Business Associate agrees to provide access, at the request of 
Covered Entity, and in the time and manner reasonably designated by Covered Entity, to 
Protected Health Information in a Designated Record Set, to Covered Entity in order to 
meet the requirements under 45 C.F.R. § 164.524.  Business Associate agrees to make 
any amendment(s) to Protected Health Information in a Designated Record Set that 
Covered Entity directs or agrees to pursuant to 45 C.F.R. § 164.526 at the request of 
Covered Entity and in the time and manner reasonably designated by Covered Entity.   
Books and Records. Business Associate agrees to make its internal practices, books, and 
records, including policies and procedures and Protected Health Information, relating to 
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the use and disclosure of Protected Health Information available to Covered Entity, or to 
the Secretary, in a time and manner reasonably requested by Covered Entity or 
designated by the Secretary, for purposes of the Secretary determining Covered Entity's 
compliance with the Privacy Rule.  If the Secretary requests such access, Business 
Associate shall promptly notify Covered Entity’s Privacy Officer and provide the Privacy 
Officer with a copy of such request.  Business Associate shall consult and cooperate with 
Covered Entity concerning the proper response to such request and shall provide Covered 
Entity with a copy of each book, document and record made available to the Secretary or 
shall identify each such book, document, and record and grant Covered Entity access 
thereto for review and copying.  Notwithstanding the foregoing, nothing in this section 
shall be deemed to require Business Associate to waive the attorney-client, accountant-
client, or other legal privilege, and nothing in this section shall impose upon Covered 
Entity any obligation to review Business Associate’s practices, books or records.  
Accounting. Business Associate agrees to document such disclosures of Protected Health 
Information and information related to such disclosures as would be required for Covered 
Entity to respond to a request by an Individual for an accounting of disclosures of 
Protected Health Information in accordance with 45 C.F.R. § 164.528.  Business 
Associate agrees to provide to Covered Entity, in a time and manner reasonably 
designated by Covered Entity, information collected in accordance with this section to 
permit Covered Entity to respond to a request by an Individual for an accounting of 
disclosures of Protected Health Information in accordance with 45 C.F.R. § 164.528.  
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Uses and Disclosures Required By Law. Except to the extent prohibited by law, Business 
Associate shall immediately notify Covered Entity’s Privacy Officer if it receives a 
request for disclosure of Protected Health Information with which Business Associate 
believes it is Required By Law to comply and disclosure pursuant to which would not 
otherwise be permitted by this Addendum.  Business Associate shall provide Covered 
Entity’s Privacy Officer with a copy of such request, shall consult and cooperate with 
Covered Entity concerning the proper response to such request, and shall provide 
Covered Entity with a copy of any information disclosed pursuant to such request. 
Electronic Protected Health Information. With regard to Electronic Protected Health 
Information, Business Associate shall: (i) comply with the applicable requirements of the 
Security Rule and  implement administrative, physical, and technical safeguards that 
reasonably and appropriately protect the confidentiality, integrity and availability of such 
information that Business Associate creates, receives, maintains or transmits on behalf of 
Covered Entity; (ii) ensure that any agent, including a subcontractor, that creates, 
receives, maintains, or transmits Electronic Protected Health Information on behalf of 
Business Associate agrees to comply with the applicable requirements of the Security 
Rule by entering into a contract or other arrangement that complies with 45 C.F.R. § 
164.314; and (iii) report to Covered Entity any Security Incident of which Business 
Associate becomes aware. Business Associate’s obligations under this section are in 
addition to its obligations under Section 0 of this Addendum.   
Standard Transactions. To the extent that, under the Agreement, Business Associate 
conducts on behalf of Covered Entity all or part of a Transaction (as defined in 45 C.F.R. 
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Parts 160 and 162 (the “Electronic Transactions Rule”)), Business Associate shall comply 
with, and shall cause any of its agents or subcontractors to comply with, the Electronic 
Transactions Rule.   
Permitted Uses and Disclosures of Protected Health Information by Business 
Associate 
Use or Disclosure to Provide Services Under the Agreement.  Except as otherwise limited 
in this Addendum, Business Associate may use or disclose Protected Health Information 
to perform functions, activities, or services for, or on behalf of, Covered Entity as 
specified in the applicable Agreement, provided that such use or disclosure would not 
violate the Privacy Rule if done by Covered Entity or the minimum necessary policies 
and procedures of Covered Entity.  To the extent Business Associate is to carry out any 
of Covered Entity’s obligations under the Privacy Rule pursuant to the terms of this 
Addendum, Business Associate shall comply with the requirements of the Privacy Rule 
that apply to Covered Entity in the performance of such obligation. 
Use or Disclosure for Business Associate’s Management and Administration.  Except as 
otherwise limited in this Addendum, Business Associate may use Protected Health 
Information for the proper management and administration of Business Associate or to 
carry out the legal responsibilities of Business Associate.  Except as otherwise limited in 
this Addendum, Business Associate may disclose Protected Health Information for the 
proper management and administration of Business Associate, provided that such 
disclosures are Required By Law, or Business Associate obtains reasonable assurances 
from the person to whom the information is disclosed that it will remain confidential and 
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used or further disclosed only as Required By Law or for the purpose for which it was 
disclosed to the person, and the person notifies the Business Associate of any instances of 
which it is aware in which the confidentiality of the information has been breached. 
Use or Disclosure to Provide Data Aggregation Services.  Except as otherwise limited in 
this Addendum and if authorized by the Agreement or with the written permission of 
Covered Entity, Business Associate may de-identify Protected Health Information or use 
Protected Health Information to provide Data Aggregation services to Covered Entity as 
permitted by 42 C.F.R. § 164.504(e)(2)(i)(B). 
Responsibilities of covered entity 
Notice of Privacy Practices.  Covered Entity shall notify Business Associate of any 
limitation(s) in the notice of privacy practices of Covered Entity in accordance with 45 
C.F.R. § 164.520, to the extent that such limitation may affect Business Associate's use or 
disclosure of Protected Health Information. 
Change or Revocation of Permission.  Covered Entity shall notify Business Associate of 
any changes in, or revocation of, permission by an Individual to use or disclose Protected 
Health Information, to the extent that such changes may affect Business Associate's use 
or disclosure of Protected Health Information. 
Restrictions on Use or Disclosure.  Covered Entity shall notify Business Associate of any 
restriction to the use or disclosure of Protected Health Information that Covered Entity 
has agreed to in accordance with 45 C.F.R. § 164.522, to the extent that such restriction 
may affect Business Associate's use or disclosure of Protected Health Information.  
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Permissible Requests.  Covered Entity shall not request Business Associate to use or 
disclose Protected Health Information in any manner that would not be permissible under 
this Addendum. 
Term and Termination 
Term.  The Term of this Addendum shall be effective as of the date on which the parties 
first entered into an Agreement, and shall expire when all of the Protected Health 
Information provided by Covered Entity to Business Associate, or created or received by 
Business Associate on behalf of Covered Entity, is destroyed or returned to Covered 
Entity, or, if it is infeasible to return or destroy Protected Health Information, protections 
are extended to such information, in accordance with the termination provisions in 
Section 0 of this Addendum.  
Termination.  If Covered Entity determines that Business Associate or any Representative 
of Business Associate has violated a material term of this Addendum, Covered Entity 
may either: (i) Provide an opportunity for Business Associate to cure the violation and 
terminate, without penalty, this Addendum and any Agreement if Business Associate 
does not cure the violation within the time specified by Covered Entity; (ii) Immediately 
terminate, without penalty, this Addendum and any Agreement if Business Associate has 
violated a material term of this Addendum; or (iii) If neither termination nor cure are 
feasible, Covered Entity may report the violation to the Secretary.  
Return or Destruction of Protected Health Information Upon Termination.  Except as 
provided below, upon termination for any reason of this Addendum, Business Associate 
shall return or destroy all Protected Health Information, including any Electronic 
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Protected Health Information. This provision shall apply to Protected Health Information 
that is in the possession of subcontractors or agents of Business Associate.  Business 
Associate shall retain no copies of the Protected Health Information.  In the event that 
Business Associate determines that returning or destroying the Protected Health 
Information is infeasible, Business Associate shall provide to Covered Entity notification 
of the conditions that make return or destruction infeasible. Business Associate shall 
extend the protections of this Addendum to such Protected Health Information and limit 
further uses and disclosures of such Protected Health Information to those purposes that 
make the return or destruction infeasible, for so long as Business Associate maintains 
such Protected Health Information.  
Notification of breach of Unsecured Protected Health Information 
Definitions.  Capitalized terms used in this Article VII and not otherwise defined herein 
have the meaning given to them in 45 C.F.R. Part 164, Subpart D (the "Breach 
Notification Rule"). 
Notification Following the Discovery of a Breach.  Business Associate shall notify 
Covered Entity without unreasonable delay in the event of a Breach or suspected Breach 
of Unsecured Protected Health Information created, received, maintained or transmitted 
by Business Associate or its agents or subcontractors.  In no event shall Business 
Associate notify Covered Entity later than ten (10) calendar days after its discovery of 
such a Breach or suspected Breach.  For the purpose of this Article VI, a Breach or 
suspected Breach is deemed to be discovered by Business Associate as provided in 45 
C.F.R. § 164.410. 
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Cooperation in Investigation.  Covered Entity and Business Associate shall cooperate 
reasonably with each other and with their respective employees, agents, consultants, 
advisors, legal counsel or other representatives in connection with any investigation by 
either of them of a Breach or suspected Breach of Unsecured Protected Health 
Information created, received, maintained or transmitted by Business Associate or its 
agents or subcontractors and shall furnish upon request to each other such further 
information as the other party may reasonably request to carry out such investigation. 
Assistance in Proceedings.  Business Associate will cooperate with Covered Entity and 
its counsel in the contest or defense of, and make available its personnel and provide any 
testimony and access to its books and records in connection with, any Proceeding 
involving or relating to a Breach or alleged Breach of Unsecured Protected Health 
Information created, received, maintained or transmitted by Business Associate or its 
agents or subcontractors.  For the purposes of this Section, a "Proceeding" means any 
action, arbitration, audit, hearing, investigation, litigation or suit (whether civil, criminal, 
administrative, judicial or investigative, whether formal or informal, whether public or 
private) commenced, brought, conducted or heard by or before, or otherwise involving, 
any governmental body or arbitrator. 
Reimbursement of Expenses.  Business Associate will reimburse Covered Entity for any 
expense reasonably incurred by Covered Entity in connection with the provision of 
notice, as required by 45 C.F.R. §§ 164.404, 164.406 or 164.408, of a Breach of 
Unsecured Protected Health Information created, received, maintained or transmitted by 
Business Associate or its agents or subcontractors. 
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Modifications to Comply with Standards 
In the event that additional standards are promulgated under the Health Insurance 
Portability and Accountability Act of 1996 or the Health Information Technology for 
Economic and Clinical Health Act, or any existing standards are amended, including 
without limitation the Privacy Rule, the Security Rule or the Breach Notification Rule, 
the parties agree to enter into a mutually acceptable amendment to this Addendum to 
enable Covered Entity to satisfy its obligations under such additional or amended 
standard(s). 
Miscellaneous 
Regulatory References.  Reference herein to any law, statute, rule or regulation (each a 
"Legal Requirement") means such Legal Requirement as amended, modified, codified, 
replaced or reenacted, in whole or in part, and in effect from time to time, including rules 
and regulations promulgated thereunder, and reference herein to any section or other 
provision of any Legal Requirement means that provision of such Legal Requirement 
from time to time in effect and constituting the substantive amendment, modification, 
replacement or reenactment of such section or other provision. 
Survival. The respective rights and obligations of the parties under Section 0, Article VI 
and Section 0 of this Addendum shall survive the termination of this Addendum.  The 
respective rights and obligations of Business Associate under Section 0 of this Addendum 
shall survive the termination or expiration of this Addendum for six (6) years from the 
date of the last disclosure of Protected Health Information by Business Associate for 
which Covered Entity is required to account under 45 C.F.R. § 164.528. 
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Ownership of Protected Health Information.  The parties agree and acknowledge that, as 
between Covered Entity and Business Associate, Covered Entity is the owner of the 
Protected Health Information. 
Injunctive Relief.  Business Associate understands and acknowledges that any use or 
disclosure of Protected Health Information in violation of this Addendum will cause 
Covered Entity irreparable harm, the amount of which may be difficult to ascertain, and 
therefore agrees that Covered Entity shall have the right to apply to a court of competent 
jurisdiction for specific performance and/or an order restraining and enjoining any such 
further use, disclosure or breach and for such other relief as Covered Entity shall deem 
appropriate.  Such right of Covered Entity is to be in addition to the remedies otherwise 
available to Covered Entity at law or in equity.  Business Associate expressly waives the 
defense that a remedy in damages will be adequate and further waives any requirement in 
an action for specific performance or injunction for the posting of a bond by Covered 
Entity.   
Limitation of Liability. Business Associate agrees that no provision of the Agreement 
purporting to limit Covered Entity’s remedies under any legal or equitable theory shall 
limit Covered Entity’s remedies with respect to a breach of this Addendum by Business 
Associate or its Representatives. 
Amendment.  This Addendum may be amended only by written agreement between the 
parties. 
Interpretation.  The headings of sections in this Addendum are for reference only and 
shall not affect the meaning of this Addendum.  Any ambiguity in this Addendum shall 
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be resolved to permit Covered Entity to comply with the Privacy Rule.  In the event that a 
provision of this Addendum conflicts with a provision of the Agreement, the provision of 
this Addendum shall control, except to the extent that the Agreement places additional 
restrictions on Business Associate’s use and disclosure of Protected Health Information.  
Otherwise, this Addendum shall be construed under, and in accordance with, the terms of 
the Agreement.  This Addendum shall be interpreted by and construed in accordance with 
the laws of the State of [REDACTED]. 
No Third Party Beneficiaries.  Nothing express or implied in this Addendum is intended 
to confer, nor shall anything herein confer, upon any person other than the parties and the 
respective successors and assigns of the parties any rights, remedies, obligations, or 
liabilities whatsoever. 
Replacement of Prior Addenda.  This Addendum shall replace and supersede any 
previously entered into Business Associate Agreement between the parties addressing the 
same subject matter. 
IN WITNESS WHEREOF, the parties hereto have executed this Addendum as of the day 
and year first written above. 
[REDACTED] 
 
By:  
Title:  
 
HEIDI WATERS 
 
By:  
Title:  
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Appendix B: Letter of Cooperation 
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Appendix C: Confidentiality Agreement 
CONFIDENTIALITY AGREEMENT 
Name of Signer:   Heidi C. Waters  
During the course of my activity in collecting data for this research: Evaluating the 
Impact of Integrated Care on Service Utilization in Serious Mental Illness, I will have 
access to information that is confidential and should not be disclosed. I acknowledge that 
the information must remain confidential, and that improper disclosure of confidential 
information can be damaging to the participant.  
By signing this Confidentiality Agreement I acknowledge and agree that: 
1. I will not disclose or discuss any confidential information with others, including 
friends or family. 
2. I will not in any way divulge, copy, release, sell, loan, alter or destroy any 
confidential information except as properly authorized. 
3. I will not discuss confidential information where others can overhear the 
conversation. I understand that it is not acceptable to discuss confidential information 
even if the participant’s name is not used. 
4. I will not make any unauthorized transmissions, inquiries, modification or purging of 
confidential information. 
5. I agree that my obligations under this agreement will continue after termination of 
the job that I will perform. 
6. I understand that violation of this agreement will have legal implications. 
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7. I will only access or use systems or devices I’m officially authorized to access and I 
will not demonstrate the operation or function of systems or devices to unauthorized 
individuals. 
 
Signing this document, I acknowledge that I have read the agreement and I agree to 
comply with all the terms and conditions stated above. 
________________________________ ________________________ 
Signature        Date 
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Appendix D: Data Use Agreement 
DATA USE AGREEMENT 
This Data Use Agreement (“Agreement”), effective as of Enter Date (“Effective 
Date”), is entered into by and between Heidi C. Waters (“Data Recipient”) and 
[REDACTED] (“Data Provider”).  The purpose of this Agreement is to provide Data 
Recipient with access to a Limited Data Set (“LDS”) for use in research in accord with 
laws and regulations of the governing bodies associated with the Data Provider, 
Data Recipient, and Data Recipient’s educational program. In the case of a 
discrepancy among laws, the agreement shall follow whichever law is more strict.   
Definitions.  Due to the study’s affiliation with Laureate, a USA-based company, unless 
otherwise specified in this Agreement, all capitalized terms used in this 
Agreement not otherwise defined have the meaning established for purposes of 
the USA “HIPAA Regulations” and/or “FERPA Regulations” codified in the 
United States Code of Federal Regulations, as amended from time to time. 
Preparation of the LDS.  Data Provider shall prepare and furnish to Data Recipient a LDS 
in accord with any applicable laws and regulations of the governing bodies 
associated with the Data Provider, Data Recipient, and Data Recipient’s 
educational program. 
Data Fields in the LDS.  No direct identifiers such as names may be included in the 
Limited Data Set (LDS). In preparing the LDS, Data Provider shall include the 
data fields specified as follows, which are the minimum necessary to accomplish 
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the research: list of clients served by the Data Provider including demographic 
information (date of birth, gender, primary diagnosis), inpatient authorization data 
(including authorization number, date of admission, date of discharge, facility, 
primary diagnosis upon admission), emergency department utilization files 
(including authorization number, date, facility, primary diagnosis for visit), list of 
clients enrolled in the Integrated Health Clinic (IHC). 
Responsibilities of Data Recipient.  Data Recipient agrees to: 
Use or disclose the LDS only as permitted by this Agreement or as required by law; 
Use appropriate safeguards to prevent use or disclosure of the LDS other than as 
permitted by this Agreement or required by law; 
Report to Data Provider any use or disclosure of the LDS of which it becomes aware that 
is not permitted by this Agreement or required by law; 
Require any of its subcontractors or agents that receive or have access to the LDS to 
agree to the same restrictions and conditions on the use and/or disclosure of the 
LDS that apply to Data Recipient under this Agreement; and 
Not use the information in the LDS to identify or contact the individuals who are data 
subjects.  
Permitted Uses and Disclosures of the LDS.  Data Recipient may use and/or disclose the 
LDS for its Research activities only.   
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Term and Termination. 
Term.  The term of this Agreement shall commence as of the Effective Date and shall 
continue for so long as Data Recipient retains the LDS, unless sooner terminated 
as set forth in this Agreement. 
Termination by Data Recipient.  Data Recipient may terminate this agreement at any time 
by notifying the Data Provider and returning or destroying the LDS.   
Termination by Data Provider.  Data Provider may terminate this agreement at any time 
by providing thirty (30) days prior written notice to Data Recipient.   
For Breach.  Data Provider shall provide written notice to Data Recipient within ten (10) 
days of any determination that Data Recipient has breached a material term of this 
Agreement.  Data Provider shall afford Data Recipient an opportunity to cure said 
alleged material breach upon mutually agreeable terms.  Failure to agree on 
mutually agreeable terms for cure within thirty (30) days shall be grounds for the 
immediate termination of this Agreement by Data Provider. 
Effect of Termination.  Sections 1, 4, 5, 6(e) and 7 of this Agreement shall survive any 
termination of this Agreement under subsections c or d.   
Miscellaneous. 
Change in Law.  The parties agree to negotiate in good faith to amend this Agreement to 
comport with changes in federal law that materially alter either or both parties’ 
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obligations under this Agreement.  Provided however, that if the parties are 
unable to agree to mutually acceptable amendment(s) by the compliance date of 
the change in applicable law or regulations, either Party may terminate this 
Agreement as provided in section 6. 
Construction of Terms.  The terms of this Agreement shall be construed to give effect to 
applicable federal interpretative guidance regarding the HIPAA Regulations. 
No Third Party Beneficiaries.  Nothing in this Agreement shall confer upon any person 
other than the parties and their respective successors or assigns, any rights, 
remedies, obligations, or liabilities whatsoever. 
Counterparts.  This Agreement may be executed in one or more counterparts, each of 
which shall be deemed an original, but all of which together shall constitute one 
and the same instrument. 
Headings.  The headings and other captions in this Agreement are for convenience and 
reference only and shall not be used in interpreting, construing or enforcing any of 
the provisions of this Agreement. 
IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be duly 
executed in its name and on its behalf. 
 
DATA PROVIDER  DATA RECIPIENT 
Signed:   
 
 
 Signed:   
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Print Name:  
 
 
  
Print Name:  
 
 
 
Print Title: 
 
 
  
Print Title: 
 
 
 
      
 
 
 
